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1. INTRODUCTION 
1.1. Peroxisome structure, functions and biogenesis 
1.1.1. Basic morphology of peroxisomes 
Peroxisomes (originally called microbodies) are cell organelles present in virtually every 
eukaryotic cell. Discovered in 1954 by Rhodin (Rhodin 1954) and originally regarded as the 
garbage pail of the cell, the organelle obtained its actual name after an hydrogen peroxide- 
based oxidation reaction was observed by De Duve and Baudhuin in 1969 (1). After this 
discovery, the morphological designation microbody was replaced by the more functional 
name peroxisome. Since then, the importance of peroxisomes for human health and 
development has been recognized, revealing this organelle as an active site of many vital 
metabolic biochemical reactions and as an essential part of the intermediate cell 
metabolism. 
Peroxisomes (0.1-1 µm in diameter in hepatocytes) have a single-limiting membrane 
enclosing a fine granular matrix and are devoid of DNA (2) (Figure: 1). They are highly 
dynamic organelles and their functions, number and shape depend on cell type, tissue and 
physiological conditions (3). 
 
Figure 1: Localization of peroxisomes in rat 
liver. 
A: Cytochemical localization of catalase in 
rat hepatic peroxisomes (4). Magnification 
x28,600. 
B: Immunocytochemical 
localization of catalase in rat liver using the 
protein A-gold technique (5). 
Magnification x72,000. PO: peroxisome. 
 
 
 
 
Currently, it is estimated that about 100 genes in humans encode for peroxisomal proteins 
(6–9). More than half of these proteins are metabolic enzymes (around 50 in mammalian 
peroxisomes), while 32 proteins called peroxins (PEX) interact with each other and are 
required for the biogenesis and maintenance of functional peroxisomes (2). The name 
peroxin was suggested by a unified nomenclature committee who numbered the proteins, 
with function in peroxisome biogenesis, according to their date of discovery independent of 
their intracellular localization (10). 
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1.1.2. Peroxisomal biogenesis 
1.1.2.1. Import of peroxisomal membrane proteins 
The current views on peroxisome biogenesis sustain that peroxisomes arise, under normal 
conditions, from pre-existing peroxisomes after undergoing growth and fission (11) with the 
subsequent import of matrix proteins. However, peroxisomes can also be formed by de 
novo synthesis from ER-associated membrane-segments as seen by the formation of the 
organelle in cells lacking peroxisomes (or defective for PEX3, PEX16, or PEX19) after the 
introduction of the defective gene (12,13). The peroxisomes originated from the ER are pre- 
mature peroxisomes and only become mature organelles after the post-translational import 
of peroxisomal membrane and matrix proteins (14). 
During the de novo synthesis of peroxisomes three peroxins PEX3, PEX16 and PEX19 were 
shown to be in charge of the post-translational import and assembly of peroxisomal 
membrane proteins (PMPs) into the peroxisomal envelop (15–18). In order to be recognized, 
PMPs contain a membrane targeting sequence mPTS (19, 20). 
In the membrane assembly process, PEX19 functions as both, a protein acceptor as well as 
chaperone, preventing the aggregation and degradation of PMPs (21, 22). In the class I 
pathway, PEX19 forms complexes in the cytosol with newly synthesized PMPs including 
PEX16 and transports them to the receptor PEX3, which serves as an anchoring site in the 
peroxisomal membrane (14, 21). In the class 2 pathway, PEX19 forms a complex with PEX3 and 
translocates it to its receptor, PEX16p (14). 
In the absence of any of the peroxins in charge of the membrane biogenesis, cells lack 
peroxisomes and no membrane remnants are found. Both pathways constitute the initial 
step essential for the formation of the peroxisomal protein import machinery. Only after the 
peroxisomal membrane is completely assembled, the import of matrix proteins into the 
peroxisome can be accomplished. 
 
1.1.2.2. Import of matrix proteins 
 
Peroxisomes neither contain DNA nor machineries for transcription/translation. Since all 
peroxisomal proteins are encoded by the nuclear genome, matrix proteins and PMPs must 
be imported postranslationally after being synthetized on free polyribosomes in the 
cytosol(23). Four consecutive steps constitute the process of peroxisomal matrix protein 
import: (1) targeting signal recognition by cytoplasmic receptors, (2) docking-complex 
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interaction, (3) cargo translocation and release, and (4) receptor release and its degradation 
or recycling (Figure: 2). 
 
Figure 2: Peroxisomal matrix protein import. A simplified scheme for matrix protein import into mammalian 
peroxisomes depicting the involved peroxins, indicated by their PEX number and their interactions, is shown. 
The peroxisomal matrix proteins (= cargo) in the cytoplasm are recognized via peroxisomal targeting 
sequences PTS1 and PTS2 by their correspondent receptors PEX5 and PEX7, whereby the import of PTS2  
matrix proteins is mediated by PEX7 bound to the long PEX5 isoform (1). The cargo-receptor complexes dock 
to PEX13/14 at the peroxisomal membrane (2). PEX14 and PEX5 interact to translocate the cargo across the 
peroxisomal membrane, followed by its release, involving the RING peroxins PEX2, 10, and 12. The cargo- 
receptors are recycled into the cytosol via an ubiquitination-dependent mechanism with the help of PEX6 and 
PEX1 anchored to the peroxisomal membrane by PEX26 (4). Adapted from (24). 
 
 
All four processes are mediated by a unique machinery of 33 peroxins (PEX), which is in 
charge of the import of folded and oligomerized (or cofactor-bound) proteins into the 
peroxisomal matrix (25). For their recognition and correct targeting, peroxisomal matrix 
proteins contain a specific targeting sequence. This is either a peroxisomal targeting signal 1 
(PTS1) or 2 (PTS2). PTS1 consists of a C-terminal tripeptide ending with serine-lysine-leucine 
(SKL) or a related sequence (26, 27). PTS1 binds to PEX5p, a cytosolic protein that interacts 
with the docking complex at the peroxisomal membrane. PTS2 is a nonapeptide located 
near the N-terminus (28) and is recognized by the cytosolic receptor PEX7p. The PTS2-PEX7p 
complex also binds the docking complex by interacting with PEX5L (a longer PEX5 isoform) 
(29). The majority of the peroxisomal matrix proteins employ the PTS1-PEX5p import system, 
while only few peroxisomal proteins possess a PTS2 (30). 
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The peroxisomal docking complex contains, amongs other peroxins, PEX14 and PEX13, two 
important peroxisomal markers. While PEX14 functions as acceptor for the cargo-loaded 
receptors, the function of PEX13 is not fully clarified. It is, however, an integral membrane 
protein that is an essential element of the docking complex (31–33). This peroxin is capable to 
interact directly with PEX14 and is involved in matrix protein import (34). The deletion of 
PEX13 results in the loss of both PTS1 and PTS2 protein import leading to disrupted 
peroxisomal protein import and the complete dysfunction of peroxisomal metabolic 
pathways (35). For this reason, proteins belonging to the PEX family are often used as target 
for the generation of knockout animals or knockdown cell cultures to study the effect of 
peroxisome deficiency in mammalian systems (36–39). 
In the absence of PEX5, PEX7, or downstream binding partners (such as PEX13), peroxisomes 
still can be found in cells. However, they are empty and without matrix content and where 
described as peroxisomal membrane ghost (40). 
When the process of peroxisomal matrix protein import fails for any reason, the non- 
imported proteins can sometimes be detected and even be still active in the cytosol (e.g. 
catalase) depending on their stability or whether or not they are degraded by proteases. 
1.1.2.3. Peroxisome proliferation and involved nuclear receptors (PPARs) 
Peroxisomes are known for their ability to adapt to cellular and environmental conditions. 
To cope with the cell morphological and metabolic requirements, peroxisomes proliferate 
by growth (e.g., elongation) and division (3, 41–43). Both mechanisms may take place 
simultaneously in mammalian cells (44). 
In mammals, three isoforms of PEX11 (PEX11, PEX11, and PEX11) are known to be 
involved in peroxisomal proliferation and regulation of the organelle abundance (41, 45–48). 
Peroxisomal division and proliferation, together with the expression of many peroxisomal 
enzymes involved in fatty acid oxidation, can be regulated by the activation of peroxisome 
proliferator-activated receptors (PPARs) (49). PPARs are ligand-activated transcription factors 
that regulate the expression of genes important in lipid and glucose homeostasis, cell 
differentiation and inflammation (50, 51). Because of their many functions, they have been 
linked to the development of diabetes, hyperlipidemia, cancer and obesity (52–55). They form 
a family of nuclear hormone receptors (NRs) belonging to the steroid receptor superfamily 
(55). The PPAR family consists of three subtypes: PPAR, PPAR and PPAR, which differ from 
one another in their ligand specificities, tissue distribution and physiological roles (50). After 
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interaction with the specific ligands, the receptors are translocated to the nucleus, where 
they change their structure and regulate inter alia the transcription of genes involved in 
glucose and fatty acid metabolism. Each member shows a distinct preference for distinct 
group of target genes (54, 56). 
Although each member of the PPAR family has its own specific ligands, all are regulated by 
fatty acids and their derivatives, including VLCFA and LCFA and their CoA esters (57). Phytanic 
acid (58), PUFAS and eicosanoids, which are exclusively metabolized by peroxisomes, function 
as natural ligands for the activation of PPAR, leading to enhanced expression levels of 
PPARα-regulated genes that activate peroxisomal -oxidation. Some PPAR synthetic ligands 
have been used in the last decades, alone or combined, in the treatment of dyslipidemias 
(e.g. fibrates, PPAR activators) or diabetes mellitus type 2 (e.g. thiazolidinediones, PPAR 
agonists) (52). 
1.1.3. Metabolic functions of peroxisomes 
Peroxisomes contain enzymes involved in different metabolic pathways that are critical for 
the maintenance of the cellular homeostasis and activity. A loss of peroxisomal functions is 
generally accompanied by the accumulation of toxic substrates and metabolic intermediates 
(e.g. VLCFA, phytanic acid) and a shortage of peroxisomal products (e.g. plasmalogens) with 
devastating consequences for human health (59, 60). Pathways that are generally found in the 
peroxisomes of mammalian cells are listed in Table 1. In the next chapters a description of 
peroxisomal metabolic pathways relevant for this thesis, namely β- and α-oxidation of fatty 
acids, as well as ROS metabolism, will be given. 
 
Table 1: Metabolic functions associated with peroxisomes in mammals 
Metabolic pathway Function 
β-oxidation Membrane lipid turnover; membrane breakdown in senescence (61) 
β-oxidation of aromatic 
and cyclic compounds 
Prostaglandins and leukotrienes degradation 
α-oxidation of fatty acids Breakdown of phytanic acid and other α-methyl fatty acids 
Branched-chain fatty acid 
oxidation 
Breakdown of branched-chain fatty acids such as pristanoyl-CoA, di- and tri- 
hydroxycholestanoyl CoA (derived from cholesterol) leading to the production of 
bile salts 
Plasmalogen biosynthesis Synthesis of ether-linked phospholipids (plasmalogens) which are particularly 
important in membranes protecting them against ROS damage. 
Dihydroxyacetone phosphate acyl transferase (DHAPAT) or 
alkyldihydroxyacetonephosphate synthase (ADHAPS) which catalyse the first 2 
steps of the pathway, are peroxisomal 
Isoprenoid biosynthesis Synthesis of sterols such as cholesterol and quinones such as ubiquinone 
Degradation of purines Xanthine is converted to urate by xanthine oxidase which is peroxisomal in some 
species (62) 
6  
Catabolism of polyamines Polyamine oxidases have been identified in mammals that carry putative 
peroxisome targeting signals (63) 
Reactive oxygen 
metabolism 
Removal of the active oxygen species produced by peroxisomal metabolism and 
H2O2 signaling (64) 
Others Viral innate immune defense (65) 
1.1.3.1. -Oxidation of fatty acids and fatty acid derivatives 
The peroxisomal fatty acid β-oxidation is a process that coexists and cooperates with the 
mitochondrial fatty acid β-oxidation system in animal cells (24, 66, 67). One of the main 
characteristics of the peroxisomal β-oxidation is that it is not involved in energy production 
and that it can metabolize a much broader spectrum of substrates that cannot be degraded 
by mitochondria. Peroxisomes catalyse the β-oxidation of very long-chain fatty acids  
(VLCFA) (C24:0 and C26:0), 2-methyl-branched fatty acids, pristanic acid (a product of the α- 
oxidation of phytanic acid), bile acid intermediates, polyunsaturated fatty acids (PUFA), 
eicosanoids, dicarboxylic medium-chain fatty acids and xenobiotics(68). This capability 
prevents toxic or proinflammatory effects resulting from the accumulation of the bioactive 
lipid derivatives (e.g. eicosanoids) or precipitation of VLCFA within the cell. Long and 
medium-chain length fatty acids, whether saturated or unsaturated, can be substrates for 
both, mitochondrial and peroxisomal β-oxidation. However, even if both processes can 
oxidize dicarboxylic acids (DC-CoAs)(69), the reduce ability of mitochondria to activate VLCFA 
to their CoA derivative (via very long-chain Acyl-CoA synthetases)(70) restricts the 
degradation of this compounds to the peroxisome. The presence of a methyl branch at the 
second carbon dictates by which β-oxidation enzymes the compound will be degraded (71). 
The peroxisomal β-oxidation also supplies acetyl-CoA for cholesterol and bile acid 
biosynthesis (72). 
Peroxisomes contain at least two acyl-CoA synthetases that activate the VLCFAs to their CoA 
derivatives and initiate the peroxisomal β-oxidation (73). Afterwards the FA chain is 
consecutively shortened by 2 carbons by a series of cyclic reactions involving four 
subsequent steps (74) (Figure: 3). The enzymes involved in this pathway present a substrate 
specificity, as shown in (Table 2). 
Products of the -oxidation include acetyl-CoA and a chain-shortened acyl-CoA. During each 
cycle, the fatty acid is shortened by two carbons and can then reenter the pathway(68). After 
the long-chain DC-CoAs are shortened in the peroxisomal matrix (till 8 carbon atoms), the 
products are shifted to the mitochondrion for complete oxidation. In addition, shortened 
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intermediates deriving from the 
peroxisomes also can be used for 
phospholipid synthesis (in the ER), whereas 
others can be exported to the bile or 
excreted via the kidneys. 
 
 
 
 
 
 
 
Figure 3: Overview of the fatty acid β-oxidation in 
peroxisomes. Oxidation of fatty acids is carried out in 
peroxisomes following four subsequent steps. The 
FAs activation occurs outside the organelle involving 
membrane bound long-chain acyl CoA synthetases. 
The activated long-chain fatty acids are imported into 
the organelles by any of the ABCD transporters (78). 
Depending on the chain length, the presence of a 2- 
methyl group, and structure of the acyl chain of the 
CoA esters, the involved enzymes will differ. The 
shortened acyl CoA can reenter the cycle or undergo 
other conversions. ACOX1-3: acyl-CoA oxidase 1-3; 
MFP 1-2: multifunctional protein 1-2; SCPx; sterol 
carrier protein x. Modified from (68, 79). 
 
 
 
VLCFA PUFA Pristanic acid / bile 
acid intermediates 
DCA Prostanoids 
ACOX1 
MFP2 
THIOLASE A and B 
SCPx 
ACOX1 
MFP2 
THIOLASE A and B 
ACOX2/3 
MFP2 
SCPx 
ACOX1 
Both MFP1/2 
SCPx 
ACOX1 
MFP2 
THIOLASE A and B 
 
Table 2: Peroxisomal β-oxidation enzymes sorted by their substrate specificity. 
Overview depicting the involvement of the different peroxisomal -oxidation enzymes in the oxidation of 
VLCFAs (very long-chain fatty acids), PUFAs (polyunsaturated fatty acids), pristanic acid and bile acid 
intermediates, DCAs (dicarboxylic acids), and prostanoids. Adapted from (80) and (81). Abbreviations: ACOX1-3: 
acyl-CoA oxidase 1-3; MFP 1-2: multifunctional protein 1-2; SCPx; sterol carrier protein x. 
 
1.1.3.2. α-Oxidation of branched-chain fatty acids 
Branched-chain fatty acids (like bile acids or phytanic acid) can arise from several different 
sources. In terms of quantity, non-steroidal branched-chain fatty acids are the most 
important ones (82). Humans endogenously synthesize bile acids, which are oxidized 
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cholesterol derivatives. Phytanic acid on the other hand 
is a common α-oxidation substrate taken up with the 
meal (dairy products and beef (83, 84)). Some FAs are first 
metabolised via peroxisomal α-oxidation before they 
can enter the β-oxidation pathway. Those FAs 
containing a methyl group at the 3-position (e.g. 
phytanic acid) require a chain shortening from the 
carboxyl group (82) generating a one-carbon unit (formyl-
CoA) instead of the two-carbon unit (acetyl- CoA) 
produced after β-oxidation. The pathway for the 
phytanic acid α-oxidation to pristanic acid comprises 
five steps (85) (Figure: 4). Pristanic acid can then enter 
the “normal” peroxisomal β-oxidation pathway and its 
end products (e.g. acetyl-CoA and propionyl-CoA) can 
be shifted to mitochondria to undergo full oxidation to 
CO2 and H2O (85). 
Figure 4: Overview of the fatty acid α-oxidation in  peroxisomes. 
The α oxidation pathway for phytanic acid is shown. Both phytanic 
acid and its precursor, phytol, are dietary lipids. ATP: adenosine 
triphosphate;  ACSVL1:    solute    carrier    family    27    (fatty  acid 
transporter) member 2; ACSL: acyl-CoA synthetase long-chain family member 1; PHYH: phytanoyl-CoA α- 
hydroxylase; HACL1: 2-hydroxyphytanoyl-CoA lyase; FALDH-V: aldehyde dehydrogenase; TPP: thiamine 
pyrophosphate; Mg: magnesium; NAD: nicotinamide adenine dinucleotide. Adapted from (68). 
 
 
1.1.3.3. Lipid transport across the peroxisomal membrane: ABCD transporters 
As described previously, peroxisomes perform a key role in a variety of metabolic pathways 
for which the import of substrates into the organelle is required. Prior to β-oxidation, fatty 
acids are activated by thioesterification to Coenzyme A (CoA). Fatty acyl CoAs are 
amphipathic in nature and therefore require a transport protein to cross organellar 
membranes (61). This is carried out by membrane transporters belonging to the subfamily D 
of the ABC superfamily of mammalian membrane-bound proteins. Three of them are 
localized in the peroxisomal membrane: the adrenoleukodystrophy protein (ALDP/ABCD1), 
the ALDP-related protein (ALDRP/ABCD2), and a 70 kD peroxisomal membrane protein 
(PMP70/ABCD3), showing a distinct affinity and specificity for different substrates (Figure: 
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5). The fourth ABCD transporter, a PMP70 
related protein (PMP70R/PMP69/ABCD4), 
was shown to be localized to the 
endoplasmic reticulum (87, 88). 
 
Figure 5: Overview of the substrate-specificities of 
the ABCD membrane transporters. Three ABC 
proteins (ABCD1, ABCD2 and ABCD3) belonging to 
subfamily D are present in the peroxisomal 
membrane. ABCD1 and ABCD2 exhibit overlapping 
substrate specificities regarding saturated and 
monounsaturated VLCFA-CoAs, where ABCD1 has 
higher specificity to C24:0-CoA and C26:0-CoA than 
ABCD2. On the other hand, ABCD2 has an affinity for 
polyunsaturated VLCFA-CoAs. ABCD3 is involved in 
the transport of LCFA-CoA, branched-chain acyl- 
CoA, THCA-CoA and DHCA-CoA. VLCFA: Very long-chain fatty acid; LCFA: Long-chain fatty acid; THCA: 3 alpha, 7 
alpha, 12 alpha-trihydroxy-5 beta-cholestanoic acid; DHCA: 3 alpha,7 alpha-dihydroxy-5 beta-cholestanoyl; 
ATP: adenosine triphosphate; ADP: adenosine diphosphate. Adapted from (88). 
 
 
The ABC protein structure is highly conserved, exhibiting one transmembrane domain 
constituting the passageway for the substrates and one nucleotide-binding domain 
energizing the directional transport by cycles of ATP binding and hydrolysis (hence its name: 
ATP binding cassette -ABC-) (89). 
1.1.3.4. Metabolism of reactive oxygen species and nitrogen species 
Oxidative stress is a condition in which the production of reactive oxygen and/or nitrogen 
species (ROS/RNS) within the cell overwhelms the capacity of the antioxidant defense and 
repair mechanisms (90). It has been extensively shown that high levels of ROS exert a toxic 
effect on biomolecules such as DNA, proteins, and lipids, leading to the accumulation of 
oxidative damage in diverse cellular compartments resulting in a wide range of pathological 
conditions, from atherosclerosis or hypertension, to cancer or type 2 diabetes (91). There are 
many processes of intracellular ROS/RNS production taking place in different cell 
compartments, among which are (1) the electron transport chain in mitochondria, (2) the 
cytochrome P-450 enzymes in the endoplasmic reticulum (ER), (3) the NADPH oxidases at 
the plasma membrane, (4) the flavin oxidases inside the peroxisomes, and (5) the nitric 
oxide synthases (NOSs) which show different subcellular localizations (92). 
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As means of defense, the cell exhibits different antioxidant systems including enzymes (e.g. 
catalase, several superoxide dismutases, peroxiredoxins, and glutathione peroxidases) and 
non-enzymatic metabolites (e.g. glutathione and ascorbic acid) (92). 
1.1.3.5. Peroxisomes as important sites of reactive oxygen species (ROS) 
production and degradation 
The capacity of peroxisomes to produce ROS and RNS is well known, a characteristic that 
has given them their name some decades ago (1). Since then, peroxisomes have been 
recognized as potential regulators of oxidative stress-related signalling pathways. Sources of 
ROS production within the peroxisome are the H2O2-producing flavin-containing oxidases 
(e.g. acyl-CoA oxidases) (76, 77), superoxide (·O2¯) generating enzymes (e.g. xanthine oxidase) 
(62)   or those  producing  nitric  oxide  (·NO)  (e.g.  iNOS, the inducible  form  of  nitric  oxide 
synthase) (93) (Table 3). The hydrogen peroxide (H2O2) is formed in the first step of the β- 
oxidation cycle where a double bond is introduced at the β position of the fatty acyl-CoA 
ester by FAD-containing acyl-CoA oxidases, which transfer hydrogen from metabolites to 
molecular oxygen (94). 
Peroxisomes contain a non-selective membrane pore large enough to allow the diffusion of 
virtually all types of ROS/RNS that can be generated or metabolized inside the organelle (95, 
96). ·NO and H2O2 are membrane permeable, diffusible molecules, which are less reactive 
and longer lived than ONOO¯ and ˙OH which are highly unstable, but are causing damage of 
the peroxisomal membrane, loss of peroxisomal functions and lipid peroxidation in a direct 
manner (97, 98). 
Table 3: Enzymes in peroxisomes that generate ROS. Adapted from (99). 
Enzyme Substrate ROS 
Acyl-CoA oxidases 
• Palmitoyl-CoA oxidase (ACOX1) 
• Pristanoyl-CoA oxidase (ACOX3) 
 
Long- and very long-chain fatty acids, straight 
2-Methyl-branched fatty acids 
 
H2O2 
H2O2 
Urate oxidase (in humans is inactive) Uric acid H2O2 
Xanthine oxidase Xanthine H2O2, ·O2¯ 
D-amino acid oxidase D-Proline H2O2 
L-pipecolate oxidase L-pipecolic acid H2O2 
D-aspartate oxidase D-aspartate, N-methyl-D-aspartate H2O2 
Sarcosine oxidase Sarcosine, pipecolate H2O2 
L-hydroxy acid oxidase 1 and 2 Glycolate, lactate H2O2 
Polyamine oxidase N-Acetyl spermine/ spermidine H2O2 
Nitric oxide synthase L-Arginine · NO 
H2O2: hydrogen peroxide; ·O2¯: superoxide; ·NO: nitric oxide. 
 
Due to the production of ROS/RNS peroxisomes are equipped with an efficient anti-oxidant 
machinery to maintain the redox homeostasis inside the organelle (100) (Table 4). 
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Peroxisomes have also the capacity to respond to oxidative stress and ROS, which have been 
generated in other intra- or extracellular compartments, presumably to protect the whole 
cell against oxidative damage (99). Catalase, the classical marker enzyme of peroxisomes, 
shows an important protective function against the toxic effects of peroxides generated in 
peroxisomes and removes them with high efficiency (101). Its inhibition in rat liver has been 
shown to suppress the peroxisomal lipid β-oxidation activity (102). A number of other 
enzymes are located inside the peroxisomal matrix involved in the maintenance of the redox 
homeostasis. Both, catalase and glutathione peroxidase are in charge of scavenging H2O2, 
Cu,ZnSOD (SOD1) protect against ·O2¯ by converting it to H2O2, peroxiredoxin 1 and 5 
(PRDX1 and PRDX5) have the capacity to degrade ONOO¯, epoxide hydrolase 2 degrades 
epoxides and PRDX5 and glutathione S-transferase kappa can metabolize lipid peroxides (96). 
Contrary to the previously described (103), our group has shown that SOD2 (the enzyme in 
charge of transforming toxic superoxide into hydrogen peroxide and oxygen) is only present 
in mitochondria and not in peroxisomes (104). 
Table 4: Enzymes in peroxisomes that degrade ROS. Adapted from (99). 
Enzyme Substrate PO Enzyme also present in References 
Catalase H2O2 ✓ 
Cytosol and nucleus in some species, 
e.g. ginea pig and some monkeys 
(4) 
Glutathione peroxidase H2O2 ✓ All cell compartments (105) 
Cu, Zn SOD (SOD1) ·O2¯ ✓ Cytosol (106, 107) 
Epoxide hydrolase Epoxides ✓ ER and cytosol (108) 
Peroxiredoxin 1 
(PRDX1) 
H2O2 ✓ 
Cytosol, nucleus, mitochondria (109) 
Peroxiredoxin 5 
(PMP20) 
H2O2, ROOH, 
ONOO¯ 
✓ 
Cytosol, nucleus, mitochondria (110) 
H2O2: hydrogen peroxide; ·O2¯: superoxide; ONOO-: peroxynitrite. 
1.1.3.6. The response of peroxisomes to oxidative stress 
Peroxisomes show an enormous plasticity regarding their response to oxidative stress. It has 
been shown that an elevation of environmental oxygen concentration induces an increase  
in the volume density of peroxisomes and their anti-oxidant enzymes up to 4-fold in CHO 
cells exposed to 99 % O2 (111). Morphological changes have also been observed in 
peroxisomes after exposure to oxidative stress: elongation of peroxisomes as a result of UV 
irradiation or direct exposure to H2O2 has been reported in HepG2 cells (112, 113), a response 
which was blocked by antioxidant treatment. PPARα agonists, that induce peroxisome 
proliferation accompanied by an increase in catalase activity, have been shown to prevent 
ROS production (114). 
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Furthermore, changes in peroxisomal redox metabolism sensitize cells to oxidative stress 
(115). This in turn suggests that peroxisome dysfunction is not only associated with rare 
inborn errors of peroxisomal metabolism, but also with more common age-related diseases 
such as neurodegeneration, type 2 diabetes, and cancer in which an increased oxidative 
stress has been proven (116). 
1.2. Metabolic interplay between peroxisomes and mitochondria 
 
In order to fulfill their metabolic roles, peroxisomes rely on the interaction with other 
subcellular organelles. This connection is based on: (1) metabolic cooperation and cross- 
talk; (2) overlap in some components of the fission machinery; (3) cooperation in anti-viral 
signalling and defense, and (4) vesicular trafficking pathways (117). Further, peroxisomal 
dysfunction can also lead to mitochondrial alterations (37). 
1.2.1. Lipid homeostasis (fatty acid oxidation) 
As mentioned before, both peroxisomes and mitochondria possess a β-oxidation machinery 
for the degradation of fatty acids. Although both mechanisms involve the same reaction 
steps, some important organelle-specific differences exist (118, 119): (1) The enzymes in charge 
of the oxidation pathway are organelle specific differing in their molecular and catalytic 
properties; (2) each pathway shows specificities for different substrates (see chapters 
1.1.3.1 and 1.1.3.2). As explained before in this work, peroxisomes metabolize complex fatty 
acids while mitochondria are in charge of the degradation of the majority of LCFA. (3) After 
peroxisomal β-oxidation, the resulting fatty acids products are shuttled to mitochondria for 
full oxidation. The export of fatty acids from peroxisomes requires a carnitine shuttle system 
and the involvement of membrane pores, formed by PMP22 (120, 121). (4) In contrast to 
peroxisomes, mitochondria are able to produce ATP for anabolic reactions, since the 
mitochondrial enzymes catalyzing the first step of -oxidation are FAD-dependent 
dehydrogenases, which feed their electrons into the respiratory chain (67). 
1.2.2. Reactive oxygen species (ROS) homeostasis 
Both, peroxisome and mitochondria are central organelles involved in the cellular redox 
balance and homeostasis (96) producing and scavenging ROS (97, 99). In the mitochondria, the 
main site of free radical generation is the electron transport chain. Superoxide radicals can 
be formed at complex I (NADH-coQ reductase) and complex III (cytochrome oxidase). The 
damage of proteins, lipids and DNA within or outside the mitochondria results from the 
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conversion of the formed ·O2¯ into H2O2, hydroxyl radicals or ONOO¯. As peroxisomes, 
mitochondria contain their own group of antioxidant molecules (glutathione, NADH) and 
enzymes (SOD2, glutathione reductase, glutathione peroxidase) to counteract the oxidative 
damage (122). However, under oxidative stress conditions, the mitochondrial antioxidant 
machinery is often inefficient in decomposing the excess of H2O2 due to the limited level of 
glutathione (and NADPH) (122). Peroxisomal catalase plays an important role in the 
maintenance of the mitochondrial function. It has been reported that in catalase deficient 
cells, the redox state of mitochondria was significantly increased (even under basal grow 
conditions) and that the reintroduction of catalase expression counteracted this effect, 
restoring mitochondrial integrity (123, 124). Furthermore, an impaired catalase activity (and 
hence H2O2 metabolism) may increase mitochondrial ROS in response to fatty acids (125) and 
leads to their dysfunction (123). 
1.3. Peroxisomes in human diseases and peroxisomal biogenesis disorders 
 
1.3.1. Peroxisomal disorders 
More than 20 inherited peroxisomal disorders have been described in the last decades, 
where one or more peroxisomal proteins are absent or dysfunctional (126). This emphasizes 
the importance of the peroxisome in human health, especially concerning lipid metabolism 
and the defense against oxidative stress as described in previous chapters. Inherited 
peroxisomal disorders can be divided into two main subgroups: peroxisomal biogenesis 
disorders (PBDs) and the more frequent peroxisomal (single) enzyme deficiencies (PEDs) (81). 
PBDs are caused by defects in peroxins involved in membrane biogenesis (e.g. PEX19), 
protein import (e.g. PEX5), or peroxisome proliferation (e.g. PEX11) (126, 127). In patients that 
are affected by PDBs, peroxisomes are either completely absent from cells, or only present 
as empty, non-functional membrane ghosts (40). PBD patients suffer from severe metabolic 
dysfunctions, as nearly all peroxisomal metabolic pathways are affected (81). Resulting from 
this is a toxic accumulation of α- and β-oxidation substrates (e.g. bile acid intermediates or 
VLCFA, pristanic acid, and phytanic acid) and a reduction of plasmalogen levels (81, 118, 127, 128). 
Zellwegers syndrome (ZS) is the prototype and the most severe form of the PBDs. It is an 
autosomal recessive lethal disorder and the patients suffer from severe hypotonia, 
craniofacial malformations, liver and kidney problems, seizures, retinopathy and neuron 
migration defects and frequently die during the first year of life (126). 
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In the case of the single peroxisomal enzyme deficiencies, as its name implies, one enzyme 
(or transporter protein) in charge of a specific function in peroxisomes is absent. Depending 
upon which peroxisomal function is impaired, patients affected by these deficiencies may 
show symptoms resembling those observed in ZS patients or even be asymptomatic (126). An 
example for PEDs is Refsum´s disease, which is caused by the deficiency of PHYH (129) 
showing an accumulation of phytanic acid in tissue lipids and in plasma (130). 
Besides of the characteristic organs compromised in most peroxisomal disorders like brain, 
liver, kidney, testis or skeletal system also affection in the accumulation of toxic compounds 
that are usually degraded within the peroxisome have been shown to have a negative 
impact also on pancreatic tissue, exhibiting slight fibrosis and islet cell hyperplasia (131). 
1.4. Overview on type 2 diabetes and structure of the pancreas 
1.4.1. Structure of the pancreas and the β-cell 
The adult mammalian pancreas is a complex serous gland composed mainly of acini, 
epithelial cells of excretory ducts, and islets of Langerhans as well as loose connective tissue. 
Exocrine cells (acini) constitute around 95 % of the pancreatic mass and produce digestive 
enzymes, which are excreted into the duodenum via the duct system. Endocrine cells are 
organized in globular clusters of cells known as islets of Langerhans, dispersed throughout 
the exocrine tissue. Each islet contains different endocrine cell types, each secreting distinct 
peptide hormones: α-cells produce glucagon, β-cells insulin, δ-cells somatostatin, and PP 
cells pancreatic polypeptide. Within the islets, β-cells make up the 
majority (60-80 %), forming a core around which the other cells are arranged (132). 
 
A B 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Representation of a murine islet of Langerhans. A: β-cells make up the core of the endocrine islet 
(UCSF Diabetes Education Online, https://dtc.ucsf.edu). B: H&E staining of a murine pancreas showing the 
morphology of the endocrine and exocrine part (own picture). Ex: exocrine pancreas; En: endocrine pancreas; 
BV: blood vessel; InD: intercalated duct. Bar = 27.5 µm. 
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1.4.2. Type 2 diabetes mellitus 
Type 2 diabetes (T2D) is a complex metabolic disorder characterized by hyperglycaemia (a 
consequence of pancreatic β-cells failure) and peripheral insulin resistance. T2D affects 
currently more than 415 million individuals worldwide (133) and it is estimated that its 
prevalence will increase in the next years (642 million patients expected for 2040). With a 
polygenic etiology that includes genetic interaction, environmental and nutritional factors, 
T2D is considered a complication of the metabolic syndrome (134). Long-term complications 
of T2D include retinopathy, nephropathy, neuropathy and cardiomyopathy, inter alia. 
Two mechanisms have been suggested to cause the pathophysiological alterations of the β- 
cell. (1) Glucotoxicity, caused by oxidative stress, resulting in β-cell damage after 
hyperglycaemia due to insulin resistance (135), and (2) lipotoxicity, inducing apoptosis of β- 
cells as a consequence of obesity-induced ectopic fat accumulation in the pancreas (136, 137). 
These mechanisms are not independent from each other and commonly their deleterious 
effects synergize (138-141). 
1.4.3. Glucolipotoxicity in pancreas and possible involvement of peroxisomes 
One important mechanism involved in β-cell glucotoxicity is glucose-induced oxidative 
stress. In an hyperglycaemic environment, ROS can be formed through oxidative 
phosphorylation, glycosylation, autoxidation, and the glucosamine pathways (142). In vivo, 
pro-oxidant and markers for oxidative tissue damage appear constantly elevated in T2D 
patients. Additionally, β-cells are among the most vulnerable cells to ROS damage mainly 
due to the fact that they contain virtually very low levels of catalase (142). In the scenario of 
ROS-induced β-cell dysfunction a defective proliferation and growth is finally followed by 
cell death. Thereby oxidative stress has been linked to insulin resistance resulting in 
impaired glucose tolerance. This in turn leads to insulin activity inhibition and secretion, 
promoting the onset of T2D (143). 
Glucolipotoxicity implies the synergetic interaction between the toxic actions of FFAs in the 
context of hyperglycaemia. However, both glucose and FFAs are key modulators of insulin 
secretion. In a homeostatic state, glucose is the fundamental stimulator of insulin secretion 
with some fatty acids (e.g. palmitate) potentiating the effect of glucose (145, 146). In vivo, 
acute infusion of FA stimulates insulin secretion in rats only in the presence of high glucose 
concentrations (147). However, chronic high glucose or high FFA concentrations can exert a 
harmful effect on β-cells (148). It has been shown that chronic hyperglycaemia induces 
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multiple β-cell defects including irreversible changes in insulin gene transcription in murine 
cell lines (149), changes in cell mass (150) and increase in ROS production (in both, human and 
rat islets) (142) accompanied by the reduction of expression and/or DNA binding capacity of 
PDX-1 (151). PDX1, a transcription factor that plays a crucial role in pancreas development, - 
cell differentiation, and insulin gene expression (141) is also affected during chronic 
hyperlipidaemia resulting in the inhibition of the insulin gene expression (152) and eventually 
β-cell dysfunction and death by apoptosis (139, 153, 154). 
Long-chain saturated fatty acids, such as PA, are mainly oxidized by mitochondria. CPT-1, 
which mediates the import of long-chain saturated fatty acids into the mitochondrion, is the 
rate-limiting enzyme for LC-CoA oxidation and can be inhibited by an overload of glucose 
and PA, shifting the metabolic pathway from oxidation to lipogenesis (144). The resulting 
accumulation of LC-CoAs, lipid intermediates (e.g. phosphatidic acid, diacylglycerol, 
lysophosphatidic acid) and ceramide synthesis play a critical role in FFA-induced toxicity (155- 
157). Here, peroxisomes could sustain the degradation of excess fatty acids reducing the risk 
of lipotoxicity. 
Palmitic acid, principal constituent of refined palm oil, is an important part of the human 
diet, and it can be also found in meets, cheese, butter and dairy products (158). In a state of 
FA metabolic homeostasis, PA is used mainly as a cellular source of energy. However, when 
this homeostasis is compromised (159) the overload of PA in β-cells has detrimental effects 
resulting in cytotoxicity through mitochondrial dysfunction and ER stress, induced by 
oxidative stress (160). It has been shown that β-cells derived from T2D murine models with 
hyperlipidemia exhibit elevated pro-oxidants and DNA and protein oxidation products (161, 
162) apparently caused by PA lipotoxicity. 
 
1.4.4. Models to study lipotoxicity in pancreatic cells 
Although -cells constitute the predominant cell type present within the islets of 
Langerhans, they comprise only about 1-2 % of the overall pancreatic cell mass. Thus, the 
use of primary -cells is limited not only by its availability but also by the difficulty of 
isolating a homogeneous cell population. This entails the main disadvantage of the correct 
interpretation of the biochemical data, since the measurements will not allow the 
differentiation of  from non- cells in the preparations. To overcome this particular issue, 
many studies of -cell physiology, pathogenesis of diabetes and testing the effects of drugs 
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or chemical compounds on this specific cell type, have been carried out with clonal 
insulinoma cell lines. Diverse cell lines are available which are derived from multiple species. 
1.4.5.1. The -TC3 cell line 
To investigate whether peroxisomes are involved in the protection of the -cell against 
lipotoxicity, we have employed the β-TC3 cell-line. The β-TC3 cell line is a tumor cell line 
obtained from a primary culture of insulinomas developed in transgenic mice, which 
expressed the large T-antigen of SV40 in pancreatic islet β-cells (163). This cell line resembles 
normal β-cells in respect to its content of insulin stored in secretory granules (3100 ± 294 ng 
insulin/100µg cellular protein, approximately 30 % of that of normal islets) (164) and remains 
among the most widely used rodent pancreatic -cell lines today. Moreover, these cells 
respond to elevated glucose levels and to diverse secretagogues, which are used to induce 
insulin release in normal islets (165). β-TC3 cells produce both proinsulin I and II and 
efficiently process each into mature insulin, making them a useful model for studying 
pancreatic β-cell function (163). 
1.4.5.2. Mouse models to study diabetes mellitus 
The New Zealand Obese (NZO) mouse is one of the most used models for the human 
metabolic syndrome and development of type 2 diabetes, presenting the main 
characteristics of this complex disease (insulin resistance, dyslipidemia, hypertension and 
early-onset obesity) (166). As consequence, NZO mice develop a high fat diet-associated T2D 
characterized by marked hyperglycaemia and low serum insulin levels associated with -cell 
failure and apoptosis (167). 
The ob/ob (obese) mouse, the second model for obesity and diabetes used in this study, 
presents a mutation in the ob gene, coding for leptin, a hormone in charge of the appetite 
regulation and energy homeostasis (168). The deficiency of this hormone leads to a fatty acid 
overload with different consequences depending of the affected tissue, from insulin 
resistance to -cell dysfunction, apoptosis and diabetes (high blood sugar). 
Pancreata from both animal models were kindly provided by Dr. Schürmann from the 
Deutsches Institut für Ernährungsforschung, Potsdam. 
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2. AIMS OF THE STUDY 
It is well known that glucolipotoxicity, the deleterious effect of chronically elevated levels of 
glucose and fatty acids, adversely affects pancreatic -cell function and thereby contribute 
to the deterioration of insulin secretion and cell death leading to the onset of T2D. At the 
cellular level, glucolipotoxicity its mainly related to alterations in intracellular energy 
metabolism and oxidative stress. To date both endoplasmic reticulum and mitochondria 
have been implicated in this phenomenon (169–171), however, scarce information is available 
concerning the function of peroxisomes in pancreatic -cells. Interestingly, and contrary to 
the initially thought (172), our group has demonstrated significant differences in the 
peroxisomal abundance and enzyme composition of different pancreatic cells (173, 174), 
revealing a high number of peroxisomes in the endocrine region of this organ. This suggests 
that the metabolic function of peroxisomes might be particularly relevant to -cell function. 
Since peroxisomes play an important role in the cellular β-oxidation of fatty acids and ROS 
homeostasis, we hypothesized that the dysfunction of this organelle should contribute to 
intracellular lipid accumulation and oxidative stress leading in consequence to -cell 
dysfunction and decreased cell viability. Therefore, we investigated whether peroxisomes 
are involved in the protection of the -cells against lipotoxicity. 
To analyse the function of peroxisomes in the maintenance of normal physiology of 
pancreatic -cells and reveal possible pathological alterations induced by the deficiency of 
peroxisomal protein import, the main aims of this project were: 
• To produce and optimize an anti-mouse catalase antibody from chicken eggs (IgY) 
with high sensitivity by using recombinantly expressed and isolated His-tagged 
protein from Escherichia coli to be used for multiple Western blot experiments. 
• To optimize the required conditions to obtain most sensitive immunofluorescence 
labelling for a large variety of peroxisomal biogenesis proteins, transporters and 
enzymes in murine pancreata. 
• To morphologically characterize peroxisomal protein distribution in paraffin- 
embedded pancreatic tissue sections and their subcellular localisation in different 
pancreatic cell populations of wild type animals. 
• To morphologically characterize the peroxisomal compartment in paraffin- 
embedded tissue sections of pancreata of diabetic mouse models (NZO and ob/ob) 
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to reveal possible peroxisomal alterations as a result of the diabetic condition 
induced by a high fat diet. 
• To establish the appropriate conditions for the dissection of -cells from 
cryosections of pancreatic tissue using the laser capture microdissection (LCM) 
technique for - cell gene profiling. 
• To establish optimal culture conditions to obtain a highly mature peroxisomal 
compartment and high insulin expression in -TC3 cell line. 
• To characterize the peroxisomal protein composition and peroxisome related gene 
expression under optimal conditions in -TC3 cells. 
• To establish a Pex13 knock down model to investigate the effects of general 
peroxisome deficiency in -TC3 cells induced by siRNA experiments. 
• To establish an Abcd3 knock down model to investigate the effects of a single 
membrane transporter deficiency in -TC3 cells induced by siRNA experiments. 
• To analyze the effect of high concentrations of palmitic acid, a fatty acid metabolized 
mainly in mitochondria but in access also in peroxisomes, on the survival and gene 
expression of normal and peroxisome-deficient -TC3 cells. 
• To analyze the effect of high concentrations of phytanic acid, a dietary fatty acid that 
is degraded via peroxisomal α-oxidation, on the survival and gene expression of 
normal and peroxisome-deficient -TC3 cells. 
• To investigate whether the induced peroxisomal defects are interfering with the cell 
biological function of insulin secretion and production. 
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3. MATERIALS AND METHODS 
3.1. Materials 
3.1.1. Laboratory instruments 
All laboratory instruments used for the experimental section of this thesis are summarized 
with corresponding supplier in Table 5 and listed in alphabetical order: 
Table 5: List of the laboratory instruments used for the experiments described in this thesis. 
Instrument Company  Instrument Company 
Biocell A10 water system 
Milli Q- 
Millipore 
Multifuge 3 centrifuge Heraeus 
Biofuge Fresco Heraeus Oven Heraeus T 5050 EKP Heraeus 
Biofuge Pico Heraeus pH meter inoLab WTW 
Dish washing machine 
(G 78 83 CD) 
Miele Pico21 centrifuge Heraeus 
ErgoOne Pipettes Starlab Pipettes Eppendorf 
Freezer Serie 4 Bosch Potter-Elvehjem homogenizer Braun 
Gel-Doc 2000 gel documentation system Bio-Rad 
Pressure/Vacuum Autoclave 
FVA/3 
Fedegari 
Hera cell 240 incubator Heraeus Pump Drive PD 5001 
Heidolph 
Instruments 
Hera safe, clean bench 
KS-12 
Heraeus Purple Nitrile-Xtra 
Kimberly- 
Clark 
Ice machine, Scotsman 
AF-100 
Scotsman 
Ice Systems 
Rotilabo mini-centrifuge Carl Roth 
I Cycler PCR machine 
MiQ2 optical module 
Bio-Rad Shaker 3005 GFL 
Incubation Shaker Infors 
SmartspecTM 3000 
spectrophotometer 
Bio-Rad 
Labquake Rotator 
Barnstead- 
Thermo 
Sorvall Evolution RC 
centrifuge 
Kendro 
Leica DMRD fluorescence microscope Leica 
Sub Cell GT lectrophoresis 
apparatus 
Bio-Rad 
Leica DC 480 camera Leica TRIO-thermoblock Biometra 
Leica TP1020 embedding machine Leica Thermal Cycler C1000 Bio-Rad 
Leica TCS SP2 cofocal laser scanning 
microscope 
Leica Thermomixer comfort Eppendorf 
Leica SM 2000R rotation microtome Leica Thermo plate Medax 
Magnetic stirring hotplate MR 3001 
Heidolph 
Instruments 
Ultra balance LA120 S Sartorius 
Microtome water bath Vieth Vasco Nitril white Braun 
Microwave oven MB-392445 LG Vortex M10 
VWR 
International 
Mini-Protean 3 cell gel chamber Bio-Rad Waterbath 1002 GFL 
Mini-Protean Tetra system Bio-Rad   
 
 
3.1.2. Chemicals 
The chemicals and drugs used in this thesis are summarized with corresponding suppliers in 
Table 6. 
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Table 6: Lists of chemicals and drugs used in this thesis. 
Chemicals Company Chemicals Company 
Acrylamide Sigma-Aldrich Palmitate Sigma-Aldrich 
Agarose LE Roche Paraformaldehyde (PFA) Sigma-Aldrich 
Ampicillin Difco Phytanic acid Sigma-Aldrich 
Bradford reagent Sigma-Aldrich Poly-L-lysine Sigma-Aldrich 
Bromophenol blue Riedel-de-Haën Ponceau S Serva 
Calcium chloride Merck N-Propyl-gallate Sigma-Aldrich 
Citric acid Roth Protease mix Serva 
Dimethylsulfoxide (DMSO) Sigma-Aldrich RNAzol RT Sigma-Aldrich 
Dipotassium phosphate 
K2HPO4 
Merck RNaseZap Sigma-Aldrich 
Disodium phospate Na2HPO4 Sigma-Aldrich Saccharose Roth 
Ethanol Riedel-de-Haën Sodium acetate Sigma-Aldrich 
Ethidium bromide Fluka Sodium carbonate Merck 
Ethylene diamine tetraacetic 
acid (EDTA) 
Fluka Sodium chloride Roth 
Glycine Roth Sodium dodecyl sulphate (SDS) Sigma-Aldrich 
Glycerol Sigma-Aldrich Sodium hydrogen carbonate Merck 
Glycogen Sigma-Aldrich Sodium hydroxide Merck 
β-Glycerolphosphate Sigma-Aldrich Sodium iodate Merck 
Hämalaun Sigma-Aldrich 
Tetramethylethylenediamine 
(TEMED) 
Roth 
Hydrogen chloride Sigma-Aldrich 
Thiazolyl blue tetrazolim 
bromide (MTT) 
Sigma-Aldrich 
2- Isopropanol Sigma-Aldrich Tissue-Tek OCT 
VWR Scientific 
Products 
Isopropyl-β-D- 
thiogalactopyranosid (IPTG) 
VWR Scientific 
Products 
Trishydroxymethylamino 
methane (Tris) 
Merck 
Blue/orange loading dye 6x Promega 
Trisodium citrate dihydrate Sigma-Aldrich 
Lysozyme Sigma-Aldrich Triton X-100 Sigma-Aldrich 
β-Mercaptoethanol Roth 
Trypan blue Fluka 
Methanol Sigma-Aldrich 
Monopotassium phosphate 
KH2PO4 
Merck Tween 20 Fluka 
3-N-Morpholino 
propanesulfonic acid (MOPS) 
AppliChem 
5-bromo-4-chloro-3-indolyl-β-D- 
galactopyranoside (X-Gal) 
VWR Scientific 
Products 
Mowiol 4-88 Polysciences Xylene Merck 
Oil Red O Sigma-Aldrich Yeast Extract Bacto DB 
 
3.1.3. Culture media and enzymes 
The cell culture media used for the cultivation of -TC3 cells and the enzymes used in this 
thesis are listed alphabetically with notice of corresponding suppliers in Table 7. 
Table 7: List of culture media and enzymes used in this thesis. 
Culture media and enzymes Company Culture media and enzymes Company 
Albumin Fraction V 
(fatty acid-free) 
Roth Milk powder Roth 
Bovine serum albumin (BSA) Roth dNTPmix 5-PRIME 
Calf intestinal alkaline 
phosphatase 
Promega PiNK prestained protein ladder 
NIPPON 
Genetics 
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Clarity Western ECL Substrate Bio-Rad Restriction enzymes Promega 
DMEM (1x) + GlutaMAX-I, 4,5g/l 
D-glucose 
Gibco RNaseOUT Invitrogen 
DMEM (1x) + pyruvate, 1 g/l D- 
glucose, without L-glutamine, 
without phenol red 
 
Gibco 
SsoAdvanced universal SYBR 
green supermix 
 
Bio-Rad 
DMEM (1x) + L-glutamine, without 
D-glucose 
Gibco Taq DNA polymerase 5-PRIME 
Dulbecco´s phosphate buffered 
saline 1x (PBS) 
Sigma-Aldrich 0.25 % Trypsin-EDTA (1x) 
Thermo-Fisher 
Scientific 
Fetal calf serum heated 
inactivated 
Thermo-Fisher 
Scientific 
 
T4 DNA ligase 
 
Promega 
Horse serum Sigma-Aldrich 
 
3.1.4. General materials and kits 
General materials and kits used for the experimental section of this thesis are listed with 
notice of appropriate suppliers in Table 8. 
Table 8: List of general materials and kits used in this thesis. 
General materials Company General materials Company 
Cell culture flask 75 cm2 Serva Ligation buffer Promega 
CL-X Posure film 
Thermo-Fisher 
Scientific 
Molecular weight marker 1kb DNA Promega 
Cover slips 12 mm diameter Menzel-Gläser Multi-well cell culture plate 12 wells 
DB 
Biosciences 
CryoPure 1.8 ml Serva mPex13 siRNA Dharmacon 
Dihydroethidium (DHE) Invitrogen Oligo(dT) 12-18 primer Invitrogen 
DNA Stain G Serva Readymatic developer and fixer Carestream 
Dynabeads His-Tag isolation & 
pulldown 
Thermo-Fisher 
Scientific 
Regenerated cellulose dialysis 
tubing Fisherbrand 
Fisher 
Scientific 
Filter tips Sarstedt RNA molecular weight marker Promega 
FuGENE transfection reagent Promega RNase out Invitrogen 
Immobilion-P transfer 
membrane 
Millipore qRT-PCR primers (see Table 13) Operon 
INTERFERin siRNA transfection 
reagent 
Polyplus ScreenFect A transfection reagent 
Wako 
chemicals 
Kits Company Kits Company 
Amplite fluorimetric H2O2 assay 
kit 
AAT Bioquest NucleoSpin plasmid 
Macherey- 
Nagel 
Catalase 
Cayman 
Chemical 
PCR purification kit QIAquick® Qiagen 
Deoxyribonuclease I, 
amplification grade 
Invitrogen RNeasy kit Qiagen 
Gel extraction Kit QIAquick Qiagen RT-PCR kit Invitrogen 
Insulin (Mouse) ultrasensitive 
ELISA 
DRG 
Diagnostics 
  
 
3.1.5. Bacterial strains, cell lines, vectors and plasmid constructs 
 
All cell lines, bacterial strains, vectors and plasmids constructs used for the experimental section of 
this thesis are summarized with corresponding suppliers in Table 9. 
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Table 9: List of cell lines, bacterial strains, vectors and plasmids constructs used in this thesis. 
Name Supplier Name Supplier 
BL21(DE3) Rosetta 
competent cells 
Kindly provided by Prof. 
Frank Voncken, University of 
Hull, UK 
DH5α competent 
E.coli 
 
Invitrogen 
 
βTC-3 cells (mouse) 
Deutsche Sammlung von 
Mikroorganismen und 
Zellkulturen „DSMZ“ 
 
pET-16b 
Kindly provided by Prof. 
Frank Voncken, 
University of Hull, UK 
pTrcHis A Invitrogen pCMV-SPORT 6- 
Catalase 
Invitrogen 
pGEM T-Easy Promega 
 
3.1.6. Buffers and solutions 
The composition of all buffers and solutions used in this thesis for the morphological and 
biochemical experiments as well as for immunofluorescence and molecular biology are listed in 
Table 10. 
Table 10: Buffers and solutions used in this work 
Immunofluorescence and morphology 
2.5 % Anti-fading agent 2.5 g N-Propyl-gallate in 50 ml 1x PBS + 50 ml glycerol 
Blocking solution PBS + 4 % BSA + 0.05 % Tween 20 
Citrate buffer 1.5 % solution A + 8.5 % solution B in dH2O; adjusted to pH 6.0 
Dilution buffer PBS + 1 % BSA + 0.05 % Tween 20 
2 % Eosin stain solution 1 g Eosin Y + 1 drop glacial acetic acid in 100 ml H2O 
Fixation solution 4 % PFA (paraformaldehyde) + 58.4 mM saccharose in 1 x PBS buffer; 
adjusted to pH 7.4 
Fixative solution 4 % PFA in 1x PBS; adjusted to pH 7.4 
1 % Glycine 13.3 mM glycine in 1x PBS buffer 
1 % Glycine + 0.2 % Triton 
X-100 
0.1 ml Triton X-100 in 50 ml 1 % glycine 
Hematoxylin stain 
solution 
1 g Aluminum Hematoxylin (Hämalaun) + 0.2 g NaJO3 + 50 g KAl(SO4)2 + 
50 g C2H3Cl3O2  + 1 g citric acid; filled up with  H2O to a final volume of   
1000 ml 
Mounting medium 3 parts of Mowiol 4-88 + 1 part of anti-fading agent 
Mowiol 4-88 solution 16.7 % Mowiol 4-88 (w/v) in 80 ml 1x PBS + 40 ml glycerol; 
centrifuged at 15,000 x g for 1 h; supernatant collected and stored at -20°C 
Oil Red O stock solution 8.5 mM Oil Red O in 99 % isopropanol 
10x Phosphate buffered 
saline (PBS) buffer 
1.5 M NaCl + 131 mM K2HPO4 + 50 mM KH2PO4; adjusted to pH 7.4 
Solution A (citrate buffer) 1 M C6H8O7·H2O in dH2O 
Solution B (citrate buffer) 0.2 M C6H5Na3O7·2H2O in dH2O 
TEDS buffer 250 mM sucrose + 1 mM EDTA + 10 mM Tris HCl buffer; 
adjusted to pH 7.2 and supplemented with protease inhibitor 1:50 
Biochemistry 
10 % Amonium persulfate 
(APS) stock solution (w/v) 
0.1 g Ammonium persulfate in 1.0 ml dH2O 
5 % Blocking buffer 5 gr dried skimmed milk in 100 ml TBST buffer 
1x Cell lysis buffer 50 mM Tris + 150 mM NaCl + 1 % Triton X-100; 
adjusted to pH to 7.4 and supplemented with 10 % protease inhibitor 
10x Electrophoresis 
running buffer 
250 mM Tris + 2 M glycin + 1 % SDS; filled up with dH2O to a final volume of 
1,000 ml 
Laemmli buffer 1.25 ml 0.5 M Tris-HCl pH 6.8 + 2.5 ml glycerol + 2 ml 10 % (w/v) sodium 
dodecyl sulfate (SDS) + 5 % β-Mercaptoethanol (added fresh before use) + 
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 1 % Bromophenol blue; filled up with dH2O to a final volume of 9.5 ml 
Resolving gel (12 %) 
(for 1 mm thick gel) 
4 ml 30 % Acrylamide solution + 2.5 ml 1.5  M Tris-HCl (pH 8.8) + 100 µl    
10 % SDS stock solution + 60 µl 10 % APS stock solution + 5 µl TEMED + 
3.35 ml dH2O 
Stacking gel (4 %) 
(for 1 mm thick gel) 
650 µl 30 % Acrylamide solution + 1.25 ml 0.5 M Tris-HCl (pH 6.8) + 50 µl  
10 % SDS stock solution + 30 µl 10 % APS stock solution + 5 µl TEMED + 
3 ml dH2O 
Stripping buffer 100 mM β-Mercaptoethanol + 2 % SDS + 62.5 mM Tris-HCl; adjusted to pH 
6.7 
10x TBS Tris buffered 
saline 
0.2 M Trizma base + 1.4 M NaCl in dH2O; adjusted to pH 7.6 
1x TBS-Tween (TBST) 
buffer 
0.1 % (v/v) Tween 20 in TBS buffer 
0.5 M Tris-HCl 6.0 g Tris base in 1,000 ml dH2O; adjusted to pH 6.8 
1.5 M Tris-HCl 27.23 g Tris base in 150 ml dH2O; adjusted to pH 8.8 
10x Towbin buffer 25 mM Tris + 192 mM glycine + 20 % Methanol; adjusted to pH 8.3 
Molecular biology 
Ampicillin 50 mg/ml in dH2O; 1 ml per liter of media was used for a final 
concentration of 50 µg/ml 
Binding/washing buffer 50 mM Sodium phosphate pH 8 + 300 mM NaCl + 0.01 % Tween 20 
Calf intestinal alkaline 
phosphatase (CIAP) stop 
buffer 
10 mM Tris-HCl pH 7.5 + 1 mM EDTA pH 7.5 + 200 mM NaCl + 0.5 % SDS 
0.1 % DEPC-water 1 % Diethylpyrocarbonate in dH2O; let set at room temperature overnight 
and autoclaved for 30 minutes at 121°C 
Elution buffer (gel 
extraction) 
10 mM Tris-Cl pH 8.5 
5x Formaldehyde loading 
dye 
16 µl Bromophenol blue saturated aqueous solution + 80 µl 500 mM EDTA 
pH 8.0 + 12.3 M formaldehyde 37 % + 3,084 µl formamide + 4 ml 10x  
MOPS buffer + 1 ml glycerol 100 % in DEPC water; filled up to a final 
volume of 10 ml 
LB Agar 50 ml LB medium + 1 g Agar + 100 µg/ml Ampicillin 
LB (Luria Bertani) 
medium 
0.17 M NaCl + 1 % tryptone + 0.5 % yeast extract; adjusted to pH 7 
Lysate buffer 4 ml Binding/washing buffer + 10 µl protease mix 1:100 (without EDTA) + 
50 µl Lysozyme 1:100 (final concentration of 1 mg/ml) + 30 U Dnase I 
10x MOPS buffer 200 mM MOPS + 50 mM C2H3NaO2 + 10 mM EDTA in DEPC water; adjusted 
to pH. 7.0 
TfbI buffer 30 mM CH3CO2K + 100 mM RbCl2 + 10 mM CaCl2 + 50 mM MnCl2·4H2O + 
glycerol 15 % (v/v); adjusted to pH 5.8 
TfbII buffer 10 mM MOPS or Pipes + 10 mM RbCl2 + 75 mM CaCl2 + glycerol 15 % (v/v); 
adjusted to pH 6.5 
 
3.1.7. Antibodies 
The primary antibodies used for the experimental section of this thesis are summarized with 
corresponding supplier, host and dilution in Table 11. 
Table 11: List of primary antibodies used in this study. All abreviations are explained below the table. 
Antigen Host Dilution (IF) Dilution (WB) Supplier 
ABCD3 Rabbit 1:1,000 1:500 Abcam 
Alpha-tubulin Mouse 1:20,000 1:10,000 Sigma-Aldrich 
Beta-actin Mouse  1:5,000 Sigma-Aldrich 
Catalase (CAT) Chicken  1:20,000 Self-made antibody of this thesis 
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    Prof. Baumgart-Vogt´s group* 
Catalase (CAT) Rabbit 1:1,000 1:30,000 Gift from Prof. Denis Crane´s group‡ (175) 
Glucagon Mouse 1:2,000  Sigma-Aldrich 
GNPAT Rabbit 1:400  Proteintech 
His-Tag Rabbit  1:10,000 Cell Signaling 
Insulin + 
Proinsulin 
Mouse 1:2,000  Abcam 
MFP2 Rabbit 1:5,000  Molecular Probes 
PEX3p Rat 1:500  Prof. Baumgart-Vogt´s group* (174) 
PEX13p Rabbit 1:500 1:1,000 Gift from Prof. Crane´s group‡ (176) 
PEX14p Rabbit 1:2,000 1:30,000 Gift from Prof. Crane´s group‡ (177) 
PEX19p Rabbit 1:10,000  Prof. Baumgart-Vogt´s group* (174) 
PPAR Rabbit  1:1,000 Santa Cruz 
PPAR Rabbit  1:1,000 Abiocode 
PPAR Rabbit  1:1,000 Santa Cruz 
SOD2 Goat  1:5,000 Everest Biotech 
Thiolase Rabbit 1:500 1:1000 Gift from Prof. Braverman´s group٭٭ 
* Institute for Anatomy and Cell Biology, JLU, Gießen, GE; ‡ School of Biomolecular and Physical Sciences, 
Griffith Univeristy, Brisbane, Qld, AUS; ٭٭Department of Pediatrics, Faculty of Medicine, McGill University, 
Montreal, CA; GNPAT: glyceronephosphate O-acyltransferase; MFP2: multifunctional protein 2; PEX3, 13, 14 
and 19: peroxisomal biogenesis factor 3, 13, 14 and 19; ABCD3: ATP-binding cassette transporter, sub-family D, 
member 3; PPAR,,: peroxisome proliferator-activated receptor alpha, beta and gamma; SOD2: superoxide 
dismutase 2 - Mn dependent; Thiolase: 3-ketoacyl-CoA thiolase; IF: immunofluorescence; WB: Western blot 
 
The secondary antibodies used for the experimental section of this thesis are summarized 
with corresponding supplier, host and dilution in Table 12. 
Table 12: List of secondary antibodies and nuclei counterstaining used in this study. 
Secondary detection system used Host Dilution Supplier 
Western blotting 
Anti-mouse IgG horseradish peroxidase 
conjugate 
Donkey 1:50,000 
Jackson Immuno Research 
Anti-goat IgG horseradish peroxidase conjugate Rabbit 1:10,000 Jackson Immuno Research 
Anti-chicken IgY horseradish peroxidase 
conjugate 
Goat 1:10,000 
Jackson Immuno Research 
Anti-rabbit IgG horseradish peroxidase 
conjugate 
Donkey 1:10,000 
Jackson Immuno Research 
Immunofluorescence 
Anti-rabbit IgG Alexa Fluor 488 Donkey 1:300 Molecular Probes 
Anti-mouse IgG Texas Red Horse 1:300 Vector Laboratories 
Anti-mouse IgG Alexa Fluor 555 Donkey 1:300 Molecular Probes 
Anti-chicken IgY Alexa 633 Goat 1:300 Molecular Probes 
Anti-rat Cy3 Donkey 1:400 Dianova 
Anti-rat IgG Alexa Fluor 594 Goat 1:300 Molecular Probes 
Anti-sheep IgG Alexa 555 Donkey 1:300 Molecular Probes 
Counterstaining of nuclei 
TO-PRO-3 Iodide 1:750 Molecular Probes 
Hoechst 33342 1:750 Sigma 
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3.1.8. Primers 
The sequences of all primers used for the qRT-PCR and RT-PCR experiments are listed in 
alphabetical order in Table 13 summarizing the annealing temperature used for the PCR and 
the size of the amplified product. 
Table 13: Sequences of qRT-PCR and RT-PCR primers used in this study 
 
Gene of interest 
 
Symbol 
 
Accession no. 
 
Forward/reverse primers 
Ann. 
Temp. 
in °C 
Prod. 
length 
Sequences of the primers used for semi-quantitative RT-PCR 
-Actin Actb 
NM_007393. 
3 
For 
Rev 
TGCCCTGAGGCTCTTTTCCA 
TGGACAGTGAGGCCAGGATG 
60 283 
Acyl-Coenzyme A 
oxidase 1, palmitoyl 
Acox1 
NM_015729. 
3 
For 
Rev 
TGAACAAGACAGAGGTCCACGAA 
TGTAAGGGCCACACACTCACATCT 
60 565 
Acyl-Coenzyme A 
oxidase 2, branched 
chain 
 
Acox2 
NM_053115. 
2 
For 
Rev 
CTCTTGCACGTATGAGGGTGAGAA 
CTGAGTATTGGCTGGGGACTTCTG 
 
62 
 
688 
Catalase Cat 
NM_009804. 
2 
For 
Rev 
ATGGTCTGGGACTTCTGGAGTCTTC 
GTTTCCTCTCCTCCTCGTTCAACAC 
63 832 
Enoyl-coenzyme A, 
hydratase/3- 
hydroxyacyl 
coenzyme A 
dehydrogenase 
(Ehhadh) 
 
 
Mfp1 
 
 
NM_023737. 
3 
 
 
Rev 
For 
 
 
ATGGCCAGATTTCAGGAATG 
TGCCACTTTTGTTGATTTGC 
 
 
55 
 
 
211 
17-Hydroxysteroid 
dehydrogenase 4 
(Hsd17b4) 
 
Mfp2 
NM_008292. 
4 
Rev 
For 
GAGCAGGATGGATTGGAAAA 
TGACTGGTACGGTTTGGTGA 
 
55 
 
223 
Peroxisomal 
biogenesis factor 13 
Pex13 
NM_023651. 
4 
Rev 
For 
GACCACGTAGTTGCAAGAGCAGAGT 
CTGAGGCAGCTTGTGTGTTCTACTG 
60 717 
Peroxisomal 
biogenesis factor 14 
Pex14 
NM_019781. 
2 
Rev 
For 
CACTGGCCTCTGTCCAAGAGCTA 
CTGACAGGGGAGATGTCACTGCT 
60 298 
Peroxisome 
proliferator- activator 
receptor  
 
Ppard 
NM_011145. 
3 
Rev 
For 
CACCGAGTTCGCCAAGAACA 
AGAGCCCGCAGAATGGTGTC 
 
60 
 
363 
Peroxisome 
proliferator- activator 
receptor  
 
Pparg 
NM_0011273 
30.1 
Rev 
For 
TCCGTAGAAGCCGTGCAAGA 
CACCTTGGCGAACAGCTGAG 
 
60 
 
441 
Peroxiredoxin 1 Prdx1 
NM_011034. 
4 
Rev 
For 
TCTCTTTCAGGGGCCTTTTT 
CCAAAACACAGCTCAGACCA 
60 396 
Peroxiredoxin 5 Prdx5 
NM_012021. 
2 
Rev 
For 
GAAAGAAGCAGGTTGGGAGTGT 
CCCAGGGACTCCAAACAAAA 
55 184 
Superoxide dismutase 
1, (Cu, Zn-dependen) 
Sod1 
NM_011434. 
1 
Rev 
For 
AGCGGTGAACCAGTTGTGTTGT 
CCACACAGGGAATGTTTACTGC 
60 405 
Superoxide dismutase 
2, (Mn- dependent) 
Sod2 
NM_013671. 
3 
Rev 
For 
AAGTAGGTAGGGCCTGTCCGATG 
CTAAGGGACCCAGACCCAACAAG 
60 624 
Sequences of the primers used for qRT-PCR 
Acetyl-Coenzyme A 
acyltransferase /13- 
Ketoacyl-CoA thiolase 
 
Acaa 1 
NM_130864. 
3 
For 
Rev 
CAATGAACTGAAGCGTCGTG 
CACCACTGTGGCACTCTCTG 
 
60 
 
147 
-Actin Actb 
NM_007393. 
3 
For 
Rev 
GTGACGTTGACATCCGTAAAGA 
GCCGGACTCATCCGTAAAGA 
60 112 
Acyl-Coenzyme A Acox1 NM_0012718 
For 
Rev 
CCGCCACCTTCAATCCAGAG 
CAAGTTCTCGATTTCTCGACGG 
60 86 
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oxidase 1, palmitoyl  98.1    
Acyl-Coenzyme A 
oxidase 3, pristanoyl 
Acox3 
XM_0065042 
00.2 
For 
Rev 
TTCTAGTGCTGATTAACTGCCTG 
AGAAACGAAAACTGTGGTTCCA 
60 98 
Alpha-methylacyl-CoA 
racemase 
Amacr 
NM_008537. 
4 
For 
Rev 
CTATTTGGCTTTATCAGGCGTTC 
TTCTCACCGCTTCTGCCAAT 
60 51 
ATP-binding cassette 
transporter, 
subfamily D, member 
1 
 
Abcd1 
 
NM_007435. 
1 
 
For 
Rev 
 
ACAGTGCCATCCGCTACCTA 
ATGAGCTACTAGACGGCTTCG 
 
60 
 
65 
ATP-binding cassette 
transporter, 
subfamily D, member 
3 
 
Abcd3 
 
NM_008991. 
2 
 
For 
Rev 
 
TCAGAATGGGACGCTCATTGA 
TGGCAGCGATGAAGTTGAATAA 
 
60 
 
86 
Catalase Cat 
NM_009804. 
2 
For 
Rev 
TGGCACACTTTGACAGAGAGC 
CCTTTGCCTTGGAGTATCTGG 
60 114 
17-Hydroxysteroid 
dehydrogenase 4 
(Hsd17b4) 
 
Mfp 2 
NM_008292. 
4 
For 
Rev 
TTAGGAGGGGACTTCAAGGGA 
TCGCCTGCTTCAACTGAATCG 
 
60 
 
119 
Insulin Ins 
NM_008386. 
4 
For 
Rev 
TGGCTTCTTCTACACACCCAAG 
ACAATGCCACGCTTCTGCC 
60 132 
Paired box 4 Pax4 NM_011038 
For 
Rev 
GACCCTGAGACCTCTTCCT 
AGCCAACTGGCAAACTGA 
60 108 
Paired box 6 Pax6 
NM_0012441 
98 
For 
Rev 
GAGTTTGAGAGGACCCATTATCC 
TCCATTTGGCCCTTCGATTAG 
60 115 
Pancreatic and 
duodenal homeobox 
1 
 
Pdx1 
NM_008814. 
3 
For 
Rev 
TCCACCACCACCTTCCAGCTCA 
AATTCCTTCTCCAGCTCCAG 
 
60 
 
250 
Peroxisome 
biogenesis factor 13 
Pex13 NM_023651. 
4 
For 
Rev 
TGGATATGGAGCCTACGGAAA 
CGGTTAAAGCCCAAACCATTG 
60 81 
Peroxisome 
proliferator-activated 
receptor  
 
Ppara 
NM_0011134 
18.1 
For 
Rev 
TCCTTTCTGAATGGGCACTT 
TTAACATTGGGCCGGTTAAG 
 
60 
 
125 
Peroxisome 
proliferator- activator 
receptor  
 
Ppard 
NM_011145. 
3 
For 
Rev 
GCGGGCTCTAGAATTCCATC 
CCGTCTTCTTTAGCCACTGC 
 
60 
 
137 
Peroxisome 
proliferator- activator 
receptor  
 
Pparg 
NM_0011273 
30.1 
For 
Rev 
TTTTCAAGGGTGCCAGTTTC 
ATGGACACCATACTTGAGCA 
 
60 
 
128 
Phytanoyl-CoA 
hydroxylase 
Phyh 
NM_010726. 
2 
For 
Rev 
ACTGCCTTCTCCCCGAGATT 
TGGGTCCAGTGAAACACTCCA 
60 51 
Sterol carrier protein 
X/2 
ScpX/2 
NM_011327. 
4 
For 
Rev 
TGGGTGGTGGATGTGAAGAA 
TGAAAGAAGGCCGACTGAGG 
60 140 
Superoxide dismutase 
1 (Cu, Zn-dependen) 
Sod1 
NM_011434. 
1 
For 
Rev 
GGAACCATCCACTTCGAGCA 
CCCATGCTGGCCTTCAGTTA 
60 87 
Superoxide dismutase 
2 (Mn- dependent) 
Sod2 
NM_013671. 
3 
For 
Rev 
GGGAGCACGCTTACTACCTTC 
GAGCCTGGCACTCAATGTG 
60 150 
 
3.2. Methods 
3.2.1. Culture of the murine β-TC3 cell line 
β-TC3 adherent cells were cultured in Dulbecco´s MEM medium containing 4,5 g/l glucose 
and supplemented with 15 % (v/v) horse serum and 2,5 % (v/v) heated-inactivated fetal 
bovine serum. The cells were used for the experiments between passages 15–40. β-TC3 cells 
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were incubated at 37°C in a humidified atmosphere of 8 % CO2 and split for subculture (1:10 
dilution) every 3 days when about 90 % confluency was reached. One ml of 1x 0.25 % 
Trypsin-EDTA was used for 2 min to harvest the cells. β-TC3 cells were seeded out at a 
density of 5 x 104 cells into each well of a 24 well cell culture plate before each experiment. 
3.2.2. Induction of insulin secretion via glucose stimulation 
β-TC3 cells were seeded into appropriate culture dishes 2–3 days before the experiment and 
grown under the cell culture conditions mentioned above. The day of the experiment the 
cells were then incubated with DMEM medium without glucose for 1 h and thereafter 
stimulated for 12 h with DMEM medium containing 20 mM glucose. 
3.2.3. Incubation with fatty acids to induce lipotoxicity 
3.2.3.1. Palmitic acid (hexadecanoic acid) 
To explore the role of peroxisomal metabolism during lipotoxic stress, wild type, Pex13- and 
Abcd3-knockdown β-TC3 cells were challenged with an overload of palmitic acid (PA). The 
preparation of the PA was performed as previously described (178). Palmitate/bovine serum 
albumin (BSA) conjugates were prepared through soaping of PA with NaOH and then mixing 
with fatty acid-free BSA. A stock solution of PA (20 mM) was prepared with NaOH (0,01M) in 
dH2O. Before use, the solution was incubated at 70°C for 30 min. Ten % fatty acid-free BSA 
in 1x PBS was combined with the fatty acid soaps in a 3:1 volume ratio. The 5 mM palmitate 
conjugates were freshly diluted in complete standard DMEM medium to obtain the desired 
final concentrations. For the experiments, the cells were treated for 48 h (unless otherwise 
specified) in the presence of BSA-NaOH (vehicle) as a control or with the PA-BSA complex as 
indicated. 
3.2.3.2. Phytanic acid (3,7,11,15-tetramethyl hexadecanoic acid) 
Phytanic acid was diluted 1:1,000 in DMSO to prepare a stock  solution  of  16.8  mM. A 250 
µM PHY solution was freshly made in complete standard DMEM medium. A working 
solution was prepared according to the desired final concentration in DMEM medium. The 
amount of DMSO in the final solution treatment was not higher than 0.6 %. For the 
experiments, wild type, Pex13- and Abcd3-knockdown β-TC3 cells were incubated in the 
presence of DMSO as a control (in a comparable concentration of the final solution 
treatment). 
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3.2.4. Knockdown of Pex13 or Abcd3 gene expression by siRNA-mediated transfection 
of β-TC3 cells 
To analyze peroxisomal dysfunction, transient transfection was accomplished by siRNA- 
mediated Pex13- or Abcd3-knockdown in β-TC3 cells via lipofection using INTERFERin siRNA 
transfection reagent (Polyplus). The cells were seeded the day before the transfection at a 
density of 5 x 104 cells per well (24-well plate), to reach ~40 % confluency at the time of 
transfection. A final siRNA concentration of 30 nM (for Pex13-si RNA) or 50 nM (in the case 
of Abcd3-si RNA) was diluted into 100 µl of serum-free DMEM medium. Then, 3 µl 
INTERFERin reagent were added and immediately homogenized for 10 s. The complex was 
incubated for 15 min at RT. Five hundred µl of fresh complete DMEM medium were added, 
subsequently 100 µl of the transfection mix was incorporated dropwise. 
Table 14: List of small interfering RNA (siRNA) used in this thesis 
Pex13-siRNA 
Company: Dharmacon® GE Healthcare 
Reference number: SO-2488657G 
Name mPEX13 modified siRNA 
Sense Sequence GCU AUA GCC CUU AUA GUU AUU 
Antisense Sequence UAA CUA UAA GGG CUA UAG CUU 
Abcd3-siRNA 
Company: Santa Cruz Biotechnology, INC 
Reference number: sc-41148 
Name ABCD3 siRNA (m) 
Sequences Not given by the company 
Control-siRNA (Scr-siRNA) 
Company: QIAGEN, Hilden, Germany 
Reference number: 1027280 
Name AllStars Negative Control siRNA 
Sequences Not given by the company 
 
3.2.5. Cell viability tests 
3.2.5.1. Methylthiazole tetrazolium (MTT) test 
To determine the viability of β-TC3 cells after being exposed to different treatments, the 
MTT test was used. A 12 mM MTT stock solution was prepared in DMEM without phenol red 
and filtrated. A working solution was freshly made by diluting the stock solution 1:10 in 
DMEM. Subsequently, the treated cells were incubated with 500 µl of the MTT working 
solution and maintained at 37°C and 8 % CO2 in a humidified chamber for 3 h. After labelling 
the cells with MTT, 1 ml DMSO/isopropanol (1:1) was added to each well to solubilize the 
newly formed formazan. The absorbance of the produced formazan was read at 570 nm 
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(background wavelength of 670 nm) using a spectrophotometer. The percentage of cell 
 
viability was calculated according to the formula: ( 
3.2.5.2. Trypan blue assay 
 
A570 of the sample 
A570 of the control 
 
) × 100. 
Cell viability was also determined by the ability of β-TC3 cells to exclude trypan blue since 
living cells with intact cell membranes do not take the stain up. Adherent cells were brought 
into suspension using 0.25 % trypsin/EDTA in HBSS without Ca2+/Mg2+and then resuspended 
in fresh warm medium containing serum. To break up clumps the cells were gently pipetted 
up and down a few times. Two hundred µl of the cell suspension were removed and added 
to an equal volume of 0.4 % filtrated trypan blue in 1x PBS. Both sides of a haemocytometer 
chamber were filled with 10 µl of the cell suspension and the number of viable and non- 
viable cells were counted under an inverted phase contrast microscope. Eight fields and at 
least 200 cells not stained with trypan blue per assay condition were counted. The cell 
density was then calculated as follows: 
( 
Number of living cells ) × Dilution factor × 1 x 104 . 
Number of large corner squares counted 
 
To obtain the number of dead cells, non-viable trypan blue-positive cells were counted and 
calculated as follows: 
( 
Number of non−viable cells ) × Dilution factor × 1 x 104 . 
Number of large corner squares counted 
 
Finally, the percentage of viability was calculated using the next equation: 
 
Number of viable cells 
( 
Total cell number 
 
) × 100. 
 
3.2.6. Molecular biological experiments 
3.2.6.1. Laser capture microdissection (LCM) of Langerhans islets 
A protocol has been carefully established taking all the precautions aimed to avoid the 
activation of tissue RNases in pancreas tissue. All materials were cleaned using RnaseZap or 
irradiated with UV light at 254 nm for 30 min. Dissection instruments were heat sterilized at 
180°C for 15 min before use and all the solutions and plastic ware were RNase free. 
Reagents were freshly prepared in DEPC-treated water. 
An icy chamber containing chilled isopentane surrounded by dry iced and 100 % ethanol 
was prepared in advance. Male wild type C57BL/6J mice (3-4 months old) were killed under 
anaesthesia by cervical dislocation and the pancreatic tissue was quickly removed, placed 
into a cryomold (so that the desired cutting surface of the tissue laid flat on the bottom) 
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and carefully covered with cold Tissue-Tek OCT embedding compound. The mold was 
transferred into the cooled isopentane until the OCT completely solidified. Thereafter, the 
isopentane in the specimen was left to evaporate onto dry ice and the sample was wrapped 
tightly in aluminum foil and stored at -80°C until sectioning. 
Sectioning was performed in a cryostat equilibrated at -20°C. Fourteen µm sections were cut 
and three of them mounted on a UV-treated membrane slide cooled inside the cutting 
chamber (-20°C) and thereafter stored at -80°C inside of sterile 50 ml Falcon tubes. One 
section out of every 5 was kept for H&E staining to evaluate the presence of islets in the 
tissue sections and to draw a tissue map of the islet distribution making the laser cutting 
procedure faster and more efficient. 
Tissue dehydration and staining were performed on one slide at a time immediately after its 
removal from a box kept on dry ice and before the LCM session (Figure: 7). 
0.1 % Cresyl 
Violet 
 
Drying 
 
     
 
     
2 min 30 s 15 s 15 s 15 s 
Figure: 7. Summary of the tissue dehydration and staining procedures performed before laser capture 
microdissection 
 
The LCM and pressure catapulting of the sample were carried out in a PALM Robo 
microdissection system using a 40 x objective. Laser power and duration were kept around 
35 mW and 2.5 ms respectively. To avoid possible cross contamination with other cell types, 
mainly the core of each islet was dissected. 
 
Figure 8: Tissue section of murine pancreatic tissue dehydrated and stained according to the described 
protocol for LCM. A: islet of Langerhans before LCM; B: same islet after LCM was performed; C: group of islets 
collected in a tube cap after catapulting the dissected cells at the end of the session. Scale bars in A-B: 150 m, 
in C: 300 m. 
100 % 
EtOH 
70 % 
EtOH 
70 % 
EtOH 
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The microdissected endocrine islet cells were then catapulted into a tube cap containing 
1.5 µl of mineral oil and RNA later. After collecting the dissected islets, 50  µl RNAzol plus    
5 µl carrier-RNA were added to the sample, which was quickly centrifuged, and stored at 
-20°C for subsequent RNA extraction. The microdissection session of one objective slide 
with 3 frozen sections was never longer than 15 min to preserve the RNA from degradation. 
3.2.6.2. RNA isolation from β-TC3 cells and reverse transcription to generate cDNA 
 
Total RNA from β-TC3 cells was isolated using RNAzol RT reagent. The cells were lysed in  
300 µl RNAzol RT containing glycogen as a carrier (250 µg/ml) and collected directly from 
the cell culture plate by using a cell scraper. After collection, 0.4 ml of RNase-free water per 
ml of RNAzol RT used were added. After vigorous shaking for 15 s, sample DNA, proteins and 
polysaccharides were precipitated for 15 min at RT and by centrifugation at 12,000 x g for 
15 min at 4°C. Thereafter, the upper supernatant containing the RNA was carefully 
transferred into a new tube and to precipitate the RNA an equal volume of 100 % 
isopropanol (~400 µl) was added. After 10 min incubation, the sample was centrifuged at 
12,000 x g for 10 min at RT. The RNA pellet was washed twice with 0.4 ml 75 % ethanol (v/v) 
in DEPC water per 1 ml of supernatant used for precipitation and centrifuged at 8,000 x g for 
3 min at RT. The RNA pellet was then solubilized in 15 µl RNase-free water at a 
concentration of ~1 µg/µl and stored at -80°C prior to further use. The final preparation had 
a A260/A280 ratio of 1.7-2.1 and a A260/A230 ratio of 1.6-2.3 measured with a NanoDrop 2000 
spectrophotometer. As a quality control the RNA was analysed on a 1.2 % formaldehyde 
agarose gel (see 3.2.6.3). 
To eliminate any possible residual genomic DNA in the RNA sample, the digestion of single- 
and double-stranded DNA was performed using a Deoxyribonuclease I kit before reverse 
transcription. To prepare the RNA sample the following ingredients were added into a 
RNase-free tube on ice: 1 µg of RNA sample, 1 µl of 10x DNase I reaction buffer, 1 µl of 
DNase I, Amp Grade (equivalent to 1 U/µl) and adjusted to a final volume of 10 µl with 
DEPC-water. After 15 min incubation at RT, 1 µl of 25 mM EDTA solution was added to the 
reaction mixture to inactivate the DNase I. Subsequently the sample was heated for 10 min 
at 65°C in a Thermoblock. 
First-strand cDNA was synthesized from 1-2 µg RNA. A 2x RT-master mix containing the 
following ingredients was prepared and kept on ice: 2 µl of 10x RT buffer, 0.8 µl of 25x dNTP 
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mix (equivalent to 100 nM), 2 µl of 10x RT random primers, 1 µl of MultiScribe reverse 
transcriptase, 1 µl of RNase OUT and 3.2 µl of DEPC-water. Ten µl of the prepared 2x master 
mix was added into a tube containing 10 µl of RNA (1 µg). Subsequently, the tubes were 
incubated at 25°C for 10 min and at 37°C for 120 min for reverse transcription. Finally, the 
samples were heated at 85°C for 5 min to inactivate the reaction. 
3.2.6.3. RNA formaldehyde agarose gel electrophoresis 
The overall quality of the isolated RNA was assessed by electrophoresis on a formaldehyde 
agarose gel. To prepare a 1.2 % agarose gel, 1.2 g agarose were dissolved in 90 ml DEPC 
water and then 10 ml 10x MOPS buffer and 1 µl ethidium bromide stock solution (10 mg/ml) 
were added. The gel was poured into a tray previously washed with RNase AWAY and then 
allowed to set at RT. Four volumes of 5x formaldehyde loading dye were added to 4 µg (~4 
µl) of RNA sample. After a heat-denaturing procedure (65°C for 5 min) the sample was 
immediately cooled on ice and then loaded into the gel in a tank containing 1x 
formaldehyde running buffer. The gel was run at 60 V for 90 min and the bands visualized 
on a UV transilluminator. An RNA marker was loaded together with the samples and 
prepared according to manufacturer´s instructions. The integrity of the RNA was 
documented by photographing of the ethidium bromide-stained intact 28S and 18S 
ribosomal RNA bands. 
3.2.6.4. cDNA amplification by semiquantitative polymerase chain reaction (RT-PCR) 
and agarose gel electrophoresis 
Amplification was performed as follows: a standard PCR reaction master mix was prepared 
containing 1 U of Taq DNA polymerase, 500 nM of forward primer, 500 nM of revere primer, 
1 µl of template cDNA, 2.5 µl of 10x PCR reaction buffer, 0.2 µl of 10 mM dNTP mix and 
adjusted to a final volume of 25 µl using DEPC-water. The PCR reactions were carried out in 
a Bio-Rad iCycler C1000 using the following parameters: 95°C for 3 min (pre-denaturation) 
followed by 35 cycles of amplification: 95°C for 30 s (denaturation), 50-65°C for 30 s 
(annealing) and 72°C for 1 min (extension) concluding with a final extension at 72°C for 5 
min. To analyse the target gene expression resulting from the amplification, agarose gel 
electrophoresis was used to separate the RT-PCR product by size. 28S rRNA was used as a 
control for the normalization of the gene expression using ImageJ software. The sequences 
of the primers used for the qRT-PCR are listed in Table 13. The specific annealing 
temperature for each primer pair was optimized with a temperature gradient from 55-65°C 
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in an iCycler basal PCR machine (without optical module) before conducting the 
experiments. 
Gel electrophoresis was used as a standard procedure for separating DNA by size (to be 
used either for visualization or purification). Depending on the size of the bands needed to 
be separated a 1, 2 or 4 % agarose gels were prepared. For a 1 % gel, 1 gr of agarose was 
poured into 100 ml of 1xTAE buffer and microwaved until the agarose was completely 
dissolved. After cooling down the solution, 4.5 µl SERVA DNA stain G were added, mixed, 
and poured into a gel tray and allowed to solidify. Gels were run in a Sub-Cell GT 
electrophoresis cell (Bio-Rad) in 1xTAE buffer at 120 V. Before loading, 2 µl of gel loading 
buffer were added to each DNA sample. A 1 kb DNA ladder was loaded in parallel to detect 
and compare the DNA band sizes after electrophoresis. The DNA fragments were visualized 
with UV light using the Gel-Doc 2000 transilluminator and analysed with the Gel-Doc 2000 
gel imaging system. 
 
3.2.6.5. cDNA amplification by quantitative real-time polymerase chain reaction (qRT- 
PCR) 
Amplification was performed using a SsoAdvanced universal SYBR green master mix on an 
IQ5 I cycler using the standard protocol recommended by the manufacturer. The samples 
were prepared in duplicates as follows: 5 µl of 2x SYBR green, 500 nM of forward primer, 
500 nM of reverse primer and 1 µl of template cDNA. The reaction was adjusted to a final 
volume of 10 µl with DEPC-water. The polymerase activation and DNA denaturation were 
performed at 95°C for 3 min followed by 40 cycles at 95°C for 15 s (denaturation), Tm 60°C 
for 30 s (annealing), and 72°C for 1 min (extension). The average threshold (Ct) values of at 
least three independent experiments were used to calculate the relative amounts of mRNA 
using the 2-ΔΔ CT method and normalized to -actin values. For the sequences of the 
primers used for the qRT-PCR refer to Table 13. The specificity and efficacy of all primers 
were validated before use. For each primer set, a standard curve was generated from cDNA 
stepwise diluted from 10-fold to 10,000-fold to investigate the efficiency of all primer pairs 
used. 
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3.2.6.6. Western blot analysis 
3.2.6.6.1. Isolation of protein from whole cell lysates 
Western blot analysis was used for the visualization and relative quantification of proteins. 
Protein samples were collected from cells grown on cell culture dishes on ice by using a 
rubber policeman in cold cell lysis buffer containing a protease inhibitor cocktail (1:100).  
The collected samples were subjected to 3 cycles of cooling for 10 min on ice and vigorous 
vortexing thereafter for 5 s. Subsequently, they were centrifuged at 2,500 x g for 10 min at 
4°C. After centrifugation, the supernatants were collected for further use. All samples were 
kept on ice during the procedure to minimize protease activity. Protein concentration was 
determined according to Bradford (179) using BSA as a standard. The average of three 
independent measurements of each sample was used to calculate the protein 
concentration. 
3.2.6.6.2. Isolation of peroxisome-enriched fractions from pancreas and liver 
To isolate peroxisome-enriched fractions from mouse pancreata and liver, male wild type 
C57BL/6J mice (3-4 months old) were killed under anaesthesia by cervical dislocation and 
immediately perfused with 1x PBS buffer injected through the left ventricle. Liver and 
pancreas were quickly removed and ~50 mg of tissue were resuspended in 2 ml TEDS buffer 
on ice. After mincing the tissue into small pieces, it was shredded with the help of an 
ultraturrax. The resulting lysate was homogenized with a Dounce homogenizer using 30 
manual up and down strokes always keeping the sample on ice. A first centrifugation step 
(1,000 x g at 4°C for 10 min) was carried out to obtain the nuclear fraction. The resulting 
supernatant was centrifuged at 5,000 x g at 4°C for 10 min to remove the large 
mitochondrial fraction and later centrifuged again at 30,000 x g at 4°C for 30 min with the 
purpose to isolate the peroxisome-enriched and cytoplasmic fraction. The peroxisomal 
pellet was resuspended in 200 µl buffer containing Tris (50 mM) pH 8.0, NaCl (150 mM) and 
0.1 % Triton X-100. Samples were stored at -20°C until used. 
 
3.2.6.6.3. Polyacrylamide gel electrophoresis (PAGE) 
Prior to SDS-PAGE, sample solubilisation was carried out in Laemmli buffer containing SDS 
and 2-β-mercaptoethanol. After addition of the sample buffer, the samples were incubated 
at 95°C for 5 min and subsequently kept on ice for another 5 min. Ten to 20 µg of total 
protein were loaded in a 12 % SDS polyacrylamide gel in 1x electrophoresis running buffer 
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for separation. The electrophoresis was performed using a Mini-PROTEAN chamber (Bio- 
Rad) for 40 min at 200 V. A precision plus protein dual color (Bio-Rad) ladder was used as 
recombinant standard. 
3.2.6.6.4. Electrophoretic transfer and immunodetection of specific proteins 
For the protein transfer onto a polyvinylidene fluoride membrane (Immobilion-P transfer 
membrane) a tank blotting procedure was performed. The transfer was carried out for 1 h 
at 100 V in cooled Towbin buffer. Non-specific protein-binding sites on the membrane were 
blocked using a blocking solution for at least 1 h at RT with gentle agitation. After washing 
the membrane in TBST buffer for 5 min, the blots were incubated for 1 h at RT with the 
primary antibody at the optimized dilution (refer to Table 11) in blocking solution with 
gentle agitation. Thereafter the membrane was washed 3 times (15, 5 and 5 min) in TBST 
buffer before incubation with a secondary antibody (see Table 12) diluted in blocking 
solution for 1 h at RT. A final washing procedure for 15 min and 2x for 5 min prior to blot 
development was performed. The chemiluminiscence detection of HRP activity was 
achieved by incubating the membrane for 5 min with the Clarity Western ECL Substrate 
(Bio-Rad). The blot was exposed to a CL-X Posure film (Thermo Scientific) and developed 
with Readymatic developer and fixer (Carestream). The transferred membranes were 
stripped and re-probed not more than 3 times to detect different target proteins. Except for 
the detection of thiolase (due to antibody shortage), all Western blot analyses were 
performed in triplicates. 
3.2.6.6.5. Total protein detection 
3.2.6.6.5.1. Ponceau S staining 
After transfer, the membrane was immersed in Ponceau S Stain solution and incubated for 2 
min to visualize pattern of the transferred proteins was satisfactory. Afterwards, the 
membrane was destained in dH2O until complete cleaning of the dye. Subsequently, the 
membrane was rinsed in TBST buffer for 5 min with gentle agitation and a standard 
immunodetection procedure was carried out. 
 
3.2.6.6.5.2. Coomassie staining 
After washing the gel or/and the membrane 3 times (5 min each) in dH2O to remove excess 
of SDS and to minimize background staining, the gel/membrane was incubated with 
Coomassie brilliant blue stain for 1 h at RT with gentle agitation. Subsequently, the 
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gel/membrane was rinsed 3 times (5 min each) in dH2O and only in the case of membrane 
staining, once more in 30 % methanol until the desired resolution was attained. 
3.2.6.6.6. Membrane stripping and re-probing 
Due to shortage of pancreatic protein samples, Western blot membranes were re-probed. 
After incubation in stripping buffer for 10 min at 60°C on a roller, the membranes were 
washed 2 times (10 min each) at RT using large volumes of TBST buffer. Subsequently, the 
membranes were immersed in 5 % (w/v) blocking solution in TBST buffer for 1 h at RT 
before performing the next immunodetection. 
 
3.2.7. Morphological experiments 
3.2.7.1. Hematoxylin and Eosin (H&E) staining 
One to 2 µm tissue sections were first deparaffinized with Xylene 3 times (5 min each) and 
then hydrated in alcohol in a downstream dilution series (99  %, 99  %, 96  %, 80 %, 70 %,   
50 %) 3 min each. The samples on objective slides were rinsed in dH2O for 3 min and 
incubated in Mayer´s hematoxylin solution for 2 min. The slides were rinsed in running tap 
water (10 min), placed in dH2O for some seconds and counterstained with Eosin Y solution 
containing 0.2 % glacial acetic acid for 30 s. Samples were rinsed shortly in dH2O followed by 
sample dehydration and clearance by immersion  in 50, 70, and 80  % EtOH (each  1 min),  
96 % EtOH (3 min), and 99 % EtOH (2 times 3 min each). Finally, the slides were immersed in 
Xylene (3 times for 5 min each), allowed to dry and mounted in DEPEX. 
 
3.2.7.2. Oil red O staining (ORO) 
Oil red O (ORO) staining was used to analyse lipid droplet appearance. After treatment, β-
TC3 cells were gently rinsed with 1x PBS and then fixed with 10 % formalin for 10 min. The 
formalin was removed and fresh 10 % formalin was added for 1 h more. After gently rinsing 
twice with dH2O, 60 % isopropanol was added and allowed to stand for 5 min with the 
purpose of preventing the carrying of dH2O into the ORO solution. The cells were then 
stained with freshly diluted oil red O solution (5.1 mM) for 10 min. Thereafter, the stain was 
removed and the cells were washed four times with tap water until the water appeared 
clear. As counterstain, the samples were incubated for 2 min with 10 % hematoxylin. The 
slides were mounted in Mowiol 4-88 solution. All the procedures were performed at RT. 
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3.2.7.3. Indirect immunofluorescence staining of cultured β-TC3 cell line 
β-TC3 cells were grown on poly-L-lysine coated coverslips before staining. After washing the 
cells with 1x PBS buffer for 2 min, they were fixed with 4 % PFA + 2 % saccharose in PBS at 
RT for 20 min. Thereafter, the cells were rinsed 3 times with 1x PBS for 10 min each. The 
samples were incubated first with fresh prepared 1 % glycine solution in 1x PBS for 10 min 
and thereafter in 1 % Glycine containing 0.2 % triton X-100 for 25 min for permeabilization. 
After washing the cells 3 times (10 min each) with PBS, the blocking of the nonspecific 
antibody-binding sites was achieved by 45 min incubation in blocking solution. 
Subsequently, the samples were incubated in diluted antibody (in blocking buffer) at the 
optimized dilution (refer to Table 11) overnight at 4°C in a light-tight box. The next day, the 
samples were washed 3 times in 1x PBS (5 min each) and incubated with the secondary 
antibody diluted in blocking buffer for 1 h at 4°C in the dark. As a counterstaining, Hoechst 
33342 (2µg/ml) in 1x PBS was used for a 10 min incubation. After rinsing the samples one 
more time with 1x PBS the coverslips were mounted with a drop of Mowiol/n-propyl-gallate 
(3:1) on super frost plus slides. Slides were stored in the dark at 4°C. 
3.2.7.3.1. Coating of coverslips for cell culture 
A 0.1 % solution of poly-L-lysine was prepared in a 1:1 (v/v) solution of 1.91 % borax buffer 
and 1.25 % boric acid buffer and filtrated. Twelve mm diameter autoclaved coverslips placed 
in a 24-well plate were coated with the poly-L-lysine solution and incubated overnight at RT. 
The next day the solution was removed, and the coverslips were rinsed 2 times with 
autoclaved dH2O and allowed to rest for 5 h. Thereafter, the coverslips were rinsed 2 times 
with autoclaved dH2O with an incubation time of 20 min in between. Finally, the coated 
coverslips were allowed to dry completely and stored at 4°C. All procedures were 
performed under sterile conditions. 
 
3.2.7.4. Indirect immunofluorescence staining of paraformaldehyde-fixed paraffin- 
embedded mouse pancreata 
Male wild type C57BL/6J mice (3-4 months old) were used for the immunofluorescence- 
based detection and the precise localization of peroxisomal antigens in pancreata. The 
animals were killed under anaesthesia via cervical dislocation and perfused-fixed with 4 % 
paraformaldehyde (PFA) containing 2 % saccharose in PBS (pH 7.4) injected through the left 
ventricle. After a second fixation procedure by immersing the dissected tissue in PFA 
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overnight, the fixed samples were paraffin-embedded using a Leica TP 1020 automated 
vacuum infiltration tissue processor. Using a Leica RM2135 rotation microtome, sections of 
1-2 µm were cut and mounted on super frost plus slides and stored at RT until needed. 
An indirect immunofluorescence protocol was established for immunolabeling of mouse 
pancreatic paraffin sections. A first deparaffinization step was carried out in an oven at 50°C 
overnight. After a second deparaffinization procedure by immersing the  slides  in  Xylene   3 
times for 10 min each, the sections were rehydrated in a series of ethanol at different 
dilutions (99 %, 99 %, 96 %, 80 %, 70 %, 50 %) 3 min each and rinsed in dH2O for 2 min. For 
antigen retrieval the samples were treated with trypsin (0.01 %) in 1x PBS for 8 min at 37°C 
followed by microwave irradiation. Before microwaving, the samples were washed 3 times 
in 1x PBS (5 min each) and once in dH2O. Thereafter, microwaving was carried out for 3x5 
min in 10 mM sodium citrate buffer at pH 6. The samples were allowed to cool slowly for 
refolding of proteins. Thereafter, they were washed, once shortly in dH2O and 3 times for    
5 min in PBS. Nonspecific binding sites were blocked with blocking solution for 2 h at RT in a 
light-tight box. The sections were washed in PBS and finally incubated with the primary 
antibodies at the optimized dilution (see Table 11) in dilution buffer overnight. The next day 
the specimen were rinsed 3 times in 1x PBS 5 min each and incubated in fluorochrome- 
conjugated secondary antibodies in dilution buffer for 2 h in the dark. The slides were rinsed 
3 times in 1x PBS for 5 min each and incubated for 10 min with TO-PRO-3 iodide and/or 
Hoechst 33342 diluted in 1x PBS (1:750) to visualize nuclei. Finally, coverslips were mounted 
with Mowiol 4-88 and n-propylgallate as an antifading agent at a 3:1 dilution and allowed to 
cure overnight at RT protected from light. Negative controls were processed in parallel by 
addition of dilution buffer instead of the primary antibody and washed separately. To be 
able to examine the co-distribution of 2 different antigens in the same sample, a double 
immunofluorescence procedure was simultaneously carried out if necessary. In that case     
2 antibodies from different species were chosen and appropriate secondary antibodies 
selected that were not cross-reacting with each other. 
 
3.2.8. Insulin enzyme-linked immunosorbent assay (ELISA) 
An insulin ultrasensitive ELISA assay was used for the quantitative determination of insulin 
secretion and cellular insulin storage. After cell treatment (see 3.2.3.) and to determinate 
the insulin secretion, the medium was collected from the samples and centrifuged for 
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10 min at 4°C and 2,000 x g. In parallel, total protein was isolated from the cells with the cell 
lysis buffer and used for insulin storage determination by ELISA. Twenty-five µl of each 
sample or the calibrators were incorporated to a 96-wells plate. Thereafter, 100 µl of the 
enzyme conjugate 1x solution were added and incubated on a plate shaker (700 rpm) for 2 h 
at RT. The wells were washed 6 times with 350 µl washing buffer 1x solution per well. 
Subsequently, 200 µl of substrate TMB were added to each well and allowed to stand for  15 
min. After the addition of 50 µl stop solution, the optical density was read at 450 nm and 
the results were calculated against the absorbance values obtained for the calibrators using 
a data analysis software (www.elisaanalysis.com). The results were normalized to the total 
protein concentration, measured by Bradford assay. 
3.2.9. Cellular reactive oxygen species detection 
3.2.9.1. 2´,7´-Dichlorofluorescein diacetate (DCFDA) detection of H2O2 generation 
Intracellular generation of ROS (hydroxyl and peroxyl) was detected with the 2´,7´- 
dichlorofluorescein diacetate (DCFDA) dye. This dye diffuses into the cell where it is 
deacetylated by cellular esterases to a non-fluorescent compound. Subsequently DCFDA dye 
can be oxidized by ROS into 2´, 7´-dichlorofluorescein (DCF) which is highly fluorescent. 
Transfected and attached β-TC3 cells were removed from the cell culture plates and brought 
into suspension by trypsinization for 2 min. Thereafter, the reaction was stopped by 
addition of fresh medium and the cells were centrifuged for 5 min at 500 x g at RT. The cells 
were resuspended and stained with 20 µM DCFDA in prewarmed DMEM medium without 
phenol red supplemented with 10 % foetal calf serum and EDTA (2 nM) at 37°C in a 
humidified atmosphere of 8 % CO2 for 30 min. Thereafter, the medium containing DCFDA 
dye was removed via centrifugation and the cells treated with palmitic or phytanic acid for  
6 h. The result was examined on a LEICA DMRD microscope (equipped with a LEICA CD480 
camera) at excitation / emission spectra of 485 nm and 535 nm respectively. The 
fluorescence change was determined as percentage after background subtraction. A 30 min 
treatment with antimycin A (65 µM) was used as a positive control due to its capacity to 
induce ROS production via inhibition of the mitochondrial electron transport chain complex 
III. 
3.2.9.2. Dihydroethidium (DHE) detection of superoxide generation 
To detect superoxide generation in living cells, the oxidizable fluorescent probe 
dihydroethidium (DHE) was used. This compound is dehydrogenated to ethidium in the 
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presence of superoxide once internalized into the cells. Sample cells were incubated in a    
10 µM DHE solution in standard complete DMEM medium at 37°C and 8 % CO2 for 30 min. 
After a washing procedure with 1x PBS (2 times, 5 min each) the cells were fixed with 4 % 
PFA for 20 min at RT. Thereafter, the samples were washed 3 times (10 min each) in 1x PBS. 
Subsequently, nuclei were counterstained with Hoechst 33342 (1:750 in 1x PBS) for 10 min. 
After rinsing 2 times for 5 min each with 1x PBS, the coverslips were mounted with a drop or 
Mowiol 4-88 on super frost plus slides. Fluorescence emission was detected with a LEICA 
DMRD microscope (equipped with a LEICA CD480 camera) with maximum excitation and 
emission spectra of 530 nm and 600 nm respectively. 
3.2.10. Catalase activity assay 
The enzymatic activity of catalase was determined based on its peroxidatic function. The 
formaldehyde produced in the reaction of catalase with methanol in the presence of an 
optimal concentration of H2O2 was measured spectrophotometrically using a catalase assay 
kit. The cells were harvested using a rubber scraper and then homogenized on ice in 2 ml 
cold buffer containing 50 mM potassium phosphate and 1 mM EDTA (pH 7.0). After 
centrifugation at 10,000 x g for 15 min at 4°C the supernatant was removed and kept on ice. 
In individual wells of a 96-wells plate, 100 µl of diluted assay buffer, 30 µl of methanol, and 
20 µl of each sample supernatant were loaded. Thereafter, 20 µl of diluted H2O2 were added 
to each well and then incubated on a shaker for 20 min at RT in the dark. To terminate the 
reaction, 30 µl of diluted potassium hydroxide and 30 µl of catalase purpald were 
incorporated to each well and incubated for 10 min on a shaker. Finally, 10 µl of catalase 
potassium periodate were added and after a 5 min incubation the absorbance was 
monitored at 540 nm using a plate reader. Results were normalized to total protein 
concentration measured by Bradford assay. 
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Preparation of 
chemocompe- 
tent DH5 
bacteria 
Transformation of 
competent DH5 
bacteria with Cat- 
pCMV-SPORT 6 
vector containing 
the catalase ORF 
for plasmid 
replication 
Isolation of 
plasmid DNA 
by mini or 
midi plasmid 
preparations 
 
Subcloning of the catalase 
constructs (Cat-Sac I / Hind 
III and Cat- Nde I / Nde I) 
into a pGEM T-Easy vector 
 
Chicken immunization 
with the eluted 
recombinant catalase 
• 600 g of protein for 
each animal (2) 
(Pineda-Antikörper 
Service, Berlin) 
3.2.11. Catalase expression for antibody generation 
 
 
 
 
*All techniques and plasmid maps are described in detail in the Appendix. 
Catalase coding sequence 
amplification from the bacterial 
vector 
Cat-pCMV-SPORT 6 by PCR 
• Design of gene-specific cloning 
primers containing the 
restriction enzymes sites for: 
Sac I / Hind III and Nde I / Nde I 
• Addition of the restriction sites 
to the piece of DNA 
Purification of 
PCR-derived 
DNA fragments 
from agarose 
gels 
Blue/white screening for the 
identification of correclty- 
generated recombinant plasmids 
Restriction digestion of plasmid 
DNA using the chosen restriction 
enzymes from: 
• Expression vectors 
(pET-16b and pTrcHis A) 
• Cat-pGEM T-Easy constructs 
Dephosphorylation of 
5´overhangs from pET-16b 
after Nde I / Nde I digestion 
to prevent re-ligation of the 
vector during cloning 
DNA ligation of: 
• pTrcHis A-Sac I / Hind III 
+ Cat- Sac I / Hind III 
construct 
• pET-16b- Nde I / Nde I 
+ Cat- Nde I / Nde I 
construct 
Catalase over-expression 
• Transformation of BL21(DE3) 
bacteria with the plasmid 
constructs 
• Setting up of large bacterial 
cultures 
• IPTG induction of Cat expression 
• Bacterial harvest 
Catalase protein affinity 
purification via His-Tag 
isolation 
Catalase elution from 
Dynabeads 
Work flow of techniques used for catalase over-expression in E. coli 
and for antibody generation* 
Preliminary analysis of chicken 
preimmune sera (used as 
primary antibody for WB 
analysis) 
Analysis of chicken sera after 3 
boostings of the catalase- 
antigen (WB analysis) 
IgY purification from 
chicken egg yolk 
• Precipitation of IgY 
• Dialysis of the sample 
Characterization of the 
chicken anti-catalase 
antibody with morphological 
and biochemical methods 
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4. STATISTICAL ANALYSIS 
 
Statistical analysis was performed by either two-way ANOVA or by the Student-t-test for 
paired values calculated with the software Prism 6 from GraphPad Software (USA). Values 
are presented as means ± SD (standard deviation). Results are representatives of at least 
three experiments (unless otherwise specified). Significance levels were set for p-values < 
0.05 (*), 0.01 (**), 0.001 (***) and 0.0001(****). 
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5. RESULTS 
Catalase was the typical marker enzyme located in the peroxisomal matrix. This important 
enzyme inactivates hydrogen peroxide (H2O2), which is produced by a variety of oxidases 
inside the peroxisomal matrix, providing the fundaments for the “peroxisome concept” by 
De Duve and Baudhuin (1). Therefore, catalase plays a central role in the defense against 
oxidative damage by reactive oxygen species (ROS). For many years, this protein has been 
the marker enzyme for the morphological or biochemical study of peroxisomes. Given the 
importance of catalase activity for the peroxisome-related research continuous 
improvement of the detection methods was required leading to the production of a variety 
of different antibodies against catalase. 
5.1. Recombinant catalase expression for antibody generation 
In general, antibodies are essential for the structural and functional study of cells and 
organelles. One of the main drawbacks of antibody generation is the limited availability of 
properly purified antigens. To further investigate the catalase expression, distribution and 
its alterations under different experimental conditions used in this study, we required an 
anti-catalase antibody i) in sufficiently high amounts to be used for further investigations 
independent from company supply, ii) sensitive enough to detect the low quantity of 
pancreatic catalase, iii) able to detect catalase in all the tissues that we are currently 
investigating in our laboratory and iv) that was usable for double-labeling in Western blots 
and immunofluorescence studies with all rabbit or mouse antibodies against other 
peroxisomal proteins present in our laboratory. For these reasons, we decided to generate 
our own anti-catalase antibody by recombinant overexpression technology in Escherichia 
coli to obtain high amounts of protein and to use chicken as a host for antibody production 
and isolation in eggs. 
For catalase overexpression, two prokaryotic recombinant expression vectors, Cat-pTrcHis A 
and Cat-pET-16b, were first constructed and then used for the expression of catalase in 
E. coli BL21 (DE3). The catalase protein was enriched by His-tag-based isolation and 600 g 
of the recombinant protein were used for the immunization of chickens to generate an IgY 
antibody. Subsequently, the effectiveness of the antibody was assessed by Western blot and 
immunofluorescence analysis. 
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5.1.1. Construction of the expression vectors and expression of recombinant catalase 
pCMV-SPORT 6 vector containing the full-length open reading frame (ORF) encoding mouse 
catalase was transformed into DH5α competent bacteria for replication. After plasmid 
isolation, the presence of the correct catalase cDNA was verified by DNA-sequencing 
(Seqlab, Göttingen) using specific primers for the T7 (5´-TAATACGACTCACTATAGGGAGA-3´) 
and the Sp6 (5´-AGCTATTTAGGTGACACTATAG-3´) polymerase promoter regions located 
inside the vector and flanking the catalase ORF. 
The open reading frame (ORF) of mouse catalase was amplified by PCR using gene-specific 
cloning primers (see Appendix 1 for a full description) located at the start (32-mer forward 
primer) and the stop (31-mer reverse primer) codon region of the ORF (Figure: 9). 
 
A 
 
 
 
 
B 
 
 
 
 
 
Figure: 9. Designed primers used for the amplification of the catalase ORF via PCR adding restriction sites for 
(A) Sac I at the 5´end and Hind III at the 3´end and (B) Nde I at both 5´and 3´ends. 
 
The primers either contained the restriction enzymes sites for Sac I (forward primer) and 
Hind III (reverse primer) for cloning of the catalase ORF into pTrcHis A or Nde I (forward and 
reverse primer) for cloning into pET-16b. This procedure introduces the chosen restriction 
sites into the catalase ORF for the further cloning procedure (Figure: 10). PCR analysis 
showed an expected 1,584 bp band corresponding to catalase proving the right size of the 
PCR product without any additional non-specific 
bands. 
 
Figure: 10. Catalase ORF amplification by PCR using specific 
primers including the restriction enzymes Sac I / Hind III and 
Nde I / Nde I. After the PCR amplification 5µl of the obtained 
product were loaded on a 2% Agarose gel to determine 
whether the size of the obtained fragment was correct (1,584 
bp). No additional, unspecific bands were visualized. 
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After assessing that we obtained only one PCR product of the expected size, the remainder 
of the PCR reaction (45 µl) was used for gel band purification. After purification of the PCR 
products, both catalase inserts (containing Sac I/Hind III or Nde I/Nde I restriction enzymes 
sites) were sub-cloned into the pGEM-T Easy vector for T/A cloning with high efficiency for 
ligations. Since the multiple cloning site present in the pGEM-T easy vector is flanked by the 
coding region of the enzyme β-galactosidase (enzyme that hydrolyzes galactose), successful 
cloning of the insert into the vector was assessed by blue/white screening (data not shown). 
Ten white, positive clones were double checked by colony PCR prior to the setup of 
miniprep cultures for plasmid multiplication (Figure: 11). The obtained PCR products were 
visualised on an agarose gel. For the Cat-Sac I/Hind III + pGEM-T Easy construct 9 out of 10 
clones were positive showing a single band around 1,584 bp corresponding to catalase. 
Clone 1, 3, and 4 with highest DNA content were chosen for subsequent replication and 
purification. The colony PCR analysis for the Cat-Nde I/Nde I + pGEM-T Easy construct 
confirmed 6 positive clones out of 10. Clones 1, 5, and 10 with highest DNA amount were 
selected for further cloning. 
Figure: 11. PCR screening of positive 
clones after pGEM-T Easy sub-cloning. 
Gene specific primers including the 
restriction enzymes sites were used  for the 
screening and the PCR reaction amplified 
35 cycles. Fifty l of each PCR product were 
loaded on a 1 % Agarose gel. Note that for 
the Cat-Sac I / Hind III + pGEM-T Easy 
construct (A) only the clone number 6 
resulted negative whereas for the Cat-Nde I 
/ Nde I + pGEM-T Easy construct (B) clones 
(3, 4, and 7) gave no visible band. 
To excise catalase from the replicated and purified pGEM-T Easy constructs, a restriction 
enzyme digestion using Sac I / Hind III or Nde I / Nde I was carried out and the fragments 
were loaded on a 1 % agarose gel to purify and extract the digested DNA. At the same time, 
the final target expression vectors pTrcHis A and pET-16b, were replicated, purified and 
digested using the same restriction enzymes as for the inserts. Additionally, pET-16b 
underwent a dephosphorylation step before purification in order to prevent 
recircularization and re-ligation of the Nde I-linearized DNA. 
Thereafter, the specifically digested expression vectors and appropriate catalase inserts 
were ligated and ligations were transformed into E. coli. As negative controls for the 
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transformation “vector alone + ligase” and the “insert alone + ligase” were used. As before, 
white positive clones were confirmed by colony PCR analysis. 
Two positive clones in which the catalase sequence was successfully integrated into the 
pTrcHis A vector (Figure: 12) and three into the pET-16b vector (figure not shown) were 
selected, propagated and the plasmid DNA isolated. 
Figure: 12. Agarose gel electrophoresis analysis after colony PCR amplification of pTrcHis A + Cat-Sac I /Hind 
III construct. 12 positive clones were selected and collected for PCR screening. Specific primers including the 
restriction enzymes sequences were used. Similar results were obtained for the pET-16b constructs. Fifty l of 
each PCR product were loaded on a 1 % Agarose gel. 
 
To ensure that the catalase insert was indeed present, the purified plasmids were first 
digested using both restriction enzymes and then analysed by agarose gel electrophoresis 
(Figure: 13). The release of a 1,600 bp target fragment corresponding to the amplified 
catalase ORF was assessed in the analysed clones by agarose gel electrophoresis. Both 
digests (pTrcHis A using Sac I and Hind III and pET-16b with Nde I) displayed the expected 
band of 1,584 bp corresponding to the catalase insert. Additionally, the digest of pTrcHis A 
showed a clear 4,400 bp band while the one of pET-16b a 5,711 bp one. These bands 
correspond to the pure linearized plasmids. The larger band of approximately 6,000 bp 
visible in clone 5 of pTRC-His-A corresponds to the digested linearized plasmid with the 
catalase ORF (most probably cut only with one enzyme). 
 
Figure: 13. Agarose gel electrophoresis analysis after digestion of pTrcHis-A + Cat-Sac I /Hind III construct 
and pET-16b + Cat-Nde I / Nde I construct. A: Note the release of a 1,600 bp target fragment corresponding to 
catalase and a 6,000 bp band of a not completely digested linearize vector (clone 5). B: Note that only the 
clone number 4 gave 2 distinctive bands: one for pET-16b (5,711 bp) and one for catalase (1,600 bp). The lack 
of bands from the other 2 clones (3 and 5) could be due to an incomplete phosphorylation with a consequent 
re-ligation of the vector (empty vector). 
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Positive recombinant plasmids were sequenced to verity that the cloned ORF sequence was 
identical to the original catalase ORF (without any base exchanges) and was positioned in 
frame with the appended His-Tag and start-codon contained in the plasmids. The 
sequencing results showed no Taq-polymerase amplification mistakes and confirmed that 
the His-tag (used for future affinity purification of the protein) was in frame with the start- 
codon. 
5.1.2. Expression optimization of the recombinant catalase 
 
The purpose of designing two different expression vectors was to use the more efficient one 
for the expression in E. coli. The two protein expression vectors used in this study contain a 
polyhistidine (6xHis) region at the N-terminus to allow the purification of the recombinant 
catalase by affinity purification with magnetic Dynabeads. The expression of the His-tagged 
catalase recombinant protein could be initiated using the Isopropyl β-D-1- 
thiogalactopyranoside (IPTG) inducible T7 promoter located upstream of the His-tag. 
To express catalase, the constructed vectors pTrcHis A + Cat and pET-16b + Cat were 
transformed into E. coli BL21 (DE3) Rosetta and the resistant clones cultured at 37°C in Luria 
broth (LB) medium containing 100 µg/ml ampicillin overnight. The next day, the starting 
culture was used to set-up a large liquid culture at 1:50 dilution in medium. When the 
absorbance of the bacterial culture reached 0.45 at 600 nm, IPTG (1 mM) was added to 
induce the expression of the recombinant protein. To optimize the expression conditions, 
the bacteria were cultured with different media (Terrific broth and/or Luria broth), different 
temperatures of induction (16, 20, and 37°C), and three different dilutions of the starting 
culture for inoculation (1:20, 1:50, and 1:100). Samples were collected every 30 min after 
induction during the first 3 h, and after 4 and 5 h and analyzed by 12 % SDS-PAGE. The gel 
was subjected to Coomassie blue staining in order to visualize the protein bands (Figure: 14, 
A-B and figure: 15, A-B) and to Western blot analysis using an anti His-Tag primary antibody 
(Figure: 14, C-D and figure: 15 C-D). Western blot analysis of total bacterial lysate 
transformed with the pTrcHis A + Cat construct after IPTG induction showed maximum 
catalase expression levels under slow bacterial growth conditions at 20°C and after 120-150 
min. After this time point, the catalase expression tended to decline, possibly due to the 
bacterial culture saturation with a concomitant decrease of nutritional elements necessary 
for bacterial growth. No improvement regarding the protein expression was found using 
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16°C as the culture temperature. Much less amount of catalase was expressed when 
bacteria were maintained at 37°C in comparison to 20°C during the same period of time 
(data not shown). Using the pET-16b + Cat construct, the expression of catalase reached its 
maximum peak after 150 min of induction at a starting dilution of 1:50 and after 120 min at 
a starting dilution of 1:100. The pTrcHis A + Cat construct proved to be more efficient than 
the pET-16 b + Cat construct for the catalase expression, whence we decided to continue 
only with the first one for the purpose of expressing larger amounts of the protein. The 
optimal conditions for the expression of the His-tagged recombinant catalase using the 
pTrcHis A + Cat construct were expression time of 150 min for a 1:50 starting dilution, 
maintained in Luria broth medium at 20°C (after induction). 
 
 
Figure: 14. Coomassie brilliant blue staining and SDS-PAGE analysis of the induction of recombinant catalase 
using the construct pTrcHis A + Cat. Optimization of the recombinant protein induction. A-B: Total bacteria 
lysate of recombinant E. coli BL21 (DE3) at different time points after induction with IPTG using pTrCHis A + 
Cat. 1:20 and 1:50 dilutions from the starter culture were used. C-D: Corresponding SDS-PAGE analysis using 
anti His-Tag as a primary antibody for the detection of the recombinant catalase. Note that the catalase 
expression was higher around 120-150 minutes after induction (with a subsequent decline) and at a starting 
dilution of 1:50. IPTG: isopropylb-D-thiogalactopyranoside. 
A B 
C D 
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Figure: 15. Coomassie brilliant blue staining and SDS-PAGE analysis of the induction of recombinant catalase 
using the construct pET-16b + Cat (see figure on page 62). Optimization of the recombinant protein induction. 
A-B: Total bacteria lysate of recombinant E. coli BL21 (DE3) at different time points after induction with IPTG 
using pET-16b + Cat. 1:50 and 1:100 dilutions from starter culture were used. C-D: Corresponding Western blot 
analysis using anti His-Tag as a primary antibody for the detection of the recombinant catalase. Note that the 
catalase expression was higher at 150 min post induction and a starting dilution of 1:100, however, the 
expression of His-tagged catalase with the pET-16b vector resulted in less complete catalase expression 
product and a higher amount of lower molecular weight bands. IPTG: isopropylb-D-thiogalactopyranoside. 
 
 
5.1.3. Affinity purification of recombinant catalase 
To isolate the expressed recombinant catalase, affinity purification using Dynabeads was 
performed taking advantage of the histidine-tagged protein. The incubation of the bacterial 
lysate containing catalase with the Dynabeads allowed the binding of the histidine to the 
cobalt beads. Thereafter, the bound catalase was subjected to an elution process using 
three different molarities of the imidazole elution buffer (100, 250, and 500 mM). The purity 
and the size of the eluted recombinant catalase protein was analyzed by SDS-PAGE and 
Coomassie brilliant blue staining. The lysate before and after the Dynabeads incubation, the 
supernatant resulting from each washing step, the eluted protein, and the used beads were 
loaded onto a 12 % SDS-gel (Figure: 16) and the membrane was probed using anti His-Tag as 
primary antibody. 
A B 
C D 
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Figure:  16.   Detection of the recombinant catalase b y  
A SDS-PAGE after Imidazole-elution. A: Coomassie brilliant 
blue staining of protein samples from the different steps 
of catalase purification after SDS-PAGE. The first two lanes 
correspond to the total bacterial lysate before and after 
being incubated with the Dynabeads. Lanes 3-5 show the 
flow-through collected after 3 subsequent washing steps; 
lanes 6-8 represent the recombinant catalase eluted from 
the beads using different imidazole concentrations. The 
last lane shows the beads (Be) after elution. The same 
volume (10    l)    was    loaded    for    each    sample.  B: 
B Corresponding Western blot analysis using an anti His-Tag 
antibody for the detection   of  the  tagged  recombinant 
catalase. C: Western blot analysis of the eluted protein 
detected by an anti-catalase antibody. The predicted 
molecular weight of approximately 58 kD for the 
recombinant catalase plus one band of ~30 kD were 
labelled with both antibodies, whereas a smaller band of 
~10 kD was only present in the Cat blot, suggesting that 
this was the cleaved C-terminal part of the catalase 
protein. 
C 
 
 
 
 
 
 
 
 
 
 
Two clear bands were identified in the eluted sample corresponding to 58 kD and ~30 kD 
respectively (Figure: 16B). To verify the identity of the bands, the same membrane was 
stripped and re-probed using a commercially available anti-catalase antibody. The efficiency 
of the stripping procedure was confirmed prior to the analysis by incubation with the 
secondary antibody alone (data not shown). Both bands obtained after the catalase labeling 
corresponded to those observed previously using the anti-His-Tag antibody (Figure: 16C). 
Even though imidazole eluted part of the recombinant catalase from the Dynabeads, the 
SDS- PAGE results showed that a significant amount of the protein was still bound to the 
beads after elution. Therefore, different elution buffers, differing in the detergent 
composition and imidazole concentration (Table: 15), were tested and the eluted protein 
and the beads were analyzed by SDS-PAGE. 
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Table: 15. Buffers used in this work for the optimization of the recombinant catalase elution from the 
Dynabeads. 
EB # PB 
(mM) 
NaCl Tween 20 
(%) 
Triton X100 
(%) 
Triton X114 
(%) 
SDS 
(%) 
Imidazol 
(mM) 
pH 
1 50 2M 0.01 - - - 100  
 
 
 
8 
2 50 2M 0.01 - - - 500 
3 50 300 mM - 0.5 - - 100 
4 50 300 mM - 0.5 - - 500 
5 50 300 mM - - 0.5 - 100 
6 50 300 mM - - 0.5 - 500 
7 50 300 mM - - - 0.5 100 
8 50 300 mM - - - 0.5 500 
EB: elution buffer; PB: phosphate buffer 
 
 
 
E 
 
Figure: 17. Detection of the recombinant catalase by 
SDS-PAGE after different elution procedures. A-B: 
Coomassie brilliant blue staining of the eluted catalase 
and the beads after the elution. Eight different elution 
buffers were tested. Ten l of each, the used beads and 
the eluted protein, were loaded. C-D: Western blot 
analysis of the eluted catalase and the beads subsequent 
the elution (10 l each) run in parallel using the same 
eight elution buffers. Anti His-Tag was used as a primary 
antibody for the detection of the His-tagged catalase. E: 
Elution efficiency of buffers #2 and #4 after 3 consecutive 
elution procedures. E: elution buffer; B/Be: beads. 
 
 
After Western blot analysis, we could conclude that the highest amount of catalase was 
eluted from the Dynabeads using buffers 2, 4, 6 and 8. We opted for the use of buffer 
A B 
C D 
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number 2 containing Tween 20 as a detergent agent and buffer number 4 with Triton X100 
both containing high imidazole concentrations (500 mM) (Figure: 17), because Triton X100 
and Tween20 are milder detergents than Triton X114 or even SDS (E8 from figure: 18). In 
subsequent experiments the elution obtained using the buffer containing Tween 20 (E2 
from figure: 18) showed higher elution efficiency (Figure: 17E) and therefore we decided to 
use this elution buffer as standard for the rest of the experiments. 
5.1.4. Preparation, purification and characterization of the antibody against catalase 
 
We decided to use the eluted recombinant catalase (600 µg of protein for each animal) to 
immunize two chickens. The animals were chosen after several preliminary experiments 
analyzing the chicken preimmune sera as primary antibody on Western blots using 2 
different sera dilutions (1:1,000 and 1:10,000) and an anti-chicken secondary antibody. 
Homogenate protein (10 and 25 µg) obtained from mouse liver and the β-TC3 tumor cell 
line were used as test-samples for the Western blot analysis (Figure: 18). Those chickens 
were chosen, whose preimmune serum did not result in the detection of protein bands in 
the Western blot procedure (chicken no. 1 and 3). 
 
Figure: 18. Selection of chickens after the analysis of the preimmune sera as primary antibody on Western 
blot. Sera from 4 chickens were collected before the catalase immunization and used at 1:10,000 dilution on 
Western blot analysis of liver and -TC3 protein homogenates. The membranes were probed with an HRP- 
labelled anti-chicken at 1:30,000 dilution. Note that in the animals 1 and 3 (marked with a *) none (using 10 g 
of protein either from liver of from -TC3 cells) or a considerable less amount of bands (in the case of 25 g of 
protein used) were detected in comparison with the chicken number 2 and 4. 
 
The animal immunization was carried out by Pineda Antikörper-Service, Berlin 
(www.pineda-abservice.de). After the 3rd boosting (repeated injection of the catalase 
antigen), the sera were collected from the chickens and tested by Western blot analysis of 
protein samples derived from liver, pancreas and β-TC3 cells (data not shown). Additionally, 
IgY was precipitated and purified also from the obtained egg yolks and the specificity of the 
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antibody against catalase was verified by Western blot analysis of the same samples as 
mentioned before. In all three samples catalase could be successfully detected using the 
sera as a primary antibody. 
Twenty µg of protein homogenate from β-TC3 cells were used to test different antibody 
dilutions (1:2,000; 1:5,000; 1:10,000 and 1:20,000) in order to estimate the best 
concentration to use for the detection of catalase by Western blot analysis. Subsequently, 
the membrane was probed with HRP-conjugated anti-chicken IgY antibody (Figure: 19). The 
highest dilution used for this experiment revealed a single band at the expected kD range 
(~58 kD) and minimal background indicating the monospecificity and high sensitivity of the 
catalase antibody. 
 
 
 
 
 
Figure: 19. Characterization of the chicken anti-catalase antibody. 
Western blot analysis of catalase expression using the IgY anti-catalase 
antibody purified from egg yolk. The antibody detected catalase in 20 µg 
protein homogenate from β-TC3 cells at different dilutions. 1:20,000 
resulted in a clear band around the expected 58 kDa with minimal 
background. The membrane was probed with HRP-labelled anti-chicken 
IgY antibody. 
 
 
 
 
Based on the above-mentioned results, we chose to further determine the antibody 
specificity by Western blot analysis at 1: 20,000 dilution using total protein homogenates of 
different mouse tissues (Figure: 20). Western blot analysis showed that a band of the 
expected molecular weight of 58 kDa was present in most analysed tissues except for 
muscle and brain (which showed one single band of lower molecular weight). As expected, 
in all analysed tissues more than one band could be detected after overexposure. The 
phenomenon of different band sizes could be due to the presence of different isoforms of 
catalase o protein degradation (since the samples were frozen and thawed repeatedly prior 
to this experiment for another purposes). As shown before in this work, the detection of 
catalase using our antibody in protein homogenates from β-TC3 cells resulted consistently in 
one single 58 kDa band (Figure:19). After the antibody was isolated, all detections of 
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catalase for Western blotting in the experimental work of this thesis were performed using 
this antibody. 
 
 
Figure: 20. Antibody specificity against catalase analysed in different murine tissues. Western blot analysis of 
the purified polyclonal IgY anti-catalase antibody. Twenty µg of total protein from different murine tissues 
were analysed by SDS-PAGE. Upper panel: obtained after 1 minute of exposure. Lower panel: prolonged 
exposure to observe the appearance of additional specific bands. 
 
5.2. Characterization of peroxisomes in pancreatic tissue 
5.2.1. Peroxisomal gene expression in pancreatic -cells 
Peroxisome-related gene expression profiling is a useful tool for studying the role of 
peroxisomes in β-cells either in normal or pathological conditions. However, isolated islets 
undergo changes in gene expression as a result of the cell exposure to the trauma of 
ischemia during their isolation (180). This problem can be overcome by dissecting the β-cells 
from the pancreatic tissue directly by laser capture microdissection (LCM). Employing this 
technic on pancreata is particularly challenging due to the high RNase activity found in this 
tissue (total RNase activity is a 181,000-fold higher than in brain) (181). Therefore, a LCM 
protocol was developed to obtain non-degraded, high quality RNA required to analyze the 
peroxisome-related gene expression by semi-quantitative RT-PCR in pancreatic  -cells. In 
rodents, unlike in humans, the insulin producing cells are the main cell type located in the 
core of the islets, therefore only this portion was dissected to minimize the possibility of 
contamination with other islet cell types. Different tissue treatments including staining and 
dehydration methods, temperature adjustments, RNase-control measurements, and general 
handling time shortening were extensively tested to achieve reliable -cell total RNA 
isolation. The integrity of the isolated RNA was validated prior to cDNA synthesis by 
electrophoresis on a denaturing formaldehyde-agarose gel and the RNA bands on the gel 
were visualized on a UV transilluminator. Due to the relatively small sample size collected 
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from LCM (2 g from ~250 dissected pancreatic islets) not more than 0.5 g RNA was loaded 
on the gel (Figure: 21, lane 1 and 2). Clear but faint 28S and 18S rRNA bands were observed 
for the total RNA sample isolated from LCM -cells using the optimized protocol (explained 
under Material and Methods, chapter 3.2.6.1.) (lane 1) with a 28S:18S ratio of 1.5:1. An 
example of a completely degraded RNA corresponding to the -cells isolated before the 
optimization of the LCM protocol is shown in the second lane with the appearance of a very 
low molecular weight smear. As comparison 2 g RNA isolated from cultured -TC3 cells are 
shown in lanes 3 and 4 where the 28S band appeared twice as intense as the 18S rRNA 
band. The presence of sharp bands with a 2:1 ratio is a good indication of the RNA integrity. 
In conclusion, using the newly developed protocol we were able to drastically reduce RNA 
degradation during the isolation from pancreatic tissue and to obtain high quality RNA 
suitable for downstream qPCR analysis. 
 
 
 
 
Figure: 21. Formaldehyde-agarose gel analysis to determine the 
integrity of the LCM isolated RNA. 0.5 µg RNA isolated from 
pancreatic islets using LCM or 2 g total RNA obtained from cell 
culture samples were run on a 1.5 % denaturing agarose gel. Note 
the maintained RNA integrity of the 28S and 18S rRNA bands after 
isolating RNA from LCM -cells using our newly developed protocol 
(lane 1) in comparison with the standard LCM protocol (lane 2). 
Lane 3 and 4 represent RNA isolated from cultured -TC3 cells as 
control. 
 
Once the RNA quality was assessed, semi-quantitative RT-PCR was used to analyse the 
steady-state levels of the mRNA encoding peroxisomal proteins in pancreatic β-cells (Figure: 
22). 
Insulin 1 and 2 (Ins1 and 2) gene expression were also confirmed in in the isolated β-cells 
(Figure: 22G). As control, glucagon (Gcg) gene expression was analyzed. Since this hormone 
is produced by the α-cells located in the outer rim of the islets of Langerhans, the absence 
of a band (Figure: 22G) denotes the purity of the sample where just the β-cell-enriched 
central core of the islet was dissected. Some peroxisomal genes such as the membrane lipid 
transporter Abcd3 (Figure: 22C), the rate-limiting enzyme of the β-oxidation pathway Acox1 
(Figure: 22D), ScpX/Scp2 and Hsd174 (Figure:22E) encoding for the sterol carrier protein X 
(SCPx) /sterol carrier protein 2 (SCP2) and the multifunctional protein 2, respectively, 
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exhibited a strong expression in β-cells (ScpX > Abcd3 = Acox1 > Hsd174). Pex14 (Figure: 
22B), Abcd2 (Figure: 22C), Acca1 (Figure: 22D), and Acox3 (Figure: 22D) mRNA were also 
expressed (Pex14 > Acox3 > Abcd2 > Acca1). In comparison, the mRNA expression of the 
biogenesis peroxin Pex13 (Figure: 22B) was weakly expressed and the mRNA for the lipid 
transporter Abcd1 (Figure: 22C), and for the β-oxidation enzymes Ehhadh and Acox2  
(Figure: 22D, E) were almost absent. As expected, Cat (Figure: 22F) encoding for the 
antioxidative enzyme Catalase, was extremely low abundant exhibiting only a faint band. In 
contrast, Sod1 (Figure: 22F) encoding for superoxide dismutase 1, a cytoplasmic antioxidant 
enzyme, was clearly expressed, however the SOD1 protein possesses a dual localization in 
the cell with the greatest part in the cytosol and less SOD1 protein in peroxisomes. 
 
Figure: 22. Semiquantitative RT-PCR analysis of cDNA prepared from total RNA of pancreatic β-cells 
obtained by laser capture microdissection (LCM). A: 28S rRNA as internal control; B: Gene expression for the 
peroxisomal biogenesis genes Pex13 and Pex14; C: Gene expression for the peroxisomal Abcd-transporters 
Abcd1-3; D: Gene expression for the enzymes of the β-oxidation pathway 1, Acox1: acyl-CoA oxidase I, Ehhadh: 
multifunctional protein 1, Acca1: 3-Ketoacyl-CoA thiolase; E: Gene expression for the enzymes of the β- 
oxidation pathway 2, Acox2 and 3: acly-CoA oxidase 2 ad 3, Hsd17β4: multifunctional protein 2 and ScpX/Scp2: 
sterol carrier protein X / sterol carrier protein 2; F: Gene expression for the peroxisomal antioxidant enzyme 
Cat: catalase, cytosolic/peroxisomal antioxidant enzyme Sod1: superoxide dismutase 1, and mitochondrial 
Sod2; G: Gene expression for Ins1 and 2: Insulin 1 and 2 and Gcg: Glucagon. 
 
5.2.2. Peroxisomal proteins are heterogeneously distributed in different cell types of 
the mouse pancreas 
Our group has already described the best conditions for the immunofluorescence-based 
detection and the precise localization of peroxisomal antigens in diverse tissues (173, 174, 182). 
However, murine pancreas presents its own challenges mainly because some antigens used 
as islet markers (e.g. glucagon) need special experimental conditions in order to be correctly 
detected. Therefore, the IF technique was optimized in a series of preliminary experiments 
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(Figure: 23) with the purpose of obtaining the ideal conditions for the localization of both, 
peroxisomal and islet markers. The best antibody concentrations to obtain optimal double- 
staining patterns for peroxisomal and islet cell markers used for each IF analysis in this work 
were determined for all antibodies in a set of serial dilution stainings. Samples were 
exposed to different boiling times (0, 5, 10, and 15 min) in citrate buffer to improve antigen 
retrieval. The incubation of the samples in non-boiling citrate buffer resulted in a good 
detection of glucagon but no PEX14 signal (Figure: 23A). The gradual increase of the boiling 
time (5 and 10 min) caused an improvement of the PEX14 signal intensity without 
compromising the glucagon staining (Figure: 23B and C). The best results with excellent 
staining for peroxisomal proteins and still acceptable glucagon stain were achieved by the 
incubation of the tissue sample in citrate buffer for 15 min (Figure: 23D). 
 
 
 
 
Figure: 23. Optimization of the 
immunofluorescence (IF) technique to 
establish the best conditions for the 
localization of peroxisomal and islet cell 
markers in mouse pancreata. 
IF analysis of paraffin sections of WT 
C57BL/6J mice against the peroxisomal 
membrane associated protein PEX14 and 
Glucagon (GCG). Sections were incubated 
in citrate buffer A: for 15 min without 
microwaving; B: 5 min; C: 10 min and D: 
15 min, in boiling citrate buffer. Nuclei 
were counterstained with Hoechst 33342 
dye. Note the improvement of PEX14 
staining with the increase of the 
microwaving time conserving a good GCG 
signal. Scale bar = 52 µm. 
 
 
Using immunofluorescence to detect peroxisomal antigens we could evaluate the 
distribution of the two peroxisomal biogenesis proteins PEX14 and PEX13 within the 
different regions of a WT C57BL/6J murine pancreas. PEX14 was detected in both the 
endocrine (En) and the exocrine (Ex) pancreas showing a less intense signal in the last one. 
Besides the characteristic punctuate peroxisomal staining pattern, tubular peroxisomes 
could also be identified, appearing evenly distributed through all the exocrine and 
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endocrine tissue. In the epithelium of the interlobular excretory duct (IrD) PEX14-labelled 
peroxisomes were much less numerous (Figure: 24D-F). 
With regard to PEX13, a markedly overall weaker signal compared to that seen with PEX14 
was observed displaying poor labeling of the islets of Langerhans and the exocrine acini 
showing a similar intracellular distribution of peroxisomes as in PEX14 staining (Figure: 24G- 
I). Furthermore, the IF signal intensity varied in the different pancreatic cell types. 
Intralobular ducts (InD) were stronger labeled suggesting a higher abundance of PEX13. 
Generally, PEX13 IF was particularly difficult to perform mainly due to the low expression of 
this protein in pancreas and because of the autofluorescence of the pancreatic tissue. 
Similar results have been found for PEX13 staining with the same antibody in an earlier 
study (173, 183) in which PEX13 labeling was hardly visible in liver or lung tissue, but stained 
excellently the germ cells in the testis (184). This suggests that the antibody is specific and 
reliable, but stains mainly tissues with high PEX13 abundance (e.g. testis). 
Two peroxins required for the assembly of the peroxisomal membrane were also analysed 
by immunofluorescence: PEX3 and PEX19. The PEX3 staining revealed an even distribution 
of peroxisomes in the basal part of the acini (Figure: 24J-L). This pattern composed by 
dotted structures, was similar to the one observed for ABCD3 but with a difference in the 
signal intensity. As catalase, PEX3 was clearly detectable in the exocrine part while the 
endocrine cells were weakly stained. The PEX3 staining for the epithelium of the interlobular 
excretory duct (IrD) was hardly visible when exposed to the same microscopy settings used 
for the exocrine part. 
 
 
 
 
 
 
Figure: 24. Immunofluorescence localization of peroxisomal proteins PEX14, PEX13, PEX3, and PEX19 in 
distinct pancreatic regions (see figure on page 60). IF analysis of paraffin sections of WT C57BL/6J mice 
against: A-F: the membrane peroxisomal biogenesis protein PEX14; G-I: the membrane peroxisomal biogenesis 
protein PEX13; J-L: the peroxisomal biogenesis factor PEX3; and M-O: the peroxisomal biogenesis factor 
PEX19. Nuclei were counterstained with Hoechst 33342 dye. A, D, G, J, and M: Representative picture of a 
pancreatic islet of Langerhans; B, E, H, K, and N: acini clusters; C, F, I, L, and O: Interlobular duct lined by a 
single layer of cubic cells. A-C: corresponding phase contrast microscopic analysis of the PEX14 stained 
pancreatic regions. En: endocrine pancreas; Ex: exocrine pancreas; IrD: interlobular duct. Scale bar = 20 µm. 
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PEX19 is a cytoplasmic receptor that binds PMPs and targets them to the peroxisome by 
binding to PEX3. It therefore exhibits a double subcellular localisation, which is particularly 
noticeable in the acini of the exocrine pancreas. In comparison, the PEX19 staining of the 
islet of Langerhans was not particularly strong (Figure: 24M and N). In contrast to PEX3 and 
PEX14, PEX19 exhibited, like catalase, a strong perinuclear staining in the excretory duct 
(Figure: 24O). 
The sub-cellular localization of catalase (CAT) differed considerably across the different 
sections of the tissue. In pancreatic endocrine cells the peroxisomal staining for CAT was 
almost absent as shown by the low intensity of the immunofluorescence signal localized to 
the islets of Langerhans (Figure: 25G and H). The enzyme was mainly detected in 
peroxisomes of endothelial cells within the islet. In contrast the epithelial cells of the acini 
showed a defined and uniformly distributed peroxisomal signal exhibiting a punctuated 
staining pattern. A higher abundance of peroxisomes positive for CAT was noted in the 
interlobular ducts (IrD) where a perinuclear distribution was observed (Figure: 25I). 
ABCD3, one of the highest abundant peroxisomal membrane proteins involved in the 
transport of branched and long-chain acyl-CoAs, and frequently used as a peroxisomal 
marker, was abundantly expressed in pancreatic cells showing the highest intensity in the 
endocrine portion (Figure: 25D and E). Similar to the pattern observed for PEX14, a fine 
punctuated staining as well as tubular structures could be identified in the exocrine (Ex) 
pancreas. However, the peroxisomal staining was not evenly distributed across the exocrine 
portion; here the most apical part of the acinar cells containing zymogen granules showed 
an absence of immunofluorescence signal. ABCD3 positive peroxisomes were mainly located 
in the lower apical part of the cells between the nucleus and the secretory granules 
(Figure:25F). 
Insulin and glucagon, both peptide hormones produced in the islets of Langerhans, were 
used as marker proteins for the visualisation of respectively pancreatic β- and α- cells by 
immunofluorescence analysis. The insulin staining showed the characteristic punctuate 
pattern associated with this protein, which is stored in secretory granules distributed 
throughout the cytoplasm of the β-cells (Figure: 25J). The α-cells, which are mainly located 
in the outer rim of the islets, showed an intense fluorescence signal resulting from the 
detection of glucagon (Figure: 25K). 
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Figure: 25. Immunofluorescence localization of ABCD3, catalase, insulin and glucagon in distinct pancreatic 
regions. IF analysis of paraffin sections of WT C57BL/6J mice against D-F: the peroxisomal membrane lipid 
transporter ABCD3; G-I: the peroxisomal antioxidant enzyme catalase; J: Insulin, a hormone produced by β- 
cells and K: Glucagon, produced by α-cells. L: Secondary antibody control. Nuclei were counterstained with 
Hoechst 33342 dye. A, D, G, J and K: Representative picture of a pancreatic islet of Langerhans; B, E, H: acini of 
the exocrine pancreas; C, F, I: Interlobular duct lined by a single layer of cubic cells. A-C: Phase contrast 
microscopic analysis of the section stained for ABCD3. En: endocrine pancreas; Ex: exocrine pancreas; IrD: 
interlobular duct; BV: blood vessel. Scale bar = 20 µm. 
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5.2.3. Protein abundance of PEX13, ACOX1, ABCD3 and CAT present in enriched 
peroxisomal fraction from pancreata in comparison with liver 
Liver is widely used as a standard tissue for the detection of peroxisomes due to the high 
amount of the organelle found in it. To compare the peroxisomal protein abundance 
between pancreas and liver Western blot analysis was performed using a peroxisomal 
enriched fraction isolated from both tissues. All peroxisomal proteins detected, including 
PEX13, ACOX1, ABCD3 and CAT were less abundant in pancreas in comparison with liver, 
particularly the -oxidation rate-limiting enzyme ACOX1 (Figure: 26). 
 
Figure 26: Western blot analysis of enriched peroxisomal fractions 
isolated from adult mouse pancreas and liver. Pancreatic and liver 
tissue were isolated from a WT C57BL/6J mice. Proteins (40 µg) were 
subjected to Western blot analysis and probed sequentially with 
antibodies against PEX13, ACOX1, ABCD3 and CAT. The 
autoradiographic signal was visualized as described under Material and 
Methods. The equal loading of liver and pancreas fractions was 
controlled via Ponceau staining before Western blot incubation with 
the antibodies against peroxisomal marker proteins. PEX13: 
peroxisomal biogenesis factor 13; ACOX1: acyl-coenzyme A oxidase 1; 
ABCD3: ATP- binding cassette transporter, subfamily D, member 3; 
CAT: catalase. 
 
5.2.4. Alteration of peroxisomal protein abundance in paraffin-embedded pancreas 
tissue of diabetic animal models 
To the best of our knowledge, little information is available concerning the impact that 
diabetes has on enzyme composition and functionality of peroxisomes. Also, the potential 
involvement of this organelle during the pathogenesis of diabetes has not been investigated 
so far. To analyze the alterations of peroxisomal abundance and proteome that might result 
from the type 2 diabetes (T2D) condition, pancreata from 2 animal models were analyzed by 
IF: i) The ob/ob mice and ii) The New Zealand Obese (NZO) mice maintained under a high- 
fat diet. The paraffin-blocks of the diabetic animal models and appropriate control tissue 
was kindly provided by Dr. Schürmann (Deutsches Institut für Ernährungsforschung, 
Potsdam). 
Paraffin embedded pancreata from these mice were thin sectioned (1m) for comparative 
IF analysis using different peroxisomal markers and the - and - cell markers glucagon and 
insulin respectively. The thickness of all sections was determined by xzy-scans (vertical 
scans) with a CLSM (pinhole: airy 1, objective: 63 x, zoom: 8) to corroborate that the 
obtained sections displayed the same thickness. 
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The detection of PEX14, the optimal peroxisomal marker, allowed the evaluation of this 
organelle distribution and abundance in the analysed sections. Control animals displayed 
the same IF staining pattern as already observed in this thesis for WT C57BL/6J animals. 
Punctuated peroxisomal staining and elongated tubular peroxisomes were identified in the 
endocrine part and in the exocrine portion of the tissue, albeit the staining of the exocrine 
part was weaker (Figure: 27A). In comparison to WT mice pancreata the IF analysis of the 
NZO diabetic animals kept under a high-fat diet, displayed a much stronger PEX14 
immunoreactivity as well as a higher number of peroxisomes (p  0.03) and peroxisomal 
clusters in the endocrine islets suggesting peroxisomal proliferation (Figure: 27B). 
Further, the abundance of ABCD3 (the most abundant peroxisomal lipid transporter in 
pancreas) and MFP2 (involved in the peroxisomal -oxidation pathway 2) were analysed 
(Figure: 27C-F). For this series of experiments, we used a different antibody than for the WT 
C57BL/6J animals, due to the antibody availability at that time. In a series of preliminary 
experiments different antibody concentrations were tested and the best one was used for 
the identification of ABCD3. In the control animals, a peroxisomal staining was clearly visible 
in the endocrine cells whereas a very low signal was observed in the exocrine region, 
however, being detectable after longer exposure times (Figure: 27C). In the contrary to 
what we observed for PEX14, the labelling intensity of ABCD3 in the islets of the NZO 
diabetic animals was drastically decreased in comparison with the one for the control 
animals (Figure: 27D). 
Whit regard to MFP2 (multifunctional protein 2 of the fatty acid -oxidation 2) a slight 
reduction of immunoreactivity was observed in the NZO diabetic animals in comparison to 
the controls. In both groups, a peroxisomal signal was observed in the pancreatic endocrine 
region heterogeneously distributed between distinct cells. As observed also for ABCD3, only 
a very faint staining was present for MFP2 in the acini showing no changes between control 
and NZO diabetic tissue (Figure: 27E and F). 
We further detected insulin in the pancreatic islets from the control and the NZO diabetic 
animals. As expected, a punctuate pattern of high intensity was observed in the control 
group, representing the insulin stored in secretory granules present inside the -cells. 
Numerous clusters of granules were observed (Figure: 27G). Insulin was barely detectable in 
the -cells from the NZO diabetic samples, leading to the hypoinsulinemia commonly found 
in this animal model (Figure: 27H). 
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Figure: 27. Double-immunofluorescence 
analysis of peroxisomal proteins with 
glucagon signal and for insulin in pancreata of 
NZO diabetic and control animals. IF analysis 
of 1 µm sections of paraffin-embedded 
pancreata. A-B: The membrane-associated 
peroxisomal biogenesis protein PEX14 and the 
-cell hormone glucagon (red) were labelled. 
The abundance of PEX14 in the NZO diabetic 
islets was higher than in the controls. C-D: The 
IF analysis of ABCD3 showed opposite 
alterations compared to PEX14: the expression 
of the lipid transporter was considerably 
decreased in the islets of the NZO diabetic 
animals. E-F: A slight reduction was observed 
after MFP2 labelling in the NZO diabetic 
animals. G-H: Insulin (INS) staining exhibiting a 
clear signal localized to -cells corresponding 
to secretory granules of control animals in 
comparison to the almost absent staining 
found in the pancreas of NZO diabetic mice. 
Bar = 52 µm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In the ob/ob mice fed with a high-fat diet, the expression of PEX14, which was strongly up- 
regulated in the endocrine pancreas of NZO diabetic animals, was scarcely increased in 
comparison to the controls (Figure: 28A and B). PEX14 exhibited a defined and uniformly 
distributed fluorescent signal showing a punctuated pattern with some elongated 
peroxisomes and peroxisomal clusters in the islets. In the exocrine part of the pancreas the 
PEX14 staining was less intense and sparsely distributed. The ABCD3 staining revealed a 
strong down-regulation of the peroxisomal labelling in the ob/ob high-fat diet mouse 
(Figure: 28C and D). As before, a strong peroxisomal staining pattern with empty nuclear 
regions was observed in the islet cells of the control group. 
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MFP2-positive stained peroxisomes were found in both, the ob/ob control and the high-fat 
maintained group. However, while the signal was low but more less distributed through the 
islet in the control group, a punctate pattern with some clusters distributed 
heterogeneously across the endocrine region of the ob/ob animals fed with a high-fat diet, 
was observed (Figure: 29E and F). 
Opposite to the findings in the NZO animals, the INS immunoreactivity in both ob/ob groups 
showed a strong signal with a punctuated, cytoplasmic pattern (Figure: 28G and H) 
suggesting healthy -cells. This result was expected since the T2D-like characteristics found 
in this animal model are due to a leptin mutation and the obesity developed thereafter and 
not due to a -cell dysfunction. Taken 
together, these results indicate 
alterations in a subset of peroxisomal 
proteins as a result of the high-fat diet 
induced diabetic condition. 
 
 
 
 
 
 
 
 
 
Figure: 28. Double-immunofluorescence 
analysis of the localization of peroxisomal 
proteins with glucagon and single staining of 
insulin in pancreata of ob/ob diabetic animals 
and its controls. IF analysis of 1 µm sections of 
paraffin embedded pancreata. A-B: The 
membrane-associated peroxisomal biogenesis 
protein PEX14 and the -cell hormone 
glucagon (red) were labelled. The expression of 
PEX14 in the ob/ob diabetic islets was slightly 
higher than in the controls. C-D: The IF analysis 
of ABCD3 showed a considerably decreased 
abundance of the lipid transporter in the islets 
of the ob/ob diabetic animals. E-F: A MFP2 
labelling heterogeneously distributed in some 
cells of the islets was observed in the ob/ob 
HFD diabetic-sections in comparison to the 
control. G-H: Insulin (INS) staining exhibiting a 
clear signal localized to -cells corresponding 
to healthy -cells. HFD: high fat diet. Bar = 52 
µm. 
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5.2.5. Characterization of β-TC3 cell line as a suitable model for the study of -cell 
function and peroxisome physiology 
To investigate the possible roles of the peroxisome in -cell dysfunction, the murine line - 
TC3 was chosen as a model for the analysis of pancreatic -cell function. We were first 
interested to determine whether this cell line could represent a genuine model for the study 
of the peroxisomal function and dysfunction in pancreas and to ensure its resemblance to 
normal -cells. For this purpose -TC3 cells were exposed to different culture conditions and 
their mRNA expression profile and morphology were characterized. Our first aim was to 
determine the optimal CO2 concentration for cell culture, mainly due to a discrepancy in the 
recommended parameters given by the supplier and those found in the literature. Two CO2 
concentrations (5 and 8 %) were tested and the abundance of mRNAs for some peroxisomal 
markers and genes encoding for various antioxidative enzymes were analysed by semi- 
quantitative RT-PCR (Figure: 29). The increase in CO2 concentration led to a significant 
increase of the expression of the Abcd1 and Abcd2 (1.9- and 2.2-fold higher), genes 
encoding for membrane lipid transporters in charge of the transport of different very long- 
chain acyl-CoA. Similarly, the mRNA levels of the -oxidation pathway 2 enzymes Hsd17 4 
(also known as Mfp2) and Acox3 showed an up regulation (2.5- and 1.6-fold) under 8 % of 
CO2 in comparison with low CO2 conditions. In contrast, the mRNAs for -oxidation enzymes 
Acox1, Acox2, and Acca1, showed a down-regulation (34, 62, and 40 %) when exposed to  8 
% CO2. Pex13, Pex14, Abcd3, and Cat mRNA levels were unaffected by the different CO2 
concentrations. The mRNA for Ehhadh could not be amplified with the primer pairs and 
conditions used in this work, suggesting that its expression level in pancreas is too low for 
being visualised. Interestingly, the three superoxide dismutase antioxidative enzymes 
showed changes in their gene expression as well. Sod1 mRNA level decreased (45 %) while 
the level of  Sod2 and Sod3  exhibited a minor but clear up-regulation when maintained at   
8 % CO2 (1.2- and 1.5-fold respectively). Since many peroxisomal genes showed higher 
expression levels in -TC3 cells cultured with high CO2 concentration, we decided to carry 
out our experiments keeping the cells under this culture condition. 
This analysis also revealed some differences in the peroxisome-related and antioxidative 
gene expression of the -TC3 cells and the LCM-isolated -cells. Pex13, Abcd1 and Cat, all 
showing next to no mRNA expression in LCM isolated -cells were expressed at higher levels 
in the -TC3 cell line. In the case of Abcd1 a strong expression was observed in -TC3 cells, 
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especially after 8 % CO2 incubation, contrary to what we observed for the LCM cells. 
Likewise, Sod2 a gene encoding for the mitochondrial antioxidative enzyme superoxide 
dismutase 2, was clearly expressed in the -TC3 cell line whereas it was very low expressed 
in LCM isolated -cells. However, several resemblances were also found: in both the 
microdissected -cells and the -TC3 cells the mRNA level of the -oxidation enzymes 
Ehhadh and Acox2 were low abundant while the other peroxisomal genes analysed, 
including genes encoding for biogenesis proteins, lipid transporters and -oxidation 
enzymes were clearly expressed. 
 
Figure: 29. Semiquantitative RT-PCR analysis of cDNAs prepared from total RNA of β-TC3 cells maintained 
under different CO2 conditions. β-TC3 cells were incubated in complete DMEM medium and maintained in two 
different CO2 conditions. One µg of RNA was used for semiquantitative RT-PCR analysis. A: 28S rRNA was used 
as internal control; B: Peroxisomal biogenesis genes Pex13 and Pex14; C: Peroxisomal ABC-transporters Abcd 
1-3; D: Acox1: acyl-CoA oxidase 1, Ehhadh: multifunctional protein 1, Acaa1: 3-ketoacyl-CoA thiolase; E: Acox2-
3: acyl-CoA oxidase 2-3, Hsd174: multifunctional protein 2; F: Peroxisomal and mitochondrial anti- oxidative 
enzymes, Cat: catalase; sod 1-3: superoxide dismutase 1-3. Red stars (*) indicate those genes in which the RNA 
expression levels increased after the exposure to 8 % CO2. Blue stars (*) show those genes with a down-
regulation after changing CO2conditions. 
 
A prominent feature of the -TC3 cell line is its capacity to respond to glucose, the major 
physiological stimulus of insulin secretion from normal -cells, hence we tested the effect of 
different glucose concentrations and length of exposure to determine the best conditions 
for the stimulation of insulin production and secretion. For this purpose, cells cultured for 
48 h in standard DMEM medium (containing 20 mM glucose) were exposed to medium 
lacking glucose for 30 min, 1, 3, 6, 12 and 24 h and subsequently stimulated for 6 or 12 h 
with the re-introduction of 20 mM glucose. Controls were kept under standard conditions 
during the progression of the experiment. Semi-quantitative RT-PCR analysis was carried out 
to determine the mRNA expression of Insulin 1 (Ins I) and Insulin 2 (Ins II). Unlike in humans, 
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rodents possess two insulin genes that are structurally similar but non-allelic. Both genes 
are functional, but Ins I has been shown to be selectively glucose responsive while Ins II is 
responsible of the basal secretion of the hormone (185). The highest expression of the Ins I 
mRNA levels was obtained using the experimental condition of 0 mM/l glucose for 1 h 
followed by 12 h of exposure to 20 mM glucose (Figure: 30). As expected, Ins II expression 
levels were not affected by the glucose exposure. 
 
 
Figure: 30. Semiquantitative RT-PCR analysis of cDNAs prepared from total RNA of β-TC3 cells stimulated 
with glucose. β-TC3 cells were incubated in DMEM medium containing 0 mM/l of glucose for different time 
periods and then stimulated with 20 mM/l glucose as described under Material and Methods. One µg of RNA 
was used for semiquantitative RT-PCR analysis. Insulin 1 (Ins I) mRNA levels showed an evident up-regulation 
after the cells were cultured for 1 h in 0 mM/l glucose followed by 12 h 20 mM/l glucose exposure. Insulin 2 
(Ins 2) showed no changes after treatment. 28S rRNA was used as internal control. 
 
After establishing the best condition for the stimulation of the Ins I gene expression, we 
assessed the capability of the -TC3 cells to release and store insulin after glucose 
stimulation using ELISA. Cells cultured with 20 mM glucose for 48 h exhibited low basal 
(~15µm/l) insulin secretion and responded with a 3-fold stimulation when challenged with 
20 mM/l glucose after 1 h in the absence of glucose (Figure: 31). The cellular insulin content 
after glucose stimulation showed a more than two-fold increase compared to those cells 
maintained at all time with 20 mM glucose (control). -TC3 cells responded to glucose 
stimulation releasing and producing insulin resembling normal -cells. 
Figure: 31. Insulin released and content in β-TC3 after glucose 
stimulation. β-TC3 cells were cultured in DMEM lacking glucose for 1 
h and then stimulated with 20 mM/l glucose for 12 h. Insulin release 
was measured by ELISA in the harvested supernatant and corrected 
for protein concentration. For the calculation of insulin content cells 
were collected for insulin assay and protein determination. A total 
protein homogenate was used to determine the protein content via 
Bradford assay. Values ±SEM represent the insulin fold change levels 
relative to control sample normalized to total protein from three 
independent experiments. C: control, S: stimulated. Statistics: 
Student´s t-test for paired values: * = p≤ 0.05; ** = p ≤ 0.01. 
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To further characterize the -TC3 cell line, we analysed peroxisomal marker proteins in cells 
kept under standard conditions (containing 20 mM glucose continuously) (Figure: 32) by 
immunofluorescence staining. The peroxisomal biogenesis proteins PEX14 and PEX13 were 
detected in punctuate structures representing peroxisomes. However, the abundance of the 
two proteins was different. The PEX14 signal was intense with some peroxisomal clusters 
distributed evenly throughout the cytoplasm, whereas the staining for PEX13 was fainter. 
PEX3 was detectable in -TC3 cells with very low peroxisomal staining, exhibiting a higher 
cytoplasmic background than other “peroxisomal” IF-staining. This PEX3 staining pattern is 
certainly due to its very low protein abundance and the high antibody concentration used. 
Similarly to PEX14, THIOLASE A (THIO), the terminal enzyme of the -oxidation pathway I, 
could be nicely visualized, exhibiting the characteristic peroxisomal staining pattern. 
Opposite to the findings previously described in this thesis for the detection of CAT in 
pancreatic islets as well as in LCM-isolated -cells, -TC3 cells display a higher content of 
this antioxidative enzyme. The IF analysis for ABCD3 showed large and strongly 
immunoreactive tubular as well as some round individual peroxisomes side by side. 
 
 
Figure: 32. Immunofluorescence localization of peroxisomal proteins in -TC3 cells. IF-staining for: A and B: 
the peroxisomal biogenesis proteins PEX14 and PEX13; C: PEX3, the peroxin required for the assembly of 
peroxisomal membrane proteins; D: THIOLASE enzyme, part of the peroxisomal -oxidation pathway 1; E: the 
antioxidative enzyme CATALASE and F: the lipid transporter ABCD3. 
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Taken all together, these results provide good evidence suggesting that the -TC3 cell line 
used under the established cell culture conditions, constitutes a useful in vitro model for the 
investigation of both pancreatic -cell function and also peroxisomal physiology and 
pathology. 
5.3. Pex13 down-regulation induced peroxisomal deficiency 
To better understand the specific role of peroxisomes in pancreatic -cell physiology, we 
developed a peroxisome-deficient -TC3 cell line model. It has been shown that mutations 
and deficiencies in peroxisomal biogenesis proteins lead to severe peroxisomal biogenesis 
disorders (68, 81, 186). The peroxin PEX13 is one of the components of the peroxisomal 
translocation machinery. It functions as a membrane docking factor for the cytoplasmic 
PTS1 receptor and is involved in the import of PTS1 and PTS2 proteins into the peroxisomal 
matrix. To simulate a peroxisomal defect in pancreas, we decided to generate a PEX13 
knockdown in β-TC3 cells by using small interfering RNA (siRNA) directed against the Pex13 
mRNA. For this purpose, different transfection methods were tested in a set of preliminary 
experiments including physical and chemical approaches e.g. microporation and lipofection, 
respectively. Even though the microporation technique resulted in 85-90 % PEX13 protein 
down-regulation (data not shown) and catalase mistargeting into the cytoplasm (a 
characteristic phenotype observed in conditions of peroxisomal deficiency) (Figure: 33), this 
result was not reproducible and the cell viability was seriously affected by the procedure 
itself. 
 
 
Figure: 33. Immunofluorescence analysis of catalase in β-TC3 cells after Pex13 knockdown using 
microporation as a transfection method. Forty-eight hours post transfection, -TC3 cells were fixed, 
permeabilized and used for IF analysis. A: The peroxisomal antioxidative enzyme, catalase, was detected in 
those cells not transfected, as punctuate structures representing peroxisomes (1). The mistargeting of catalase 
into the cytoplasm in -TC3 cells after the knockdown of Pex13 (2) demonstrates the disruption of the 
peroxisomal matrix proteins import. B: The microporated plasmid for Pex13 shRNA contain the gene encoding 
the green fluorescent protein (GFP) for fluorescence microscopy-based observation of transfected cells. Scale 
bar = 32 µm. 
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As an alternative method to introduce the Pex13-siRNA into the -TC3 cells, transfection via 
lipofection was therefore chosen and optimized. Diverse reagents, time points, and siRNA 
concentrations were tested to obtain the optimal conditions for Pex13 mRNA and PEX13 
protein down-regulation. As a control, we performed all the transfection experiments in 
parallel with the corresponding scrambled siRNA (Scr-si) that did not result in the down- 
regulation of the PEX13 protein abundance. Protein samples from the transfected -TC3 
cells were subjected to Western blot analysis 48 h after transfection. Neither the use of 
ScreenFect A (Wako Chemicals, USA) nor FuGENE (Promega, USA) reagent in combination 
with 15 or 30 nM Pex13 siRNA resulted in a significant PEX13 down-regulation (Figure: 34A). 
By using Interferin (Polyplus, FR) as a transfection reagent in combination with 15 nM siRNA 
we could achieve a ~66 % down-regulation of the PEX13 protein and further improved this 
result to achieve ~80 % down-regulation of PEX13 protein by employing 30 nM siRNA. 
Once the best transfection reagent and siRNA concentration were determined, different 
time periods of transfection were tested to analyze the duration and stability of the gene 
silencing and accordingly establish the best conditions for the further experiments using RT- 
qPCR analysis and Western blotting (Figure: 34B-C). Transient transfection of Pex13 siRNA 
led to a significant decrease (up to a maximum 85 %) of Pex13 mRNA expression (p  
0.0001) compared with the Scr-si control group after 48 h of transfection (Figure: 34C) and 
the decrease of PEX13 abundance was stable up to 96 h (Figure: 34B), time after which the 
protein level increased gradually (data not shown). 
 
 
 
 
 
Figure: 34. siRNA-mediated Pex13 knockdown in β-TC3 cells as a means of inducing peroxisomal  dysfunction 
(see figure on page 73). A: Different transfection reagents and si-RNA concentrations (15 and 30 nM) were 
used to establish the right conditions for β-TC3 cell transfection via lipofection. The cells were transfected with 
Pex13-si or Scr-siRNA and 48 h after transfection total protein was isolated, 20 µg protein were subjected to 
SDS-page and Western blot analysis and probed sequentially with antibodies against PEX13 and α-Tubulin. 
Alpha tubulin was used as a loading control and for normalization. The autoradiographic signals were 
visualized and quantified as described under Material and Methods. B-C: β-TC3 cells were transfected with 
Pex13-si (30 nM) or Scr-siRNA via lipofection. B: Representative immunoblotting showing the reduction of 
PEX13 in β-TC3 cells after Pex13-si transfection at different time-points post transfection. C: After 48 h total 
RNA was isolated and analysed by real-time RT-PCR analysis using the primers for Pex13 and Actb. The average 
threshold (Ct) values of at least three independent experiments were used to calculate the relative amounts of 
mRNA using the 2-ΔΔ CT method and normalized to Actb values. Values ±SEM represent the Pex13 expression 
levels relative to the Scr-si transfected sample. Actb: -actin. Statistics: Student´s t-test for paired values: 
****: p  0.0001. 
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Figure: 34. For figure legend refer to page 72. 
 
5.4. The knockdown of Pex13 did not affect -TC3 viability 
To determine whether the knockdown of PEX13 affected β-TC3 cell survival, cell viability 
was assessed using the Trypan blue exclusion test at different time points (48, 72, 96 h) 
after transfection (Figure: 35). Cell survival remained almost unchanged in both groups 
showing no lethality upon Pex13 gene silencing. 
 
 
Figure: 35. β-TC3 cell viability was not affected by the down- 
regulation of Pex13. Cells were transfected with Pex13-si or 
Scr-siRNA as a control using Interferin transfection reagent. 
After 48, 72 and 96 h, the Trypan blue exclusion test was used 
to determine cell viability. The number of intact cells, which 
exhibited no blue staining, was determined (eight fields per 
experiment) and percentage of live cells in relation to 
untreated control is depicted. 
 
 
5.5. The knockdown of Pex13 altered peroxisome-related gene expression and protein 
abundance in -TC3 cells 
To further examine the possible effects of the Pex13 down-regulation we analyzed the 
expression level of some key peroxisomal genes involved in lipid transport, -oxidation and 
reactive oxygen species (ROS) regulation as well as the transcription factors of the Ppar 
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family (Ppar   γ) by standard semiquantitative RT-PCR (Figure: 36). The silencing of 
Pex13 in -TC3 cells resulted in a significant increase (1.5-fold) of Ppar mRNA levels 48 h 
post transfection. No significant alteration was seen for PPAR mRNA whereas the PPAR 
mRNA could not be amplified with two different primer pairs used, even though these 
primers were successfully used from other doctoral candidates for total RNA of other 
organs. By contrast, Abcd3, Cat and Acox1 showed a decrease in their mRNA levels (64 %,  
86 %, and 77 % respectively). For the calculation of the differences in the mRNA expression 
levels, the PCR band intensities of peroxisome-related genes and Ppars were normalized for 
the band intensity of the 28S rRNA of the same cDNA preparation. 
Figure: 36. Semiquantitative RT-PCR analysis on cDNAs 
prepared from total RNA from β-TC3 cells after Pex13 
down-regulation. Cells were transfected with Pex13-si or 
Scr-siRNA and 48h post transfection, total RNA was 
isolated and 1 µg was reverse transcribed and used for 
semiquantitative RT-PCR analysis. mRNAs for: Pex13: 
Peroxin 13; Abcd3: ATP-binding cassette, subfamily D 
(ALD), member 3; Acox1: acyl-CoA oxidase 1; Cat: 
Catalase; Ppar, , : Peroxisome proliferator-activated 
receptors ,  and ; 28S rRNA as internal control. 
 
 
 
Once evaluated the peroxisomal gene expression on the Pex13 knockdown background, the 
effect of the Pex13 silencing on the abundance of PEX13, PEX14, CAT, and ABCD3 was 
assessed by immunofluorescence analyses. After PEX13 labelling Scr-si transfected cells 
showed a clear punctuate peroxisomal pattern with some cytoplasmic background (Figure: 
37A). PEX13 staining in Pex13-si transfected cells was almost absent, showing only very few 
individual peroxisomes evenly distributed throughout the cell (Figure: 37B). This 
corresponds well to the results obtained by Western blot analysis showing that 
approximately 20 % of the protein was still present in the cells. PEX14, which is a part of the 
docking complex in the peroxisomal membrane and binding partner of PEX13, was detected 
in the Scr-siRNA transfected cells as small dots as well as larger aggregates, which were 
identified as single peroxisomes as well as peroxisomal clusters (Figure: 37C). Interestingly, 
the down-regulation of PEX13 resulted in a change of peroxisomal morphology and 
intracellular distribution of PEX14, however, with no change in the signal intensity. In 
comparison to cells transfected with Scr-si, peroxisomes did not appear as single dots and 
aggregates but in the majority as tubular structures (Figure: 37D). 
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As explained previously, PEX13 is essential for the proper import of peroxisomal matrix 
proteins and its depletion leads to the mistargeting of peroxisomal matrix proteins to the 
cytosol where they might be degraded or not. As expected, instead of the usual peroxisomal 
pattern (observed in the Scr-si transfected cells) Pex13-siRNA transfected -TC3 cells labeled 
with an anti-catalase antibody showed a faint nuclear staining (even after prolonged 
exposure times), most likely due the mistargeting of the protein (Figure: 37E and F). 
The immunofluorescence analysis of ABCD3 in the Scr-si transfected cells showed many 
positive-stained peroxisomes, with clear dots as well as many tubular structures. However, 
in contrast to the results observed for the Abcd3 mRNA levels, the silencing of Pex13 
resulted in an increase of the ABCD3 
immunofluorescence signal (Figure: 
37G and H), the molecular 
mechanisms of which has to be 
elucidated in future studies. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure: 37. Immunofluorescence analysis of 
PEX13, PEX14, CAT, and ABCD3 after   Pex13 
silencing in β-TC3 cells. 48h after the siRNA 
treatment, the cells were fixed, 
permeabilized and used for IF analysis. A-B: IF 
staining for PEX13 localization in (A) control 
cells transfected with Scr-siRNA and (B) cells 
transfected with Pex13-siRNA; C-D: IF analysis 
for PEX14 localization in (C) Scr-siRNA and (D) 
Pex13-si transfected cells; E-F: IF analysis of 
Catalase localization in (E) Scr-siRNA and (F) 
Pex13-siRNA transfected cells. G-H: ABCD3 IF 
staining in Control Scr-siRNA and Pex13-si 
transfected cells respectively. 
Scale bar = 15µm. 
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5.6. Reactive oxygen species (ROS) production in -TC3 cells after Pex13 down- 
regulation 
Since the knockdown of Pex13 leads to the mislocalization of catalase to the cytosol, an 
enzyme playing a central role in the oxidative stress management of the cells, its effects on 
the accumulation of ROS in comparison to wild type (WT) and Scr-si transfected cells were 
examined. Two fluorescent dyes, dihydroethidium (DHE) and dichlorodihydrofluorescein 
diacetate (H2-DCFDA) were used to detect superoxide and hydrogen peroxide (H2O2) 
production, respectively. These experiments revealed that in Scr-siRNA treated cells the 
amount of superoxide was significantly increased (p≤ 0.0001) in comparison with the non- 
treated cells (WT) as shown by the DHE staining (Figure: 38A, B and G). Interestingly, after 
Pex13-siRNA transfection, the signal intensity of the DHE staining was significantly lower (p≤ 
0.0001) than the one observed in the Scr-siRNA transfected cells (Figure: 38B, C and G), 
nearly reaching the WT levels again. 
On the other hand, the silencing of Pex13 led to a notable increase in the H2O2 levels in 
comparison with to the Scr-si transfected cells (p≤ 0.0001) (2.5-fold) (Figure: 38E, F and H) 
as well as with the WT control group (5-fold) (Figure: 38D-F and H) as shown by the DCFDA 
staining. The fluorescence signal in -TC3 cells after Scr-siRNA treatment revealed a weak 
but significant increase in its intensity in comparison to the WT control group. 
Next to testing the amount of oxidative stress generated after the down-regulation of 
PEX13, we also analysed whether the abundance of key enzymes of the oxidative stress 
management were affected. Western blot analysis of the peroxisomal antioxidative enzyme 
catalase showed slightly reduced protein levels in Pex13 KD cells after 48 h of transfection, 
whereas no significant changes were observed 24 h post-transfection (Figure: 38I), despite 
the fact that the protein was mistargeted to the cytoplasm (Figure: 37E and F). Moreover, 
the abundance of the mitochondrial antioxidative enzyme superoxide dismutase 2 (SOD2) 
was slightly increased by the Pex13-siRNA transfection after 48 h, which could explain the 
shift of O2¯ to H2O2 production (Figure:38I). 
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Figure: 38. Measurements of superoxide and hydrogen peroxide levels by relative quantification of DHE and 
DCFDA fluorescent signals and Western blot analysis of antioxidative enzymes in β-TC3 cells after Pex13- 
siRNA transfection. β-TC3 cells were transfected with Pex13-siRNA and Scr-siRNA. Wild type cells were used as 
control. After 48 h the cells were stained with DHE or DCFDA as indicated in Material and Methods. A-C: WT- 
control, Scr-siRNA and Pex13-siRNA transfected cells stained with DHE to detect superoxide production. D-F: 
Control, Scr-siRNA and Pex13-siRNA transfected cells stained with DCFDA to analyze H2O2 levels as an indicator 
of ROS. G: Relative quantification of superoxide generation. At least 100 cells from 3 independent experiments 
were used for the measurements. H: Relative quantification of H2O2 production. Only 30 cells could be 
photographed to measure the fluorescence intensity due to the short-lived stability of the DCFDA staining 
(light susceptible and rapidly metabolized in living cells). The quantification of the fluorescence intensity was 
done with the ImageJ software (National Institutes of Health, Bethesda, MD, USA). Statistics: Student´s t-test 
for paired values: *: p≤0.05; ****: p≤0.0001. I: Western blot analyses of catalase (CAT) (60kD) and superoxide 
dismutase 2 (SOD2) (25kD) after 24h or 48h Pex13-siRNA transfection. Scale bar = 32 µm for all figures. 
5.7. Impaired peroxisomal lipid transport after Abcd3 knockdown 
As we were interested in the role of peroxisomes in pancreatic β-cells under lipotoxicity, we 
decided to study the effect of the down-regulation of ABCD3 in β-TC3 cells. The peroxisomal 
lipid transporter ABCD3, which is one of the most abundant integral membrane proteins of 
peroxisomes in pancreatic β-cells, is involved in the transport of branched- and long-chain 
G H I 
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acyl-CoAs into the organelle. The model system to study the peroxisomal lipid transport 
dysfunction was accomplished via siRNA-mediated Abcd3 knockdown in β-TC3 cells. 
Preliminary experiments were set up to optimize the conditions of the transfection. 
Different Abcd3-si RNA concentrations were tested (15, 30, 40, 50, and 60 nM) achieving the 
highest percentage (~82 %) of mRNA down-regulation with 50 nM Abcd3-siRNA after 48 h 
transfection as shown by qPCR analysis (Figure: 39A). Having decided on the best Abcd3-si 
RNA concentration to use, the Abcd3 gene expression was analyzed by qPCR at different 
time-points after transfection (24, 48, 72, and 96 h) to analyze the duration and stability of 
the gene silencing. As expected, we observed that the Abcd3-si RNA treatment caused a 
time-dependent decrease of the Abcd3 mRNA levels to 20 % of the expression level 
observed in Scr-si RNA transfected cells at 96 h post-transfection (Figure: 39B). 
A 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure: 39. Optimization of the conditions for Abcd3 knockdown in β-TC3 cells by siRNA-mediated 
transfection. A: β-TC3 cells were transfected with Abcd3-si RNA via lipofection using different RNA 
concentrations (15, 30, 40, 50 and 60 nM). After 48 h, the expression of Abcd3 was analyzed by qRT-PCR, 
ensuring the efficiency of the down-regulation. One µg total RNA was used for the analysis and Abcd3 and  
Actb (-Actin) expression levels were examined as described in Materials and Methods. The relative amounts 
of mRNAs were calculated using the threshold (Ct) values by the 2-ΔΔ CT method and normalized to Actb. B: β- 
TC3 cells were transfected with 50nM Abcd3-si or Scr-si RNA. Different time points were used to ensure the 
efficiency of the down-regulation. The average threshold (Ct) values of at least three independent experiments 
were used to calculate the relative amounts of mRNA. Values were normalized to Actb. 
 
The reduction of the Abcd3 mRNA levels after Abcd3 silencing was corroborated by the 
decrease in the ABCD3 protein abundance after 24, 48, 72, and 96 h of transfection as 
assessed by immunoblot analysis (Figure:40C). Of the two bands observed after the analysis 
using an antibody against ABCD3 the lower one of ~65 kDA corresponds to ABCD3 as shown 
by the knockdown (Figure:40C). It is currently not clear what the additional band with 
molecular weight of ~70 kDa represents. The down-regulation of ABCD3 was confirmed by 
immunofluorescence analysis conducted 96 h after transfection (Figure: 40A and B). In the 
B 
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Scr-siRNA transfected cells round and strongly stained peroxisomes, evenly distributed 
across the cell, were detected. On the other hand, the silencing of Abcd3 resulted in next to 
no detectable ABCD3 staining. The future experiments and treatments were therefore all 
conducted at 96 h post transfection. 
 
Figure: 40. ABCD3 protein abundance after 
siRNA-mediated Abcd3 silencing in β-TC3. β- 
TC3 cells were transfected with Abcd3-si (50 
nM) or Scr-si RNA via lipofection. A-B: After 
96 h ABCD3 was detected with an antibody 
against ABCD3 as described in Materials and 
Methods. The nuclei were counterstained 
with Hoechst 33342 dye. Scale bar = 12µm. C: 
Representative immunoblot showing the 
down-regulation of ABCD3 in β-TC3 cells after 
Abcd3-si transfection at different time points. 
Total protein (20 µg) was subjected to 
Western blot analysis and probed with an 
antibody against ABCD3. Autoradiographic 
signals were visualized as described under 
Material and Methods. As loading control, 
membranes were stained with Coomassie 
Blue Stain (Invitrogen). 
 
 
 
 
 
5.8. Stimulation of lipotoxicity by palmitic and phytanic acid in -TC3 cells 
Fatty acids have been reported to influence -cell function and viability. A short exposure 
(acute) of β-cells to fatty acids can stimulate the release of insulin (187, 188). This acute 
exposure is not toxic to the β-cells if the fatty acids are properly metabolized within the 
cells(189). However, prolonged (chronic) exposure of β-cells to increased levels of fatty acids 
results in lipid accumulation, β-cell dysfunction and finally apoptosis (lipotoxic effect) (136, 
155). Moreover, changes in β-cell gene expression are commonly observed during the 
progression of lipotoxicity (190). Since peroxisomes play an important role in the oxidation of 
fatty acids, we decided to treat Pex13 KD β-TC3 cells with the saturated fatty acid palmitic 
acid (PA) or the branched- chain fatty acid phytanic acid (PHY) as a means to stimulate 
lipotoxicity. With this set-up, we intended to investigate whether β-cells lacking functional 
peroxisomes were more susceptible to lipotoxicity, whereas PA can be oxidized in 
mitochondria (and peroxisomes), PHY is only oxidized by peroxisomes. 
C 
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A preliminar viability experiment was conducted to establish the right fatty acid 
concentration (LD50) needed to exert cell toxicity on β-TC3 cells. To determine cell viability, 
we used the dye Trypan blue, which is only staining dead cells. 
Palmitic acid was prepared according to Choi et al. (178): complexes of fatty acids were 
formed with albumin prior the incubation. Solubilized palmitic acid was added at different 
concentration freshly to the cell culture every 24 h over a period of 2 days. The results of 
this experiment showed that cell death was induced by PA in a concentration and time 
dependent manner (Figure: 41A). At 0.1 mM only 10-15 % cells were affected after 2 days of 
treatment, while the exposure to 0.5 mM showed toxicity already after 24 h and was 
sufficient to increase cell death by 4-fold after 2 days. With 1 mM PA more than 95 % of the 
cells died at the end of the experiment. 
As with PA, the exposure of β-TC3 cells to PHY resulted in a time and concentration- 
dependent cytotoxicity (Figure: 41B). One, 10 and 20 µM PHY were not enough to cause cell 
death, however, using 50 µM PHY, a toxic effect was detected after only 12 h treatment 
with 60 % cell death reaching a nadir (~90 %) after 2 days. The highest PHY concentration 
(100 µM) used in this experiment proved to be extremely toxic for the cells even after 24 h, 
time after which no cell survived. Parallel incubations were performed to determine the 
toxicity of the BSA-NaOH complex (vehicle) and dimethyl sulfoxide (DMSO), both used for 
PA and PHY respectively. Neither solvents showed toxic effect when used at the same 
concentrations and time-points as in the PA or PHY suspensions (data not shown) thus 
corroborating that the toxicity was only due to the fatty acids. For future experiments in this 
study we decided to expose the cells to 0.2 mM PA or to 40 / 60 µM PHY. 
 
 
Figure: 41. Increased β-TC3 cell death after different fatty acid treatments. A: Cells were incubated with 
DMEM medium containing different concentration of palmitic acid (0, 0.1, 0.2, 0.5 and 1 mM) for 6, 12, 24 and 
48 h. The cell viability was evaluated by Trypan blue exclusion test. The number of intact cells, which exhibited 
no blue staining, was determined (eight fields per experiment) and percentage of live cells in relation to 
A B 
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untreated control is given. B: An incubation with DMEM medium containing different concentration of 
phytanic acid (1, 10, 20, 50, and 100 µM) was carried out for 6, 12, 24, and 48h. 
 
5.9. Elevated glucose concentrations enhance palmitate cytotoxicity in -TC3 cells 
It has been shown that free fatty acids together with high glucose (hyperglycaemia) 
synergize causing islet -cell damage due to the inhibition of fatty acid oxidation and 
therefore of lipid detoxification (189, 191). To analyse the interaction of PA with glucose during 
cell death, -TC3 cells were treated for 24, 48, and 72 h with different concentrations of PA 
(0, 0.2, and 0.5 mM) in the background of hyperglycaemia (20 mM glucose) or low glucose 
concentration (5 mM) (Figure: 42). 
 
 
Figure: 42. Induction of cell damage caused by the synergistic effect of elevated concentrations of glucose 
and palmitic acid. β-TC3 cells were incubated in DMEM medium at 5 (Gluc 5) and 20 (Gluc 20) mM glucose in 
the absence (control) or presence of 0.2 and 0.5 mM palmitic acid (PA) during 24, 48 and 72h. The Trypan blue 
exclusion test was carried out for the determination of cell viability. The number of intact cells, which showed 
no blue staining, was determined (eight fields per experiment) and percentage of death cells in relation to 
living cells per group is given. Gluc: glucose (in mM); PA: palmitic acid. Statistics: ANOVA test for multi-paired 
values. * p  0.05; ** p  0.01. 
 
In the presence of 5 mM glucose, none of the PA concentrations displayed a significant 
change in cell viability throughout the duration of the experiment. Remarkably, cell 
exposure to low glucose (5 mM) along with high physiological PA concentrations (0.5 mM) 
resulted in minimal toxicity (less than 20 % after 72 h) in comparison to the control (0 mM 
PA) (~16 % cell death after 72 h) or the 0.2 mM PA treated group (~18 % cell death after 72 
h). In contrast, in the cells incubated with 20 mM glucose, the PA toxicity was markedly 
increased in a time and concentration dependent manner, showing a reduction in the cell 
number after only 24 h of treatment, where the exposure to 0.2 mM and 0.5 mM resulted  
in 19 % and 32 % of cell death respectively, compared to the group exposed to 0 mM of PA. 
At the end of the experiment ~65 % of the cells incubated in high glucose medium 
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supplemented with 0.2 mM PA died, while this toxic effect increased to 90 % when cells 
were exposed to 0.5 mM PA. Taken together, these results support the glucolipotoxicity 
hypothesis of -cell death, which suggests that elevated fatty acids (in this case, PA) are 
particularly toxic in the context of hyperglycaemia. 
 
5.10. Intracellular lipid accumulation of palmitic acid and phytanic acid in -TC3 cells 
Since one of our aims was to better define the role that peroxisomes play during lipotoxicity 
in -cells, we decided to verify the fatty acid uptake and/or accumulation in our cell model 
using PA and PHY at different concentrations. Intracellular lipid accumulation was analyzed 
by light microscopy after staining the cells with Oil red O as described in Materials and 
Methods. When β-cells take up free fatty acids (FFA), they convert them to triglycerides or 
cholesterol ester for intracellular storage in form of lipid droplets within the cytoplasm. If 
the storage capability of the cells is exceeded, excessive FFA may impair insulin secretion 
and induce apoptosis (192). The exposure of -TC3 cells to PA showed an increase in the 
amount of intracellular lipid accumulation in form of Oil red O stained lipid droplets in a 
concentration dependent manner (0, 0.1, 0.2, 0.4, 0.5, and 1 mM). The droplets, clearly 
observed in the control group as small and circular structures scattered across the 
cytoplasm of some cells (Figure: 43A), became more prominent, numerous, and larger as 
the PA concentration increased, appearing as well-defined large round structures occupying 
very large parts of the cytoplasm (Figure: 43D). Higher PA concentrations (0,5 and 1 mM) 
were also analyzed, however, due to their high toxicity and resulting cell damage it was not 
possible to obtain a representative picture. 
Figure: 43. Effect of palmitic acid treatment on the cellular lipid storage in wild type β-TC3 cells. A: β-TC3 
cells were maintained in DMEM medium supplemented with serum without PA as control. B-D: β-TC3 cells 
treated with PA at different concentrations (0.1, 0.2, and 0.4 mM) for 48 h, time after which the appearance of 
lipid droplets was observed by Oil red O staining. Nuclei were stained with hematoxylin providing better cell 
visualization and identification. The results were examined using a phase contrast microscope (LEICA DMRD 
equipped with a LEICA CD480 camera). PA: palmitic acid. Scale bar = 26 µm for all images. 
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In comparison with PA, PHY, which is exclusively metabolized in peroxisomes, showed a 
similar but less intense Oil red O staining. While the staining of control cells resulted in 
sporadically distributed, very small round structures (Figure: 44A), the exposure to PHY led 
to the formation of larger, strongly stained droplets, the number of which increased with 
increasing PHY concentration (Figure:44D). A high percentage of cell death was observed 
after 48 h of treatment with 60 µM PHY, yet enough cells could be obtained for the analysis. 
Interestingly, the number of lipid droplets observed after the treatment with PHY at a toxic 
concentration, was clearly lower than that found for PA at toxic concentration. In other 
words, for PA a higher accumulation of intracellular lipid droplets could be achieved than for 
PHY using similar toxic conditions. 
Figure: 44. Effect of phytanic acid treatment on the cellular lipid storage in wild type β-TC3 cells. A: Cells 
were maintained in DMEM medium without PHY as control. B-D: β-TC3 treated with serum supplemented with 
PHY at different concentrations (20, 40, and 60 M) for 48 h, time after which the appearance of lipid droplets 
was observed by Oil red O staining. The results were examined using a phase contrast microscope (LEICA 
DMRD equipped with a LEICA CD480 camera). Phy: phytanic acid. Scale bar = 26 µm for all images. 
 
5.11. The peroxisomal lipid transporter ABCD3 showed an opposite regulation in −TC3 
cells treated with palmitic and phytanic acid 
As observed previously, the cell exposure to palmitic and phytanic acid resulted in the 
increase of cytoplasmic lipid droplet formation. We were further interested in analyzing this 
effect on the ABCD3 protein amount since this membrane lipid transporter is in charge of 
the peroxisomal lipid transport. Interestingly, the treatment of β-TC3 cells with increasing 
PA concentrations resulted in an inversely proportional ABCD3 IF staining intensity. A very 
strong IF signal was observed in the untreated control group (0 mM PA) displaying round 
peroxisomes forming clusters  throughout  the  cytoplasm  (Figure:  45A).  The addition o f  
0.2 mM PA into the culture medium resulted in a strong decrease of the ABCD3 IF signal 
intensity. Individual peroxisomes were evenly distributed throughout the cell and still 
weakly positive for ABCD3 (Figure: 45B). A further increase of the PA concentration to 
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0.4 mM resulted in an even weaker signal, revealing only faintly stained granular structures 
(Figure: 45C). 
 
Figure: 45. Effect of palmitic and phytanic acid treatment on the peroxisomal lipid transporter ABCD3 in β- 
TC3 cells. A-C: IF analysis of β-TC3 cells after PA treatment. The cells were incubated with PA at two different 
concentrations: 0.2 (B) and 0.4 (C) mM for 48 h to observe the effect of the saturated fatty acid on the 
abundance of the peroxisomal membrane lipid transporter ABCD3. D-F: β-TC3 cells were incubated with PHY 
at two different concentrations: 40 (E) and 60 (F) µM for 48 h. Cells were subjected to IF staining using an 
ABCD3 antibody at a dilution of 1:500 and nuclei were visualized with Hoechst 33342 dye as described in 
Materials and Methods. PA: palmitic acid; Phy: phytanic acid. Scale bar = 20 µm for all images. 
 
Contrary to the results observed after the PA treatment, the exposure to PHY resulted in an 
increase in the abundance of ABCD3. IF analysis of β-TC3 cells maintained in medium lacking 
PHY (control) revealed a peroxisomal pattern composed of punctuate structures evenly 
distributed across the cytoplasm as well as some tubular peroxisomes (Figure: 45D). In 
comparison with the non-treated cells, the exposure to 40 µM PHY produced an increase in 
the ABCD3 staining intensity depicted as big round peroxisomes (Figure: 45E). Moreover, 
rising the PHY concentration to highly toxic 60 µM resulted in an even stronger signal with 
large peroxisomes clustering in patches across the cytosol (Figure: 45F). 
To ensure the ABCD3 down-regulation observed in -TC3 cells exposed to the PA treatment, 
RT-qPCR analysis for Abcd3 mRNA levels was carried out. Interestingly, the exposure to 0.2 
mM PA led to a 4-fold increase of Abcd3 mRNA levels after 6 h (Figure: 46). This effect 
decreased after 12 h of incubation, where the Abcd3 mRNA level after the PA treatment did 
not show a variation in comparison with the control group. The analysis of later time-points 
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revealed, as expected, a decrease in the Abcd3 expression after 24 h of PA exposure, 
reaching a 50 % suppression after 48 h, in agreement with the results observed by IF 
analysis. 
 
 
 
Figure: 46. Effect of palmitic acid treatment on Abcd3 mRNA 
levels in β-TC3 cells. Real-time RT-PCR analysis of Abcd3 at 6, 12, 
24, and 48 h after 0.2 mM PA treatment in β-TC3 cells compared 
with the control group. The primers for Abcd3 and Actb (-Actin) 
were used as described in Materials and Methods. The relative 
amount of mRNA was calculated using the 2-ΔΔ CT method and 
data was normalized to Actb values. The graphic shows the 
result of a single experiment. 
 
 
 
5.12. Reactive oxygen species (ROS) production in TC3 cells after their exposure to 
palmitic acid 
 
It was suggested in the literature that intracellular accumulation of ROS produced by some 
metabolites of PA (such as diglycerol) (193) can result in β-cell apoptosis and decrease of 
insulin secretion, thereby impairing the function and reducing the number of β-cells (194). 
Since β-cells are poorly protected against oxidative stress due to their low content of 
antioxidative enzymes (195) it was of our interest to investigate the cellular levels of ROS 
along with the activity and mRNA expression of catalase in response to PA exposure in β-
TC3 cells. Interestingly, as determined by DHE staining, a significant (p ≤ 0.01) decrease in 
the fluorescence signal intensity corresponding with lowered intracellular superoxide levels 
was observed in those cells exposed to 0.2 mM PA for 48 h in comparison with the non- 
treated cells (Figure: 47A, B and E). 
Since the DCFDA staining has a relatively short-time stability mainly due to its light 
susceptibility and metabolism in living cells, only a 6h PA exposure was used to assess the 
H2O2 production. The cell exposure to high PA concentration (2 mM) resulted in a significant 
(p ≤ 0.001) 2.8-fold increase in the DCFDA staining an indication for the presence of elevated 
hydrogen peroxide levels (Figure: 47C, D and F). 
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Figure: 47. Palmitic acid treatment 
induces H2O2 but decreases 
superoxide levels in -TC3 cells. A- 
B: Control and PA (0.2 mM) treated 
β-TC3 cells stained with DHE to 
analyze superoxide presence and 
general ROS production. C-D: 
DCFDA staining showing a stronger 
fluorescence signal resulting from 
the increase in H2O2 levels after PA 
(2 mM) exposure in comparison 
with the control group. The 
fluorescence measurement was 
done 6 h after treatment. E: 
Relative quantification of 
superoxide levels. At least 100 cells 
from 3 different experiments were 
used for the measurements. 
F: Quantification of H2O2 
production. Only 30 cells could be 
photographed to measure the 
fluorescence intensity due to the 
short-lived stability of the DCFDA 
staining (light susceptible and 
rapidly metabolized in living cells). 
The quantification of the 
fluorescence intensity was done 
with the ImageJ software. Statistics: 
Student´s  t-test  for  paired  values: 
**: p≤0.01; ***: p≤0.001.  Scale  bar 
= 32 µm. 
 
 
 
 
 
 
 
Since the peroxisomal antioxidative enzyme catalase and the mitochondrial enzyme 
superoxide dismutase 2 (SOD2) play an important role in the degradation of H2O2 and 
superoxide, we investigated their protein abundance by Western blot and 
immunofluorescence analysis after 48 h of PA exposure (0.2 mM). When compared with the 
non-treated cells, the PA treatment produced a notorious increase in the catalase staining 
intensity (Figure: 48A, B) sustained by the 1.6-fold rise in the catalase amount as shown by 
the Western blot analysis. No significant changes were found in SOD2 protein amount 
(Figure: 48). 
E F 
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Figure: 48. Catalase and SOD2 
analysis in -TC3 cells after palmitic 
acid treatment. A-B: IF analysis of β- 
TC3 cells after PA treatment. The cells 
were incubated with vehicle (A) or 0.2 
mM PA (B) for 48 h to observe the 
effect of the saturated fatty acid on 
the abundance of catalase. Cells were 
subjected to IF staining using a CAT 
antibody at a dilution of 1:200. Scale 
bar = 20 µm. C: Western blot analysis 
of catalase (CAT) and superoxide 
dismutase 2 (SOD2) after 48 h of PA 
(0.2 mM) treatment. Total protein (20 
µg) was subjected to Western blot 
analysis and was sequentially probed 
with antibodies against catalase and 
SOD2. As loading control, membranes 
were stained with Simply Blue Stain 
(Invitrogen). 
 
 
 
 
 
Furthermore, the treatment with PA led to a biphasic induction of the catalase mRNA 
expression, showing the first peak after 6 h of exposure (3-fold) followed by a decline (1.5- 
fold after 12 h) and a gradual time-dependent rise in the following time points (24 and 48 h) 
up to a slightest higher level (3.2-fold), as revealed by RT-qPCR analysis (Figure: 49A). To 
further assess the functional consequences of the PA exposure, we analyze the enzymatic 
activity of catalase after 48 h of treatment. Despite catalase showing a protein and mRNA 
level up-regulation after the fatty acid exposure, this did not result in a statistically 
significant increase in its enzymatic activity (Figure: 49B). 
Figure: 49. Catalase mRNA 
levels   and   enzymatic activity 
B after PA treatment in -TC3 
cells. A: RT qPCR analysis of 
catalase at different time points 
after 0.2 mM PA treatment in β- 
TC3 cells. The relative amount of 
mRNA was calculated using the 2-
ΔΔ CT method and data was 
normalized to Actb values. B: β-
TC3 cells were treated with 
0.2 mM PA for 48 h and the 
peroxidatic function of the 
enzyme Catalase  was 
determined.   
Data were normalized to sample 
protein concentrations.  
PA: palmitic acid. 
A 
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5.13. Increased hydrogen peroxide production in -TC3 cells exposed to phytanic acid 
As with PA, we also analysed the effect of PHY in the production of ROS (superoxide and 
hydrogen peroxide) in -TC3 cells. No changes were observed in the amount of superoxide 
generated after the treatment with 60 M PHY for 48 h, as shown by the DHE staining 
(Figure: 50A, B and E). Opposite to  this, the introduction  of high  concentrations of  PHY  
(60 M) to the culture medium led to significant (p ≤0.0001) increase of H2O2 accumulation 
(4.2-fold) observed as a rise in the DCFDA fluorescence signal intensity (Figure: 50C, D and 
F). 
The exposure of -TC3 cells to 60 M PHY for 48 h further led to a minor but clear increase 
of 1.3-fold in CAT protein amount whereas SOD2 showed a 0.6-fold decrease (Figure: 51). 
 
Figure: 50. Phytanic acid treatment 
induces H2O2 production in -TC3 
cells. A-B: Control and PHY (60 M) 
treated β-TC3 cells stained with DHE 
to analyze superoxide presence and 
general ROS production. C-D: DCFDA 
staining showing a stronger 
fluorescence signal resulting from the 
increase in H2O2  levels after  PHY  (60 
M) exposure in comparison with the 
control group. The fluorescence 
measurement was realized 6 h after 
treatment. E: Relative quantification 
of superoxide levels. At least 100  
cells from 3 different experiments 
were used for the measurements. F: 
Quantification of H2O2 production. 
Only 40 cells could be photographed 
to measure the fluorescence intensity 
due to the short-lived stability of the 
DCFDA staining (light susceptible and 
rapidly metabolized in living cells). 
The quantification of the 
fluorescence intensity was done with 
the ImageJ software. Statistics: 
Student´s   t-test   for   paired  values: 
****: p≤0.0001. Scale bar = 32  µm 
for all IF-images. 
E F 
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Figure: 51. Phytanic acid treatment increases the catalase protein 
amount in -TC3 cells. Western blot analysis of catalase (CAT) and 
superoxide dismutase 2 (SOD2) after 48 h of PHY (60 M) 
treatment. Total protein (20 µg) was subjected to SDS-PAGE and 
Western blot analysis and was sequentially probed with antibodies 
against Catalase and SOD2. As loading control, membranes were 
stained with Simply Blue Stain (Invitrogen). 
 
5.14. Influence of palmitic acid exposure in -TC3 cells displaying a Pex13-KD 
5.14.1. The down-regulation of Pex13 did not result in an increased lethality in -TC3 
cells after palmitic acid exposure 
 
To investigate whether -cells displaying a peroxisome-deficiency were more susceptible to 
lipotoxicity, our β-TC3 cell Pex13 knockdown model was exposed to toxic concentrations of 
PA. Since our results showed that glucose plays an important role in cell death caused by 
elevated PA concentrations, our experiments were conducted in the background of 
hyperglycaemia (20 mM). The cell lethality was analyzed using the Trypan blue exclusion 
test. At a high PA concentration (0.5 mM) we observed that transfected cells (Scr-si and 
Pex13-si) were generally more susceptible to the fatty acid exposure compared to similarly 
treated WT cells (data not shown). For this reason, we decided to carry out our further 
experiments using a lower but still toxic PA concentration (0.2 mM). Since we wanted to 
mimic chronic PA exposure in our Pex13 knockdown cell-culture model, we started the cell 
treatment 24 h after transfection adding the solubilized PA freshly every 24 h over a period 
of maximum 2 days to make sure that the PEX13 knockdown was still present. Vehicle (BSA- 
NaOH complex) was used as a control treatment. Our experiments showed that both control 
(Scr-siRNA) and Pex13 knockdown cells were more susceptible to the PA treatment than the 
cells that were treated with vehicle only (Figure: 52). However, no significant 
difference was observed between Scr-si and Pex13-si 
transfected groups. 
 
Figure: 52. Increased β-TC3 cell dead after PA treatment. 
Transfected cells were incubated with DMEM medium containing 0.2 
mM palmitic acid (PA) for 48 h. Trypan blue exclusion test was 
carried out for the determination of cell viability. The number of 
intact cells, which exhibited no blue staining, was determined (eight 
fields per experiment) and percentage of living cells per group is 
given. Statistics: ANOVA test for multi-paired values. * p  0.05. Veh: 
vehicle; PA: palmitic acid. 
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5.14.2. The silencing of Pex13 in -TC3 cells resulted in an increased intracellular lipid 
accumulation after the exposure to palmitic acid 
To investigate whether there was an increase in intracellular lipid accumulation after the 
Pex13 knockdown in TC3-cells exposed to PA, we analyzed the appearance of lipid droplets 
by light microscopy using the Oil red O staining method. Oil red O stains mainly neutral 
lipids (such as triglycerides or cholesterol) synthesized de novo after PA exposure and stored 
in lipid droplets within the cytoplasm. The silencing of Pex13 led to a minor increase in the 
lipid droplet abundance compared with the Scr-si transfected cells (both groups treated 
with vehicle only). The cells display small and round droplets, scattered across the 
cytoplasm (Figure: 53A and C). 
Figure: 53. Oil red O staining for 
detection of lipid droplet 
accumulation in β-TC3 cells. β-TC3 
cells were transfected with Pex13-si 
and Scr-siRNA for 24 h before being 
exposed to PA (0.2 mM) for 48 h. 
BSA-NaOH complex (Veh) was used 
as a control treatment. The 
appearance of lipid droplets was 
observed after Oil red O staining. A-
B: Scr-siRNA treated cells exposed 
to vehicle (A) and PA (B); C-D: 
Pex13-si transfected cells exposed 
to vehicle (C) or PA (D). Nucleoli 
were stained with hematoxylin. 
Results were examined using phase 
contrast (LEICA DMRD equipped 
with a LEICA CD480 camera). Scale 
bar = 26 µm. 
 
 
 
 
When cells were treated with 0.2 mM PA for 48 h, a clear increase in the number and size 
of the lipid droplets was found (Figure: 53A and B). This effect was much more prominent in 
the Pex13 knockdown than in the Scr-si transfected cells (Figure: 53B and D). 
5.14.3. ABCD3 regulation after Pex13 silencing in -TC3 cells exposed to palmitic acid 
 
We observed an increased lipid droplet accumulation in Pex13-si transfected cells caused by 
the lack of functional peroxisomes. To investigate whether the import of fatty acids into the 
peroxisomes was disturbed we investigated the expression of ABCD3, the most abundant 
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peroxisomal lipid transporter, under the same experimental setting. For this purpose, we 
investigated the Abcd3 mRNA expression as well as the ABCD3 protein abundance by qRT- 
PCR and Western blotting respectively. Our experiments showed that the treatment with PA 
significantly increased the mRNA expression of Abcd3 in both, the Scr-si and the Pex13-si 
transfected cells (a fold change of 0.8 and 1.4) (Figure: 54A). Further, in both control and 
Pex13 knockdown cells the ABCD3 protein amount was visibly decreased when the cells 
were treated with palmitate instead with vehicle. This agrees with the decreased ABCD3 
staining seen during the IF analysis of PA-treated WT cells previously shown in this work 
(Figure: 45). 
Figure: 54. Abcd3 mRNA levels and protein 
abundance in Pex13-si transfected β-TC3 cells 
after palmitic acid treatment. β-TC3 cells were 
transfected with Pex13-si or Scr-siRNA and 
treated with PA (0.2 mM) for 48 h. A: The 
expression of Abcd3 was analyzed by qRT-PCR. 
Total RNA was used for the analysis and Abcd3 
and Actb (-Actin) expression levels were 
examined. The average threshold (Ct) values of 
at least three independent experiments were 
used to calculate the relative amounts of 
mRNA using the 2-ΔΔ CT method and data was 
normalized to Actb values. Results are 
presented as a fold over control. B: Western 
blot analysis of ABCD3. Total protein (20 µg) 
was used for the analysis and the Western blot 
was probed with an antibody against ABCD3. 
Equal loading of protein was controlled by 
Coomassie staining of the membrane after 
detection of antibodies. Statistics: ANOVA test 
for multi-paired values. * p  0.05. Veh: 
vehicle; PA: palmitic acid; Abcd3: ATP-binding 
cassette, subfamily D, member 3. 
 
 
 
 
 
 
 
 
5.14.4. Superoxide and hydrogen peroxide generation in the Pex13 knockdown β-TC3 
cells after palmitic acid exposure as an indicator of oxidative stress 
To further assess the functional consequences of the Pex13 knockdown in β-TC3 cells after 
PA exposure, we investigated the superoxide (O2-) and hydrogen peroxide (H2O2) production 
as an indicator of oxidative stress. As previously described in this thesis, the Pex13 silencing 
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resulted in the mislocalization of catalase to the cytosol, an effect that potentially could 
surrender the -cell to the adverse consequences of ROS accumulation. In addition, -cells 
exposed to PA showed a high rate of apoptosis and impaired insulin secretion as result of 
the increased ROS accumulation (193, 194). 
We used DHE to examine the amount of superoxide generated after Pex13 silencing and 
exposure to 0.2 mM PA for 48h (Figure: 55A-D). In comparison with Scr-si transfected cells, 
we observed a significant (p  0.0001) reduction of the DHE staining after the down- 
regulation of Pex13 in cells treated with vehicle, suggesting a decrease in the superoxide 
accumulation (Figure: 55A, C and I). Similarly to the effect observed in WT cells (Figure: 47), 
the addition of PA to the culture medium of either Scr-si or Pex13-si transfected cells 
resulted in a significant (p  0.0001) decrease of 0.5-fold and 0.75-fold respectively in the 
DHE fluorescence signal (Figure: 55B, D and I). Our results revealed that both the PA 
treatment and Pex13 silencing caused independently of each other a decrease in the DHE 
fluorescence signal intensity. The combination of PA treatment and Pex13 silencing resulted 
in a cumulative effect with cells displaying almost absent DHE staining (Figure: 55D). This 
suggests lowered intracellular superoxide levels in the Pex13-si + PA treated cells. 
Next, we investigated the amount of H2O2 production by DCFDA staining. We observed that 
the Pex13 silencing resulted in a significant (p  0.0001) increase of H2O2 accumulation (1.9- 
fold) in those cells treated with the vehicle (Figure: 55E, G, and J). Also, the exposure to PA 
resulted in a statistically significant increase of the DCFDA signal intensity in both control 
and knockdown cells (3- and 2.7-fold respectively) (Figure: 55F, H, and J). Furthermore, a 
tendency of H2O2 to be less upregulated after PA treatment in the Pex13-si group was 
observed (p  0.064) (Figure: 55J). 
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Figure: 55. Measurement of superoxide and hydrogen peroxide levels by relative quantification of DHE and 
DCFDA fluorescent signal in Pex13 knockdown -TC3 cells after PA exposure (see figure on page 98). β-TC3 
cells were transfected with Pex13-si or Scr-siRNA, treated with PA, and stained with Dihydroethidium (DHE) or 
with 2´,7´-dichlorofluorescin diacetate (DCFDA) to visualize the accumulation of superoxide or H2O2 
respectively. A-D: DHE staining of: A: Scr-siRNA transfected cells treated with vehicle or with B: 0.2 mM PA for 
48h; C: Pex13-si transfected cells treated with vehicle or with D: 0.2 mM PA for 48h. Nuclei were counter 
stained with Hoechst 33342 dye. E-H: DCFDA staining of: E: Scr-siRNA transfected cells treated with vehicle or 
with F: 2 mM PA; G: Pex13-si transfected cells treated with vehicle or with H: 2 mM PA. The fluorescence 
measurement was done 6 h after treatment. I: Relative quantification of superoxide levels. At least 100 cells 
from 3 independent experiments were used for the measurements. J: Quantification of H2O2 production. 40 
living cells from 3 independent experiments could be photographed to measure the fluorescence intensity due 
to the short-lived stability of the DCFDA staining. The quantification of the fluorescence intensity was done 
with the ImageJ software. Statistics: ANOVA test for multi-paired values. **** p ≤ 0.0001. Veh: vehicle; PA: 
palmitic acid. Scale bar = 32 µm. 
 
 
5.14.5. The protein abundances of the antioxidative enzymes Catalase and SOD2 are 
affected as a result of the PA exposure in transfected -TC3 cells 
As many normal metabolic processes within the cell produce ROS, antioxidative enzymes 
such as catalase or superoxide dismutase 2 (SOD2) are required to maintain the intracellular 
redox homeostasis to ensure cellular protection and health. As shown above, peroxisomal 
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dysfunction induced by the Pex13 knockdown and PA exposure had opposite effects 
concerning the cellular accumulation of superoxide or hydrogen peroxide, which are both 
potentially toxic if not properly metabolized. Since the knockdown of Pex13 led to a 
cytoplasmic mislocalization of the most important peroxisomal antioxidative enzyme, 
catalase (normally located within the peroxisomal matrix), we were interested to evaluate 
changes in the protein abundance and gene expression of this enzyme in response to Pex13 
silencing and PA treatment in -TC3 cells. For this purpose, we treated the Pex13-si or Scr- 
siRNA transfected cells with 0.2 mM PA for 48 h. The extracted mRNA and obtained protein 
homogenates were analyzed by qRT-PCR and Western blotting respectively. Vehicle (BSA- 
NaOH) was used as a control treatment. 
We observed a trend for the Pex13 knockdown to induce a decrease in the Cat mRNA and 
protein levels in those cells exposed to vehicle (p  0.42 and p  0.83 respectively) (Figure: 
56A, C and D). On the other hand, the addition of PA into the culture media resulted in a 
significant (p  0.05) increase in the Cat expression and protein abundance in control cells 
treated with Scr-siRNA. Also, the PA treatment of the Pex13 knockdown significantly 
increased the amount of both Cat mRNA expression and protein abundance (p  0.01 and p 
 0.05, respectively) (Figure: 56A, C, and D). However, the silencing of Pex13, in 
combination with PA did not further increase catalase mRNA and protein abundance in 
comparison to the Scr-si transfected group treated with PA. 
SOD2 is an important mitochondrial antioxidative enzyme in living cells exposed to oxygen, 
playing a role in the regulation of the redox balance by catalyzing the dismutation of 
superoxide radicals produced as a by-product of the oxygen metabolism, into H2O2 and 
molecular oxygen. The Sod2 mRNA expression and SOD2 protein abundance were analysed 
under the same experimental conditions used for the CAT analysis. Opposite to our catalase 
results, the amount of SOD2 (mRNA and protein) was strongly (p  0.01) increased (> 2,2- 
fold) in cells lacking PEX13 (Figure: 56B, C and E). Furthermore, the addition of PA to the 
culture led in both groups, to a significant decrease (p  0.05) of the SOD2 protein 
abundance whereas the addition of the FA to the Scr-si group showed a tendency (p  0.29) 
to decrease the Sod2 mRNA levels (Figure: 56B, C, and E). Interestingly, also here the value 
of SOD2 in the Pex13-si + PA treated group was higher as the one in the corresponding Scr- 
siRNA group. 
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Figure: 56. mRNA levels and protein abundance of the peroxisomal antioxidant enzyme CAT and the 
mitochondrial antioxidant enzyme SOD2 in Pex13-si transfected β-TC3 cells after PA treatment. A-B: β-TC3 
cells were transfected with Pex13-si or Scr-siRNA and treated with PA (0.2 mM). After 48 h the expression of 
Cat and Sod2 were analyzed by qRT-PCR. Total RNA was used for the analysis and Cat, Sod2 and Actb (-Actin) 
expression levels were examined. The average threshold (Ct) values of at least three independent experiments 
were used to calculate the relative amounts of mRNA using the 2-ΔΔ CT method and data was normalized to 
Actb values. Results are presented as relative differences over control. C: Representative immunoblotting of 
CAT and SOD2 in transfected β-TC3 cells after 48 h of PA (0.2 mM) exposure. Total protein (20 µg) was used for 
the analysis and was sequentially probed with antibodies against CAT and SOD2. Equal loading of protein was 
controlled by Coomassie staining of the membrane after detection of antibodies. D-E: Western blot analysis of 
CAT and SOD2. Autoradiographic signals were visualized and quantified with the ImageJ software. Values 
±SEM represent the protein abundance (in %) relative to Scr-si / vehicle sample normalized to total protein 
loaded from at least three independent experiments. Statistics: ANOVA test for multi-paired values. * p  0.05; 
** p  0.01. Veh: vehicle; PA: palmitic acid; Cat: catalase; Sod2: superoxide dismutase 2. 
5.14.6. The palmitic acid treatment in combination with the silencing of Pex13 in -TC3 
was accompanied by an increase in the Catalase activity and H2O2 production. 
To further assess the functional consequences of the Pex13 knockdown on the H2O2 
homeostasis in -TC3 cells exposed to toxic concentrations of PA (0.2 mM), the catalase 
activity and the H2O2 production after 48 h of PA treatment was measured. As shown in IF- 
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experiments on pages 72 and 76, the peroxisome-deficient -TC3 model exhibited a 
defective import of peroxisomal matrix proteins that led to a cytosolic accumulation of 
catalase. Although the protein is upregulated after PA exposure in the Pex13-si transfected 
cells (Figure: 56C and D), it might, however, not be enzymatically active due to the 
mistargeting of catalase. Therefore, we determined the catalase enzyme activity in an assay, 
based on its peroxidatic function to form formaldehyde from methanol and H2O2. Our 
experiments showed that the Pex13 silencing (and consequently, the mistargeting of 
catalase) generally resulted in an increase of the enzymatic activity of catalase (Figure: 57A). 
Further, in both the control and the Pex13 knockdown background the addition of PA led to 
a significant (P<0.05) increase in the catalase activity. This indicates that the mistargeting of 
the enzyme into the cytosol in Pex13 knockdown cells did not abolish the activity of 
catalase, leading to a similar (~1.6-fold) upregulation in both PA-treated groups. Moreover, 
the highest induction of the catalase activity was observed in the Pex13-siRNA transfected 
group in combination with PA treatment. 
Next, the H2O2 production was assessed in control or Pex13-si transfected cells, with higher 
catalase level, after the exposure to PA to corroborate the results previously obtained by 
the DCFDA dye staining. The highest amount of H2O2 was measured after exposing the Scr-si 
treated cells to PA (Figure: 57B). In agreement with the results obtained by the DCFDA 
analysis, the H2O2 level was less elevated (p  0.05) in the Pex13-siRNA model when treated 
with PA in comparison to the Scr-si group exposed to PA. 
 
 
 
 
 
 
 
 
 
 
 
Figure: 57. Catalase enzymatic activity and H2O2 production after PA treatment in Pex13-si transfected cells. 
β-TC3 cells were transfected with Pex13-si or Scr-si RNA and treated with 0.2 mM PA for 48 h. A: The 
peroxidatic function of the antioxidative enzyme catalase was determined. Data were normalized to sample 
protein concentration determined with the Bradford assay. Values ±SEM represent the fold change relative to 
Scr-si / vehicle sample from three independent experiments. B: H2O2 production assayed from the sample 
supernatants. Values ±SEM represent the H2O2 in M from three independent experiments. Data were 
normalized to sample protein concentration. Statistics: ANOVA test for multi-paired values. * p  0.05; *** p  
0.001. Veh: vehicle; PA: palmitic acid; H2O2: hydrogen peroxide. 
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5.14.7. The insulin release and content were not affected in the Pex13 knockdown - 
TC3 cells exposed to palmitic acid 
Because the presence and excretion of insulin is the most obvious evidence for the proper 
function of the -cell, we further assessed the functional consequences of the combination 
of Pex13 silencing and the PA exposure on insulin homeostasis. Transfected cells were 
cultured in the presence of 20 mM glucose and exposed to 0.2 mM PA for 48h and insulin 
biosynthesis and secretion were measured in the protein homogenate and culture medium 
by ELISA. The down-regulation of Pex13 did not affect either insulin secretion or its 
intracellular content (Figure: 58A and B). Similarly, the exposure to PA in combination with 
the down-regulation of Pex13 did not result in any significant change. However, we 
observed a slight elevation of insulin secretion and cell content after PA treatment only. 
However, due to the large standard deviation the results obtained from this experiment 
were not significant. 
 
 
Figure: 58. Insulin release and content in Pex13-si transfected β-TC3 exposed to PA. β-TC3 cells were 
transfected with Pex13-si or Scr-si RNA and 24 h post transfection, treated with PA (0.2 mM) for 48 h under 
high glucose condition (20 mM). A: Insulin release was measured by ELISA in the harvested supernatant and 
corrected for protein concentration. B: Cell extracts were collected and assayed for insulin content. Data were 
normalized to sample protein concentration determined with Bradford assay. Values ±SEM represent the 
insulin fold change levels relative to Scr-si / vehicle sample from three independent experiments. Veh: vehicle; 
PA: palmitic acid. 
5.14.8. Peroxisomal and -cell specific markers regulation after Pex13 silencing in -TC3 
cells exposed to palmitic acid 
One of the main functions of peroxisomes is the -oxidation of a variety of fatty acids 
(including long- and medium-chain length FA) playing a key role in their metabolism. For 
that reason, we were interested in determining whether PA in combination with the Pex13 
gene silencing had any effect on the mRNA expression as well as the protein abundance of 
peroxisomal enzymes involved in the -oxidation pathway 1 (Acox1 and Acaa1). qRT-PCR 
and Western blot were performed in our peroxisome-deficient model after the exposure to 
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0.2 mM PA for 48 h. As expected, the transient transfection with Pex13-siRNA led to a 
significant (p ≤0.0001) decrease in the Pex13 mRNA and protein levels (85 %) independently 
of the addition of PA to the culture medium (Figure: 59A, D and E). 
Surprisingly, the expression of Acox1, encoding for the first and rate-limiting enzyme of the 
β-oxidation pathway located in the peroxisome, was not affected by the Pex13 silencing 
whereas the protein abundance of subunit B increased 2.8-fold under the same conditions 
(Figure: 59B, D and F). To our surprise the band pattern of ACOX1 in -TC3 cells was 
different from the one that were regularly obtained in hepatocytes ((78) since the full 
enzyme (subunit A) of the ACOX1 was not detected, but only the cleaved subunit B, against 
which part the antibody was made. In hepatocytes, a clear band would be present at around 
74 kD for the complete enzyme. Because of its function in the degradation of fatty acids, we 
expected an increased expression of Acox1 in the presence of PA. While no changes were 
found in the protein levels of subunit B of ACOX1, we observed a slight increment of the 
mRNA expression of this enzyme after treatment of the cells with PA, which was however 
not significant (Figure: 59B). 
Opposite to these observations, the down regulation of Pex13 led to a significant (p≤ 0.01) 
decrease in the mRNA levels of Acaa1, the gene encoding for Thiolase, whereas its protein 
abundance was not affected (Figure: 59C, D and G). Thiolase is the enzyme in charge of the 
last step of the peroxisomal -oxidation pathway. Additionally, the PA treatment led to a 
tendentially reduced expression of Acaa1 and a significant (p≤ 0.001) decrease in its protein 
abundance. 
 
 
 
 
Figure: 59. Regulation of peroxisomal genes and protein abundance after PA exposure in Pex13-si 
transfected β-TC3 cells (see figure on page 99). A-C: β-TC3 cells were transfected with Pex13-si or Scr-si RNA 
for 24 h and treated with PA (0.2 mM). After 48 h the expression of Pex13, Acox1, Acaa1 and Actb (-Actin) 
was analyzed by qRT-PCR. The efficiency of all primer pairs was ensured in advanced by running a qPCR on 
dilutions of the template cDNA. The average threshold (Ct) values of at least three independent experiments 
were used to calculate the relative amounts of mRNA using the 2-ΔΔ CT method and normalized to Actb 
values. Results are presented as a fold over control (Scr-si / Veh). D-F: Total protein (20 µg) was used for the 
analysis and was sequentially probed with antibodies against PEX13, ACOX1 and THIOLASE. Values ±SEM 
represent the protein abundance (in %) relative to Scr-si / vehicle sample normalized to total protein loaded 
from at least three independent experiments. G: Representative immunoblotting of PEX13, ACOX1 and 
THIOLASE after Pex13-siRNA transfection and PA treatment in β-TC3 cells. Statistics: ANOVA test for multi- 
paired values. ** p  0.01; *** p  0.001; ****p  0.0001. Pex13: peroxisome biogenesis factor 13; Acox1: 
acyl-coenzyme A oxidase 1; Acaa1: acetyl-Coenzyme A acyltransferase 1; Veh: vehicle; PA: palmitic acid. 
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Figure: 59. For figure legend refer to page 98. 
 
We next assessed the mRNA levels for insulin and other -cell specific markers. Insulin, the 
prominent feature of -cells and indicator of their differentiation-state, showed a significant 
decrease (p≤ 0.05) in its mRNA levels as a result of the Pex13 silencing in those cells treated 
with the vehicle alone. Notably, the treatment of the PEX13 depleted -TC3 cells with PA, 
led to an elevation of the insulin expression (p≤ 0.05) (Figure: 60A) up to levels even higher 
than the PA Scr-si values. 
Furthermore, we investigated the Pax6 expression level since this transcription factor is 
crucial for the control of key genes coding for proteins that are involved in insulin 
biosynthesis (Ins), secretion, and cell differentiation (Pdx1). It has also been shown that a 
Pax6 KD leads to decreases in intracellular insulin content, insulin processing and defects in 
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glucose-induced insulin secretion (196). Interestingly, the specific silencing of Pex13 resulted 
in a significant decrease (p ≤ 0.0001) of Pax6 mRNA expression independently if the cells 
were exposed to PA or not (Figure: 60B). 
Pdx1, a homeobox gene essential for pancreatic development and glucose homeostasis (197), 
showed a significant decrease in its mRNA levels as a result of the specific silencing of Pex13 
in the vehicle-treated group. Treatment of the -TC3 cells with PA on the other hand led to 
an up-regulation of Pdx1 without, however, reaching statistical significance (p ≤ 0.189). 
Moreover, the response to PA showed a 1,5-fold increase in the Scr-si group compared to a 
> 2-fold increase of the value for the Pex13-si group (Figure: 60C). The overall Pdx1 mRNA 
value of the PA stimulated Scr-si group was, however, not reached. 
Pax4, a transcriptional factor involved in β-cell differentiation exhibited a non-significant (p 
≤ 0.09) reduction in its mRNA levels upon Pex13 silencing in the vehicle-treated groups 
(Figure: 60D). PA treatment in the Scr-si transfected cells led to a significant (p ≤ 0.05) 
decrease in the Pax4 mRNA expression. In contrast, we observed the opposite effect in cells 
with the Pex13 knockdown background where the PA exposure resulted in an (p ≤ 0.05) 
increase in Pax4 mRNA levels, suggesting a different regulation of the gene under 
peroxisome-deficient conditions. 
 
Figure: 60. Regulation of insulin, 
Pax6, Pdx1 and Pax4 mRNA levels 
after palmitic acid exposure in 
Pex13-si transfected β-TC3 cells. 
β-TC3 cells were transfected with 
Pex13-si or Scr-si RNA for 24 h and 
treated with PA (0.2 mM). After 48 
h the expression of Ins, Pdx1, 
Pax4, Pax6 and Actb (-Actin) was 
analyzed by qRT-PCR. The average 
threshold (Ct) values of at least 
three independent experiments 
were used to calculate the relative 
amounts of mRNA using the 2-ΔΔ 
CT method and normalized to Actb 
values. Statistics: ANOVA test for 
multi-paired values. * p ≤ 0.05; 
** p  0.01; **** p ≤ 0.0001. Ins: 
insulin; Pdx1: pancreatic and 
duodenal homeobox 1; Pax6: 
paired box 6; Pax4: paired box 4; 
Veh: vehicle; PA: palmitic acid. 
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5.14.9. Analysis of the mRNA levels and protein abundance of PPARs in -TC3 cells 
treated with either Pex13- or Scr-siRNA after palmitic acid exposure 
PPARs represent one of the best-recognized sensor systems for fatty acids, responding to 
changes in the cell metabolic status and lipid fluxes (54). Since their activation (by some fatty 
acids) results in the regulation of many peroxisomal enzymes involved in fatty acid oxidation 
as well as in peroxisomal division and proliferation (51), we analyzed the mRNA levels and 
protein abundance of the PPARs after the Pex13 silencing in βTC3 cells exposed to PA. Our 
qPCR results indicated that all the treatments performed on the -TC3 cells (PA exposure, 
Pex13 knockdown and the combination of both) induced the expression of Pparα mRNA, 
whereas the treatment with PA caused a significant reduction (p  0.05) of the PPAR 
protein abundance independently of the Pex13 silencing (Figure: 61A, D and E). 
The expression of Ppar mRNA showed a significant (p≤ 0.05) decrease after silencing Pex13 
in the vehicle-treated cells. This effect was surprisingly counteracted following the PA 
exposure of the Pex13 knockdown group, were a massive expression of the Ppar mRNA 
was induced. The exposure of the Scr-si RNA transfected -TC3 cells to PA alone did not 
affect the Ppar expression (Figure: 61B). 
The down regulation of Pex13 induced a 1.8-fold increase of the Ppar mRNA levels (p  
0.001) and did not affect its protein abundance. The addition of PA to the culture medium of 
the Scr-siRNA transfected group reduced the gene expression (p≤ 0.05) and protein 
abundance (p  0.01) of Ppar. Similarly, in the cells exhibiting the Pex13 knockdown, the 
fatty acid treatment caused a 1.4-fold decrease in the PPAR protein abundance (p≤ 0.05) 
(Figure: 61C, D and F). 
 
 
Figure: 61. Regulation of PPARs gene and protein abundance after PA exposure in Pex13-si transfected β- 
TC3 cells (see figure on page 102). A-C: β-TC3 cells were transfected with Pex13-si or Scr-si RNA for 24 h and 
treated with PA (0.2 mM). After 48 h the expression of Ppar, Ppar, Ppar and Actb (-Actin) was analyzed by 
qRT-PCR. The average threshold (Ct) values of at least three independent experiments were used to calculate 
the relative amounts of mRNA using the 2-ΔΔ CT method and normalized to Actb values. Results are presented 
as a fold-change of control values (Scr-si / Veh). D: Representative immunoblotting of PPAR and PPAR in 
transfected β-TC3 cells after 48 h of PA (0.2 mM) exposure. Total protein (20 µg) was used for the analysis and 
was sequentially probed with antibodies against PPAR and PPAR. Equal loading of protein was controlled by 
Coomassie staining of the membrane after detection of antibodies. E-F: Western blot analysis of PPAR and 
PPAR. Autoradiographic signals were visualized and quantified with the ImageJ software. Values ±SEM 
represent the protein abundance (in %) relative to Scr-si / vehicle sample normalized to total protein loaded 
from at least three independent experiments. The bands on films were quantified with ImageJ Software. 
Statistics: ANOVA test for multi-paired values. * p ≤ 0.05; ** p  0.01; *** p  0.001; ****p  0.0001. PPAR / 
 peroxisome proliferator-activated receptor alpha / gamma; Veh: vehicle; PA: palmitic acid 
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Figure: 61. For figure legend refer to page 101. 
 
5.15. Influence of phytanic acid in -TC3 cells displaying a Pex13-KD 
5.15.1. The down-regulation of Pex13 led to an increased lethality in -TC3 cells after 
phytanic acid exposure 
Since phytanic acid (PHY) depends completely on the peroxisomal -oxidation for its 
degradation, we analyzed whether -cells displaying a peroxisome-deficiency were more 
susceptible to lipotoxicity as a result of toxic PHY concentrations. To that end, we exposed 
our -TC3 cell Pex13 knockdown model to 60 µM Phy for 48 h in the background of 
hyperglycaemia (20 mM). The cell lethality was analyzed subsequently using the Trypan blue 
exclusion test. Parallel incubations were performed using the PHY solubilizing compound 
dimethyl sulfoxide (DMSO) as control. Similar to the experiments carried out with PA, we 
started the cell treatment 24 h after transfection adding the PHY solution every 24 h over a 
period of 2 days to ensure the down-regulation of Pex13. We observed that the treatment 
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with PHY led to a reduction of the cell viability in both, the Scr-si and Pex13-siRNA treated 
groups. However, cells exhibiting the Pex13 knockdown showed higher susceptibility to PHY 
(p<0.0001) reaching more than 70 % lethality in comparison to the cells treated with DMSO 
only (Figure: 62). 
 
 
Figure: 62. Increased β-TC3 cell dead after PHY treatment. β-TC3 cells 
were prepared and transfected with Pex13-si and Scr-siRNA. Transfected 
cells were incubated with DMEM medium containing 60 M phytanic 
acid (PHY) diluted in DMSO for 48 h. Trypan blue exclusion test was 
carried out for the determination of cell viability. The number of intact 
cells, which had no blue staining, was determined (eight fields per 
experiment) and percentage of living cells per group is given. Statistics: 
ANOVA test for multi-paired values. * p  0.05; ****p  0.0001. DMSO: 
dimethyl sulfoxide; PHY: phytanic acid. 
 
 
 
 
5.15.2. The silencing of Pex13 in -TC3 cells led to an increased intracellular lipid 
accumulation after phytanic acid exposure 
We analyzed whether the exposure to PHY modified the intracellular lipid accumulation in 
-TC3 cells treated with Pex13-siRNA. The appearance of the lipid droplets was examined by 
light microscopy using the Oil red O staining method. Our results showed an increase in the 
lipid droplet abundance after the down-regulation of Pex13 suggesting a rise in the cellular 
lipid storage. In both cases (Scr-si and Pex13-si) the droplets appeared as small and round 
bodies scattered heterogeneously across the cytoplasm of some cells (Figure: 63A and C). 
The introduction of 60µM PHY into the culture medium led to an increase in the droplet size 
(Figure: 63A and B), an effect, which was potentiate in the Pex13 knockdown (Figure: 63B 
and D). 
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Figure: 63. Oil red O staining for 
detection of lipid droplet 
accumulation in Pex13 KD β-TC3 
cells after phytanic acid exposure. 
β-TC3 cells were transfected with 
Pex13-si and Scr-si RNA for 24 h 
before been exposed to PHY (60 
µM) or DMSO/medium as a control 
for 48 h. The appearance of lipid 
droplets was observed after Oil red 
O staining. A-B: Scr-siRNA treated 
cells exposed to DMSO/medium (A) 
and PHY (B); C-D: Pex13-si 
transfected cells exposed to 
DMSO/medium (C) or PHY (D). 
Nucleoli were stained with 
Hematoxylin. Results were 
examined using a phase contrast 
microscope (LEICA DMRD equipped 
with a LEICA CD480 camera). Bar = 
26 µm. 
 
 
5.15.3. Regulation of peroxisomal lipid transporters Abcd1 and Abcd3 after Pex13 
silencing in -TC3 cells exposed to phytanic acid 
Following the same trend as the one observed after PA treatment, the exposure of -TC3 
cells lacking functional peroxisomes to PHY led to an increased lipid droplet accumulation. 
To further investigate the role of peroxisomes in this phenomenon we decided to analyze 
whether the import of fatty acids into the organelle was disturbed. For this purpose, we 
investigated Abcd1 and Abcd3 mRNA expressions as well as the ABCD3 protein abundance 
by qRT-PCR and Western blot respectively. Our results showed a trend for the Pex13 
knockdown to induce an increase in Abcd1 mRNA levels (p = 0.1), while the exposure to PHY 
in the Scr-siRNA group did not alter the mRNA expression of the lipid transporter (Figure: 
64A) whereas the combination of PHY with the Pex13 silencing exhibited a trend to reduce 
the Abcd1 mRNA to control levels again (p = 0.29). No changes in the Abcd3 mRNA levels 
either after the down-regulation of Pex13, the treatment with PHY or the combination of 
both (fold change between 1.2 and 1.6) were observed (Figure: 64B). In contrast, the cell 
exposure to PHY did indeed increase the ABCD3 protein abundance in both, the Scr-si 
transfected cells and the Pex13 silencing group (Figure: 64C), whereas the peroxisome- 
deficiency alone showed a tendency to decrease the ABCD3 protein amount. 
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Figure: 64. Peroxisomal membrane lipid transporters Abcd1 and Abcd3 mRNA levels and ABCD3 protein 
abundance in Pex13-si transfected β-TC3 cells after phytanic acid treatment. β-TC3 cells were transfected 
with Pex13-si or Scr-si RNA and treated with PHY (60 µM) for 48 h. A-B: The expression of Abcd1 and Abcd3 
was analyzed by qRT-PCR. The average threshold (Ct) values of three independent experiments were used to 
calculate the relative amounts of mRNA using the 2-ΔΔ CT method and data was normalized to Actb (-Actin) 
values. Results are presented as a fold over control. C: Representative Western blot analysis of ABCD3. Total 
protein (20 µg) was used for the analysis and the Western blot was probed with an antibody against ABCD3. 
Equal loading of protein was controlled by Coomassie staining of the membrane after detection of antibodies. 
DMSO: dimethyl sulfoxide; Phy: phytanic acid; ABCD1/3: ATP binding cassette subfamily D member 1 and 3. 
 
5.15.4. Superoxide and hydrogen peroxide generation in -TC3 cells with Pex13 
knockdown after phytanic acid exposure as an indicator of oxidative stress 
 
To further evaluate the functional consequences of the peroxisome dysfunction in -TC3 
cells after PHY exposure, we analyzed the generation of intracellular oxidative stress by 
analysing the production of superoxide (O2-) and hydrogen peroxide (H2O2). Superoxide 
generation was monitored by the ROS-sensitive dye dihydroethidium (DHE) after Pex13 
silencing and the exposure to 60 µM PHY for 48 h. We observed no changes in the DHE 
fluorescence intensity either after the down-regulation of Pex13, the treatment with PHY or 
the combination of both (Figure: 65). 
The amount of H2O2 produced was examined by DCFDA staining using 150 µM PHY for 6 h. 
In the Scr-siRNA group, the addition of PHY to the culture medium resulted in a significant 
2.9-fold increase (p ≤ 0.0001) in the DCFDA fluorescence signal (Figure: 65J). In contrast, 
already the Pex13 silencing led to an accumulation of H2O2 (1.9-fold) in comparison to the 
Scr-siRNA group, however, the addition of PHY to the Pex13-si transfected group did not 
result in a significant H2O2 increase, suggesting that the cytoplasmic catalase result of the 
Pex13 knockdown, protects the cells against further H2O2 accumulation. (Figure: 65J). 
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Figure: 65. Measurement of superoxide and hydrogen peroxide levels by relative quantification of DHE and 
DCFDA fluorescent signal in β-TC3 cells with Pex13 knockdown after phytanic acid exposure. β-TC3 cells were 
transfected with Pex13-si or Scr-si RNA, treated with PHY, and stained with Dihydroethidium (DHE) (A-D) to 
visualize the accumulation of O2¯or with 2´,7´-dichlorofluorescin diacetate (DCFDA) to visualize the 
accumulation of H2O2 (E-H). A-D: DHE staining of: A: Scr-siRNA transfected cells treated with DMSO/medium or 
B: 60 M PHY for 48h; C: Pex13-si transfected cells treated with DMSO/medium or D: 60 M PHY for 48h. 
Nuclei were counterstained with Hoechst 33342 dye. E-H: DCFDA staining of: A: Scr-siRNA transfected cells 
treated with DMSO/medium or B: 150 M PHY; C: Pex13-si transfected cells treated with DMSO/medium or D: 
150 M PHY. The fluorescence measurement was completed 6 h after treatment. I: Relative quantification of 
superoxide levels. At least 100 cells from 3 independent experiments were used for the measurements. J: 
Relative quantification of H2O2 production. 30 living cells could be photographed to measure the fluorescence 
intensity due to the short-lived stability of the DCFDA staining. The quantification of the fluorescence intensity 
was done with the ImageJ software. Statistics: ANOVA test for multi-paired values. **p≤0.01; **** p ≤ 0.0001. 
DMSO: dimethyl sulfoxide; Phy: phytanic acid. Scale bar = 32 µm in A-D and 24 µm in E-H. 
 
5.15.5. Analysis of Cat, Sod1 and Sod2 mRNA expressions and protein abundances after 
phytanic acid exposure in transfected -TC3 cells 
As shown before in this thesis, the peroxisome import deficiency induced by the Pex13 
silencing in -TC3 cells resulted in the cytoplasmic mislocalization of catalase. Therefore, we 
were interested in evaluating the influence of the Pex13 knockdown together with the PHY 
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exposure in the protein abundance and gene expression of this and other antioxidative 
enzymes with the purpose of obtaining an overview of the regulation of ROS in our model. 
Pex13-si or Scr-siRNA treated cells were exposed to 60 µM PHY for 48 h and the extracted 
mRNA and obtained protein homogenates were analyzed by qRT-PCR and Western blot 
respectively. DMSO/medium was used as a control treatment. 
Interestingly, neither the silencing of Pex13 nor the introduction of PHY to both (Scr-si or 
Pex13-si) groups resulted in significant changes in the cat mRNA levels, although a tendency 
of PHY to decrease the cat mRNA levels was observed (Figure: 66A). No changes in the CAT 
protein abundance either after the down-regulation of Pex13, the treatment with PHY or 
the combination of both were observed (Figure: 66A, D and E). Interestingly, the 
transfection with Pex13-siRNA resulted in a 2.5-fold increase of Sod2 gene expression (p ≤ 
0.01) (Figure: 66C) whereas the exposure of both groups (Scr-si and Pex13-si) to PHY 
showed a tendency to decrease the SOD2 protein abundance (Figure: 66D and F). 
SOD1 (superoxide dismutase 1/ Cu-Zn) is an enzyme that converts superoxide radicals to 
molecular oxygen and H2O2 that is localized to several intracellular compartments (e.g. 
cytoplasm, mitochondria and peroxisomes). The transfection of -TC3 cells with Pex13- 
siRNA led to a significant (p  0.001) increase of Sod1 mRNA levels. Moreover, the 
introduction of PHY to the Scr-siRNA transfected group resulted as well in an upregulation of 
the Sod1 gene expression (p ≤ 0.01) (Figure: 66B). Despite the elevated Sod1 mRNA levels in 
the Pex13 knockdown, the addition of PHY to the peroxisome-deficient group led to a small 
but significant reduction (p  0.05) in its gene expression (Figure: 66B). 
 
 
Figure: 66. mRNA levels and protein abundances of the antioxidative enzymes CAT, SOD2 and Sod1 in Pex13-
si transfected β-TC3 cells after PHY treatment (see figure on page 108). A-C: β-TC3 cells were transfected with 
Pex13-si or Scr-siRNA and treated with PHY (60 M). After 48 h the expression of Cat, Sod1 and Sod2 were 
analyzed by qRT-PCR. Total RNA was used for the analysis and Cat, Sod1, Sod2 and Actb (- Actin) expression 
levels were examined. The average threshold (Ct) values of at least three independent experiments were used 
to calculate the relative amounts of mRNA using the 2-ΔΔ CT method and data was normalized to Actb values. 
Results are presented as a fold over control. D: Representative immunoblotting of CAT and SOD2 after 48 h of 
PHY (60 M) exposure. Total protein (20 µg) was used for the analysis and was sequentially probed with 
antibodies against CAT and SOD2. Equal loading of protein was controlled by Coomassie staining of the 
membrane after detection of antibodies. E-F: Western blot analysis of CAT and SOD2. Autoradiographic signals 
were visualized and quantified with the ImageJ software. Values ±SEM represent the protein abundance (in %) 
relative to Scr-si / DMSO sample normalized to total protein loaded from at least three independent 
experiments. Statistics: ANOVA test for multi-paired values. * p  0.05; ** p  0.01; *** p ≤ 0.001. DMSO: 
dimethyl sulfoxide; Phy: phytanic acid; Cat: catalase; Sod1 and Sod2: superoxide dismutase 1 / 2. 
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Figure: 66. For figure legend refer to page 107. 
 
5.15.6. The phytanic acid treatment in -TC3 led to an increase in the H2O2 production 
To extend our overview of the functional consequences of the Pex13 silencing together with 
the phytanic acid treatment on ROS homeostasis, we analysed the H2O2 production after 48 
h of PHY (60 M) treatment in peroxisome-deficient -TC3 cells. This assay, as in the case of 
the PA experiments, helped us to ensure the DCFDA results as well as to understand the 
involvement of the cytoplasmic catalase (in the case of the Pex13-si transfected cells) or the 
peroxisomal one (for the Scr-si treated controls) in the H2O2 decomposition. 
As shown in Fig. 76, the Pex13 silencing induced a mild increase of H2O2 already in 
comparison to the Scr-siRNA group. However, the introduction of PHY to the culture 
medium resulted in the highest amount of H2O2 produced in the Scr-siRNA group (Figure: 
67), while after the Pex13 silencing, PHY induced only a very modest H2O2 increase. 
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Figure: 67. H2O2 production after PHY treatment in Pex13-si 
transfected cells. β-TC3 cells were transfected with Pex13-si or Scr-si 
RNA and treated with 60 M PHY for 48 h. H2O2 production was 
assayed from the sample supernatants. Values represent the H2O2 in 
M from one experiment. Data were normalized to sample protein 
concentration. DMSO: dimethyl sulfoxide; Phy: phytanic acid; H2O2: 
hydrogen peroxide. 
 
 
 
 
 
 
 
 
5.15.7. Insulin release and content in Pex13 knockdown -TC3 cells exposed to phytanic 
acid 
Next, we evaluated insulin biosynthesis and secretory capacity in our model. Pex13si- 
transfected cells were cultured in the presence of 20 mM glucose and exposed to 60 µM 
phytanic acid for 48 h and insulin content and release were measured in the protein 
homogenate of cell pellet and culture medium by ELISA. Neither the silencing of Pex13 nor 
the treatment with PHY in the control cells resulted in any change in the insulin release or in 
its intracellular content although we observed a slight trend for the insulin content (p = 
0,16) to decrease after PHY treatment (Figure: 68). Moreover, we observed that in the 
group displaying a Pex13 knockdown background the addition of PHY led to a significant (p ≤ 
0.05) increase in the insulin secreted as well as a decrease (p ≤ 0.01) in the intracellular 
content of this protein (Figure: 68A and B). 
 
Figure:  68.  Insulin release 
transfected β-TC3 exposed 
to PHY. β-TC3 cells were 
transfected with Pex13-si or 
Scr-si RNA and treated with 
PHY (60 M) for 48 h under 
high glucose condition (20 
mM). A: Insulin release was 
measured by ELISA in the 
harvested supernatant and 
corrected for protein 
concentration. B: Cell pellet 
extracts   were   collected and 
assayed for insulin content. Data were normalized to sample protein concentration determined with the 
Bradford assay. Values ±SEM represent the insulin fold change levels relative to Scr-si / DMSO sample from 
three independent experiments. Statistics: ANOVA test for multi-paired values. * p  0.05; ** p  0.01. DMSO: 
dimethyl sulfoxide; Phy: phytanic acid. 
and content in Pex13-si 
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5.15.8. Analysis of peroxisomal and -cell specific marker regulation after Pex13 
silencing in -TC3 cells exposed to phytanic acid 
Phytanic acid is metabolised exclusively in the peroxisome. We were therefore interested to 
analyse whether the combination of PHY exposure with the Pex13 silencing regulate the 
expression of genes involved in the peroxisomal - and -oxidation pathways. For this 
purpose, qRT-PCR was performed in the Pex13si-RNA treated β-TC3 cells after the exposure 
to 60 µM PHY for 48 h. As control and to assure that the Pex13 knockdown was still active 
during our experiment, the mRNA levels and protein abundance of Pex13 under the same 
experimental conditions were first analyzed. The transfection with Pex13-siRNA led to a 
significant decrease in the Pex13 mRNA levels and protein amounts (p ≤ 0.0001 and p ≤ 0.01 
respectively) independently of the exposure to PHY (Figure: 69A-C). 
 
 
Figure: 69. Regulation of Pex13 gene expression and protein abundance after PHY exposure in β-TC3 cells 
transfected with Pex13-siRNA. A: β-TC3 cells were transfected with Pex13-si or Scr-si RNA for 24 h and treated 
with PHY (60 M). After 48 h the expression of Pex13 and Actb (-Actin) were analyzed by qRT-PCR. The 
average threshold (Ct) values of at least three independent experiments were used to calculate the relative 
amounts of mRNA using the 2-ΔΔ CT method and normalized to Actb values. Results are presented as a fold 
over control (Scr-si / DMSO). B: Total protein (20 µg) was used for the analysis and was sequentially probed 
with antibodies against PEX13. Values ±SEM represent the protein abundance (in %) relative to Scr-si / DMSO 
sample normalized to total protein loaded from at least three independent experiments. The bands on films 
were quantified with ImageJ Software. C: Representative immunoblotting of PEX13 after Pex13-siRNA 
transfection and PHY treatment in β-TC3 cells. Statistics: ANOVA test for multi-paired values. ** p  0.01; 
****p  0.0001. Pex13: peroxisome biogenesis factor 13; DMSO: dimethyl sulfoxide; Phy: phytanic acid. 
 
Further, our results showed a significant increase in the expression of Phyh, the gene 
encoding for phytanoyl-CoA hydroxylase (an enzyme required for the -oxidation of 
phytanic acid), after Pex13 silencing (1.7-fold) (Figure: 70A). Interestingly, the addition of 
PHY into the culture medium induce a strong Phyh increase (2.8-fold) only in the Scr-siRNa 
group. The PHY-induced upregulation was not present in the -TC3 cells with Pex13 
deficiency. 
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In contrast to Phyh mRNA, the mRNA levels of Acox3, encoding for the first enzyme of the 
peroxisomal -oxidation pathway involved in the desaturation of branched fatty acids, 
showed a significant (p ≤ 0.05) increase of 2.2-fold only after PHY treatment in the Scr-siRNA 
group. No significant differences were observed between the non-treated groups (Scr-siRNA 
and Pex13-siRNA transfected) as well as between the Pex13 deficient cells with and without 
the PHY exposure (Figure: 70B). 
 
 
 
Figure: 70. Regulation of peroxisomal genes after PHY exposure in Pex13-si transfected β-TC3 cells. β-TC3 
cells were transfected with Pex13-si or Scr-si RNA for 24 h and treated with PHY (60 M). After 48 h the 
expression of Phyh, Acox3, Mfp2, Scp2, Amacr and Actb (-Actin) was analyzed by qRT-PCR. The efficiency of 
all primer pairs was ensured in advanced by running a qPCR on dilutions of the template cDNA. The average 
threshold (Ct) values of three independent experiments were used to calculate the relative amounts of mRNA 
using the 2-ΔΔ CT method and normalized to Actb values. Results are presented as a fold over control (Scr-si / 
DMSO). Statistics: ANOVA test for multi-paired values. * p  0.05; ** p  0.01; *** p  0.001. Phyh: phytanoyl- 
CoA hydroxylase; Acox3: acyl-coenzyme A oxidase 3; Mfp2: multifunctional protein 2; Scp2: sterol carrier 
protein X/2; Amacr: alpha-methylacyl-CoA racemase; DMSO: dimethyl sulfoxide; Phy: phytanic acid. 
 
 
Surprisingly, neither the Pex13 silencing, the PHY exposure or the combination of both 
affected the expression of Mfp2 mRNA, encoding for the multifunctional protein 2, also 
involved in peroxisomal -oxidation (Figure: 70C). 
Scp2 is a gene that encodes 2 proteins: sterol carrier protein X (a peroxisome-associated 
thiolase involved in the last step of branched-chain fatty acids -oxidation) and sterol carrier 
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protein 2 (an intracellular lipid transfer protein). The Scp2 mRNA was not significantly 
altered after the Pex13 silencing. However, a significant increase (p  0.001) in the Scp2 
mRNA levels was noted following the introduction of PHY into the Scr-siRNA group (3-fold) 
which was attenuated in the Pex13-si treated cells (Figure: 70D). 
Some derivatives from phytanic acid (e.g. CoA esters of pristanic acid) require the 
conversion from their 2R-methylacly-CoA ester to 2S-methylacyl-CoA epimers in order to be 
-oxidized. The enzyme responsible of this catalysis is an alpha-methylacyl-CoA racemase, 
encoded by the Amacr gene. The Amacr mRNA level was increased 1.9-fold (p = 0.09) in the 
Pex13 siRNA-treated cells in comparison to the Scr-siRNA control group. Moreover, the 
Amacr mRNA level exhibited a tendency to increase by 1.9-fold after the exposure to PHY in 
the Scr-siRNA group (p = 0.18) and the Pex13 knockdown cells (p = 0.14) (Figure: 70E). 
Additionally, the mRNA levels of Ins, the gene encoding for the precursor of insulin 1 and 2 
were investigated. The results revealed a significant increase of Ins mRNA after the Pex13 
silencing (p ≤ 0.05) whereas PHY treatment only led to an increase of Ins mRNA in the Scr- 
siRNA group (p ≤ 0.01). The combination of the PHY treatment and the Pex13 knockdown 
did not result in further upregulation of the Ins gene expression (Figure: 71A). 
The Pax6 mRNA level was strongly (4.4-fold) elevated (p = 0.06) in the Pex13-siRNA group, 
whereas the introduction of PHY led to an attenuation of this phenomenon (Figure: 71B). 
Similarly, also the expression of Pdx1 was elevated (2.8-fold) as a consequence of the Pex13 
silencing and this upregulation was slightly attenuated by PHY treatment (Figure: 71C). 
Pax4 expression behaved similar to the one of Pdx1, showing a strong increase after Pex13 
knockdown and exhibiting no further elevation after PHY treatment (Figure: 71D). 
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Figure: 71. Regulation of insulin, 
Pax6, Pdx1 and Pax4 mRNA levels 
after PHY exposure in Pex13-si 
transfected β-TC3 cells. β-TC3 cells 
were transfected with Pex13-si or 
Scr-si RNA for 24 h and treated 
with PHY (60 M). After 48 h the 
expression of Ins, Pdx1, Pax6, 
Pax4, and Actb (-Actin) was 
analyzed by qRT-PCR. The average 
threshold (Ct) values of three 
independent experiments were 
used to calculate the relative 
amounts of mRNA using the 2-ΔΔ 
CT method and normalized to Actb 
values. Results are presented as a 
fold over control (Scr-si / DMSO). 
Statistics: ANOVA test for multi- 
paired values. * p  0.05; ** p  
0.01. Ins: insulin; Pdx1: pancreatic 
and duodenal homeobox1: Pax6: 
paired box6; Pax4: paired box 4; 
DMSO: dimethyl sulfoxide; Phy: 
phytanic acid. 
 
5.15.9. Analysis of the mRNA levels of PPARs in -TC3 cells treated with Pex13-siRNA 
after phytanic acid exposure 
Numerous fatty acid–derived compounds including acyl-CoAs and phytanic acid (inter alia) 
have been shown to activate PPARs ((203). This phenomenon in turn results in the 
regulation of the expression of many peroxisomal genes. For this reason, we analyzed the 
mRNA expression and the protein abundance of the three PPAR subtypes, PPAR ,  and , 
after Pex13 silencing in -TC3 cells exposed to 60 M PHY for 48 h. 
Our results showed that the Ppar mRNA levels were not significantly affected by any of our 
treatments (Pex13  silencing, PHY exposure, or the combination of both) (Figure: 72A). 
However, PPAR protein abundance increased 2.1-fold (p ≤ 0.01) and 1.8-fold (p ≤ 0.01) 
after the treatment with PHY in the Scr-si and Pex13-si transfected cells (Figure: 72D and E). 
Interestingly, our results showed no significant changes in Ppar mRNA levels and protein 
amount following any of our treatments (Figure: 72B, D and E). 
In contrast to the result of PPAR and  mRNAs, the expression for PPAR mRNA was 
significantly increased after the Pex13 knockdown (~4.5-fold). Moreover, PHY treatment 
induced a strong PPAR upregulation (6.4-fold) in the Scr-siRNA group, whereas this 
upregulation was attenuated in the Pex13-si RNA group (p = 0.05) (Figure: 72C). The 
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silencing of Pex13 in -TC3 cells did result in an increase in PPAR protein abundance. 
Furthermore, the introduction of PHY to the medium led to a massive increase of the PPAR 
protein amount in both, the Pex13-si and the Scr-si mRNA transfected cells (2.2-fold) 
(Figure: 72C, D and E). 
 
 
 
 
Figure: 72. Regulation of PPAR gene and protein abundances after PHY exposure in Pex13-si transfected β- 
TC3 cells. A-C: β-TC3 cells were transfected with Pex13-si or Scr-si RNA for 24 h and treated with PHY (60 M). 
After 48 h the expression of Ppar, Ppar, Ppar and Actb (-Actin) was analyzed by qRT-PCR. The average 
threshold (Ct) values of at least three independent experiments were used to calculate the relative amounts of 
mRNA using the 2-ΔΔ CT method and normalized to Actb values. Results are presented as a fold over control 
(Scr-si/DMSO). D: Representative immunoblotting of PPAR PPAR and PPAR after Pex13-siRNA transfection 
and PHY treatment in β-TC3 cells. Total protein (20 µg) was used for the analysis. Equal loading of protein was 
controlled by Coomassie staining. E-G: Western blot analysis of PPAR, PPAR and PPAR. Values ±SEM 
represent the protein abundance (in %) relative to Scr-si/DMSO sample normalized to total protein loaded 
from at least three independent experiments. Statistics: ANOVA test for multi-paired values. * p ≤ 0.05; ** p  
0.01; *** p  0.001. PPAR   peroxisome proliferator-activated receptor alpha/ beta or gamma; DMSO: 
dimethyl sulfoxide; Phy: phytanic acid. 
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6. DISCUSSION 
The impact of defective peroxisomal metabolism on the development of diabetes mellitus 
type 2, particularly on pancreatic -cell pathophysiology has been overlooked in the past 
decades. Increasing evidence suggests that the onset of this age-associated disease is linked 
to the accumulation of reactive oxygen species (ROS), resulting in oxidative stress and 
cellular damage (93, 198, 199), and to -cell toxicity by excess plasma saturated long-chain fatty 
acids, commonly found in obesity (139). Peroxisomes perform a wide range of important 
metabolic functions including the -oxidation of very long-chain and branched-chain fatty 
acids and are actively involved in the metabolism of ROS. Interestingly, peroxisomes also 
metabolize long-chain FA through -oxidation taking over the function of mitochondria 
when these are deficient or overloaded by fatty-acids (200). Because of these properties, we 
hypothesized that peroxisomes could protect -cells against lipotoxicity and oxidative stress 
damage. To investigate the molecular mechanisms underlying -cell dysfunction in 
connection to peroxisomal dysfunction, a knockdown of the peroxisomal biogenesis protein 
gene Pex13 in -TC3 cells was generated.  
6.1. Peroxisomes and peroxisomal dysfunction in pancreas 
In former times, the study of catalase gene expression and protein level in pancreatic -cells 
led to the notion that peroxisomes are rare organelles in this cell type (172, 201). This was 
mainly due to the relatively low expression of catalase in pancreas when compared to liver. 
However, the use of different peroxisomal markers (e.g. PEX14) helped us to verify the 
presence of peroxisomes in the whole organ by IF analysis (173). Further we demonstrated 
that in pancreas, peroxisomes exhibit a heterogeneous protein composition and 
intracellular localization, suggesting that they may adapt according to the specific metabolic 
needs of each distinct group of cells. PEX14 and ABCD3, both integral membrane proteins, 
resulted to be the best markers for the identification of peroxisomes in -cells, and for the 
analysis of their distribution within the different regions of the tissue. 
The results presented in this thesis revealed that -cells express all genes related to 
peroxisomal -oxidation pathways I and II and for the ABCD3 lipid transporter. This suggests 
that peroxisomal -oxidation is particularly active in -cells. 
One of the aims of the present work was to achieve a knockdown of the peroxisomal 
membrane protein Pex13, a peroxin that is necessary for peroxisomal protein matrix import 
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(e.g. for -oxidation enzymes) in -TC3 cells. We successfully established a Pex13 deficient 
-TC3 cell model in which catalase was less abundant and mistargeted to the cytoplasm 
demonstrating the defective peroxisomal matrix protein import and partial degradation of 
the missorted protein. Within the cell, intact organelles are necessary to compartmentalize 
metabolic pathways and substrate flows. Similarly to catalase, also -oxidation enzymes 
require PEX13 for their peroxisomal matrix import. Mistargeting to the cytoplasm as a 
consequence of the Pex13 KD, could lead to the loss of the -oxidation chain functionality 
decreasing lipid oxidation and causing steatosis. 
In contrast to catalase, ABCD3 was not mistargeted since ABCD3 targeting does not involve 
the matrix protein import pathway through PEX13. In fibroblasts of Pex13−/− animals ABCD3 
is indeed retained in empty membrane structures called peroxisomal membrane ghosts (40) 
without being degraded (38). 
The Pex13 knockdown did not only alter the subcellular localisation of proteins but also the 
expression of some peroxisome-related genes. For example, the expression of Abcd3 and 
Acox1 was substantially decreased. Furthermore, -TC3 cells lacking functional peroxisomes 
exhibit an altered regulation of PPAR and PPAR gene expression, an effect that will be 
discussed later in this thesis. 
6.2. Possible involvement of peroxisomes in the onset of type 2 diabetes. 
In the last decades only few conditions have had as much medical, social and economical 
impact as diabetes mellitus type 2 (T2D). Representing the most common type of diabetes, 
T2D accounts for around 90% of all cases of diabetes (202). This chronic condition is 
characterized by hyperglycaemia due to decreased or absent insulin production (-cell 
failure) and/or the inability of the body to respond fully to this hormone. There is a strong 
link correlating T2D with genetic background, obesity, increasing age and lifestyle (physical 
inactivity, poor diet, prediabetes inter alia). However, despite all the efforts made so far, the 
precise mechanism of action behind T2D is not completely elucidated. Globally, the 
prevalence of T2D is rising, wherefore uncovering the molecular pathophysiology involved in 
the -cell malfunction, the key feature of this condition, is of high importance. 
T2D shows high prevalence in aged people older than 65 (203). It has been shown that aging 
also compromises peroxisomal number (204) as well as peroxisomal protein import 
(particularly the import of PTS-1 containing proteins (205)). Catalase is particularly affected 
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since it contains a non-canonical PTS-1 (-KANL) (206), which interacts with PEX5 less efficiently 
than the normal PTS-1 (-SKL) (207). This phenomenon has been observed not only in late-
passage cells (205) but also under conditions of oxidative stress (208). Catalase plays a critical 
role preventing oxidative stress, but it is low expressed in -cells. This, coupled with the 
progressive mislocalization of catalase into the cytosol as cells age (207) has been directly 
correlated with the pathophysiology of T2D as observed in patients with 
hypocatalasaemia(209). This implies that an imbalance in the ratio of ROS to catalase results 
in oxidative stress, cellular damage, aging and is probably involved in the onset of T2D. 
Several reports revealed the beneficial effect of catalase expression: In fibroblasts increased 
import of catalase specifically targeted to peroxisomes (SKL-catalase) dramatically reduced 
the cellular hydrogen peroxide levels (207) and in aging cells it delayed the appearance of 
senescence markers. Further, catalase protected peroxisomal -oxidation, re-established 
mitochondrial membrane potential and reduced mitochondrial ROS production (210). In 
contrast, it has been recently shown that the inefficient import of catalase, and in 
consequence its retention in the cytosol, could be a redox-regulated protective mechanism 
under conditions of elevated cellular oxidative stress (211). Peroxisomal catalase can 
efficiently clear the internally-generated oxidative degradation products (101) but it only 
insufficiently degrades H2O2 produced in other subcellular compartments (95, 211). So, 
cytosolic retention of catalase may indeed constitute a defense mechanism against cellular 
oxidative stress. The shuttling receptor for peroxisomal matrix proteins PEX5 thereby acts as 
a redox-regulated import receptor decreasing the import of PTS-1 proteins into the 
peroxisome under oxidizing conditions (212). When the cellular redox states are re- 
established, the peroxisomal import machinery could then return to normal and import 
catalase into the peroxisomal matrix. 
Also, when peroxisomes are deficient, medium-chain dicarboxylic acids (DCAs) are 
generated as a final product of the LCFA -oxidation (in the smooth endoplasmic reticulum) 
(213) as an alternative pathway to the -oxidation. Under physiological conditions these -FA 
are degraded by peroxisomal -oxidation, protecting cells against their toxicity and 
preventing the induction of inflammation and fibrosis (214). When peroxisomes are depleted 
of PEX13, this protective function is inhibited, leading to medium-chain dicarboxylic acid 
toxicity. 
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These observations reinforced the notion that peroxisomes are particularly relevant for the 
-cell wellbeing, however, as cells age and ROS levels increase, the protective mechanism 
performed by the peroxisome might be overwhelmed and the permanent mislocalization or 
inactivation of peroxisomal catalase result in -cell damage and T2D. 
6.3. Glucolipotoxicity in pancreatic -cells 
Obesity, (commonly accompanied by dyslipidaemia) is one of the main risk factors for the 
development of T2D (153) because increased levels of circulating FFA (non-esterified “free” 
fatty acids) in combination with hyperglycemia contribute to progressive -cell loss (215). In 
the search of the metabolic pathways associated with -cell failure scientists have focused 
their attention on the effects of high glucose and FFA concentrations in -cell metabolism, 
signal transduction pathways and viability. 
As indicated by our results, the exposure of -TC3 cells to different glucose concentrations 
(5 and 20 mM) for 72h did not result in any significant alteration in cell survival in 
agreement with previous results showing that an elevated glucose concentration alone is 
not toxic to pancreatic islets in normal or prediabetic stages (216). Presumably, the duration 
of the exposure to the hyperglycaemic condition was insufficient to induce a toxic response 
since -cells adaptative responses can counteract acute toxic effects (217). Indeed, -cells 
activate gene expression that induces the glycolytic pathway (218), which results in glucose 
degradation and detoxification (217). Pinpointing the mechanisms by which -cells fail is 
difficult because the experimental setups employed by different laboratories differ 
conspicuously. Depending on the genetic background of the used cell-lines (219–222), 
differences in the applied conditions for cell culture and glucose concentrations (alone or 
combined with FAs), a wide range of sometimes contradictory effects were obtained (222, 223). 
As for glucose, the treatment with FFAs entails its owns challenges: contrasting, beneficial 
(likely short exposure) or detrimental (likely long exposure), effects for -cell performance 
can be obtained when using FFAs depending on their concentration, the exposure time (156, 
190, 224), and the level of concurrent hyperglycaemia (153, 193). In primary rat -cells, human - 
cells or insulinoma cell lines, increasing the time of exposure to saturated fatty acids leads 
to cellular dysfunction causing reduced glucose-stimulated insulin secretion (225–227), 
decreased insulin gene expression (225) and apoptosis (139, 155, 169, 228, 229). 
Furthermore, the FFA/BSA ratios (193) and the use of serum in the culture medium could lead 
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to different results. 
The FAs concentrations and exposure times required to achieve a toxic effect in -TC3 cells 
in this thesis were defined by the following criteria: (i) the doses at which 40-50 % of the 
cells were still viable, taking into account that some of the experiments required a si-RNA 
transfection treatment resulting in increased cell stress and higher susceptibility to the fatty 
acid treatment, and (ii) the need of sufficient material of viable cells for later analysis. 
It is generally accepted that a causal relationship exists between chronically high FFA levels 
and pancreatic β-cell failure (lipotoxicity) (230, 231). The metabolic interaction between 
glucose and palmitate and the resulting potentiated harmful effect on -cells has led to the 
concept of glucolipotoxicity. Glucolipotoxicity is the combined deleterious effects of 
hyperglycaemia and high fatty acid levels on pancreatic -cell function and survival (193). 
In this thesis, it was shown that elevated PA concentrations in vitro are relatively benign to 
-cells when glucose is not simultaneously elevated. Indeed, under physiological 
circumstances, long-chain fatty acids serve as regulators of -cell function (153) and have 
been suggested as being beneficial during the hypersecretion of insulin by protecting 
against glucose intolerance in the early stages of obesity and diabetes (232). Also, studies 
performed in INS-1E insulinoma cells by Barlow et al. (171) suggest that PA alone is non-toxic 
due to the capacity of -cells to oxidize FFAs. These findings are supported by evidence that 
in animal models elevated FFAs per se function in the adaptation of the -cell to insulin 
resistance through lipid-signaling molecules like PPAR and  (144, 233). 
Our results suggest a marked synergistic effect of high glucose and palmitate in inducing cell 
death in -TC3 cells cultured for 3 days. This typical phenomenon was previously observed 
in experiments conducted in rat islets, INS 832/13 cells and human islet -cells, and resulted 
in increased DNA fragmentation and decreased cell proliferation (144, 152, 156, 189, 234–237). The 
cell death observed in the experimental set-up of this thesis might be caused by the 
influence of glucose on lipid metabolic pathways via alterations of substrate availability, 
changes in the activity and the expression of enzymes involved in glucose and lipid 
metabolism and of key transcription factors. 
In this respect, it is of interest that the signaling molecule malonyl-CoA creates a metabolic 
link between the metabolism of glucose and the one of FFAs. Malonyl-CoA regulates lipid 
partitioning (FFA oxidation versus synthesis/esterification) in dependence of the 
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intracellular glucose concentration through the inhibition of carnitine palmitoyltransferase- 
1 (CPT-1), which catalyzes the rate-limiting step of the mitochondrial -oxidation (144, 237). 
Under condition of hyperglycaemia, malonyl-CoA accumulates in the cell, thereby lowering 
the oxidation-rate of FFA-derived long-chain acyl-CoA esters. As a result, FA-CoAs are 
directed towards their incorporation into complex lipids, some of which are cytotoxic 
(phosphatidic acid, lysophosphatidic acid, sphingolipids, ceramides, cyclo- and lipo- 
oxygenase products inter alia) (144, 155, 156, 228, 238) and accumulate in the cytoplasm causing - 
cell apoptosis (226, 231) and insulin resistance in muscle tissue (239). For the interpretation of 
the results presented in this thesis we have to consider that since our experiments are 
performed with high glucose concentration, mimicking a glucolipotoxic diabetes-like 
environment that promotes sustained formation of citrate and malonyl-CoA, this can result 
in the inhibition of FA oxidation with concomitant increased phospholipid and triglyceride 
deposition (240). Further analysis of the intracellular fluctuations of malonyl-CoA could 
provide insight into how hyperglycemia impacts -cells in our particular experimental setup 
and model and in correlation to peroxisome dysfunction. It is worth mentioning that acetyl- 
CoA, the final product of the peroxisomal -oxidation is used as a substrate for the 
biosynthesis of fatty acids via its carboxylation to malonyl-CoA and be therefore responsible 
for the regulation of intracellular malonyl-CoA concentrations (24, 241). 
It is unlikely that glucolipotoxicity acts alone in the failure of the -cell in T2D. Other 
pathways and variables that could contribute to the loss of -cell mass and function are ROS 
production and peroxisomal dysfunction, which will be discussed later in this thesis. 
6.4. Alterations in peroxisomal protein patterns in pancreata from animal models of 
diabetes and dyslipidaemia 
With the purpose of detecting alterations in peroxisome abundance and proteome caused 
by T2D, ob/ob and NZO animals, models for diabetes and hyperlipidaemia, were employed 
for IF analysis. The peroxisomal abundance was massively increased in the islets of NZO 
animals and in the ob/ob(-/-) group exposed to a high lipid diet. This phenomenon is 
comparable with the one observed in the liver of db/db mice, another model for obesity, 
diabetes and dyslipidaemia, where the expression of the peroxins PEX11, PEX5 and PEX7 
were elevated (242). 
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Presumably, the increase in peroxisome number in pancreatic islets that we have observed 
indicates a compensatory mechanism to decrease the accumulation of FFA (non-esterified 
“free” fatty acids) caused by the high-fat diet by increasing peroxisomal -oxidation. 
Furthermore, an intriguing finding was the massive ABCD3 down-regulation in the 
pancreatic islets of both animal models after the exposure to the high lipid diet. 
Analogously, we observed a strong decrease of ABCD3 abundance in -TC3 cells after PA 
treatment. Furthermore, preliminary experiments generated in -TC3 cells with an Abcd3 
knockdown exposed to PA, showed a significant increase in cell death (data not shown) 
suggesting that the absence of ABCD3 causes -cell toxicity. It has been shown that in rat 
glial cells the downregulation of Abcd3 coupled with FA exposure (lignoceric and PA) caused 
a reduction of the rate of peroxisomal and mitochondrial -oxidation activities (243). Since 
ABCD3 is one of the most abundant peroxisomal membrane proteins (244) and is responsible 
of the transport of straight long- and very-long chain acyl-CoAs, as well of 2-methyl 
branched-chain acyl-CoAs, we could expect that the high lipid diet given to the animal 
models studied in this thesis, together with the observed ABCD3 downregulation could lead 
to an increased FA esterification and in consequence chronic pancreatic steatosis. 
Interestingly, after exposure of the -TC3 cells to the fatty acid PHY, ABCD3 was 
upregulated. This suggests that the expression of this transporter might be differentially 
regulated by specific fatty acids. 
In summary, our investigations show that, in these mouse models, peroxisomes are altered 
and their manipulation might be a key factor to neutralize pathophysiological alterations in 
pancreatic islets under diabetic or hyperlipidaemic conditions. 
6.5. Pathophysiological consequences of peroxisomal deficiency in -TC3 cells 
6.5.1. Palmitic and phytanic acid lipotoxicity in Pex13 KD -TC3 cells 
Intracellular accumulation of FA in non-adipose tissue (steatosis) has been associated with 
cellular dysfunction and death (243). In -cells, which are not a physiological site of lipid 
storage, in vitro and in vivo studies have clearly demonstrated that long-term exposure to 
FFAs and their accumulation induces apoptosis in cell culture and in isolated islets ultimately 
contributing to the pathogenesis of T2D (155, 156, 189, 243–245). Cause of steatosis can be either 
increased import and synthesis or decreased catabolism of fatty acids. The latter is caused 
by dysfunction of pathways in different subcellular compartments controlling intracellular 
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lipid homeostasis such as: the cytosol, for synthesis and storage of lipid droplets, and 
mitochondria or peroxisomes, for lipid degradation (242). In accordance with previous reports 
(246, 247), our study showed that long-term exposure to either PA or PHY induced -cell death 
in a concentration dependent manner. Though some studies have already compared the 
steatogenic capacity of PA and unsaturated fatty acids (e.g. oleic acid) (248), to our 
knowledge, the experiments presented in this thesis are the first ones proving PHY toxicity 
in -cells. PHY, a methyl-branched fatty acid found in ruminants fats, dairy products and 
beef with an estimated daily intake of 1 mg/kg body weight for an adult (83, 84), is solely 
oxidized in peroxisomes via one round of -oxidation and subsequent -oxidation (249). PHY 
is a powerful ligand for PPARα, whose activation in pancreas enhances the transcription of 
genes implicated in peroxisomal and mitochondrial β-oxidation, lipid metabolism, and 
peroxisome proliferation, thereby protecting β-cells against lipotoxicity (250). However, the 
accumulation of PHY due to a decrease or defect in peroxisomal metabolism has been 
proven toxic. This is exemplified by the peripheral neuropathy and demyelinisation 
observed in patients with Refsum´s disease (251). Furthermore, the induction of oxidative 
stress by PHY has been also documented (252) resulting in ROS production, calcium 
deregulation and apoptosis (253, 254). 
Several molecular mechanisms have been associated with -cell PA-triggered apoptosis, 
including: (i) ER impaired function and stress (138, 178), (ii) de novo ceramide synthesis (155), (iii) 
generation of reactive oxygen species (255) and of NO (256), (iv) accumulation of LC-CoAs and 
lipid intermediate molecules (144), and (v) release of apoptogenic factors, such as 
cytochrome c, from the mitochondrial intermembrane space to the cytosol (257). 
Furthermore, as already discussed, the metabolism of FFA can be shifted from their 
oxidation to their esterification, particularly when glucose is supplied like in our 
experiments, a process that promotes the accumulation of FFA. Less is known about the 
cytotoxic effect of PHY, although mitochondrial dysfunction and ROS production have been 
proposed to decrease cell viability in astrocytes and cardiomyocytes of wild type rats 
exposed to PHY (252, 254). 
It is so far unclear to what extent peroxisomes contribute to fatty acid metabolism in -cells. 
The involvement of the organelle is suggested by the decreased toxicity of PA after the 
stimulation of peroxisomal -oxidation and proliferation (250) and by the dramatic pathogenic 
consequences observed in the inherited peroxisomal disorder, Refsum´s disease, 
123  
where the defective oxidation of PHY leads to its accumulation in the serum. However, to 
the best of our knowledge, in different general knockout mice with complete peroxisomal 
deficiency (e.g. PEX2, PEX5, PEX13), no development of T2D has been described (36, 38, 258). 
This is due to the fact that these KO animals die shortly after birth, making the study of 
functional long-term pathologies with these animal models impossible. 
In this thesis it was shown that peroxisome-dysfunction increased cell-death only after 
treatment with PHY but not with the PA concentrations used, suggesting that metabolically 
intact peroxisomes are important for the removal of high concentrations of PHY in -cells. In 
the literature it has been demonstrated that the increase of either the activity of the 
peroxisomal matrix enzyme catalase or of the peroxisomal -oxidation in rat -cells and in 
the cell line INS-1 resulted in an improved -cell resistance against PA-toxicity (178, 259–261). By 
inducing peroxisomal activity, these cells channel PA towards initial degradation in the 
peroxisomes instead of performing the entire -oxidation in the mitochondrion (250). 
6.5.2. Lipid droplet accumulation in -TC3 cells is incremented by peroxisomal 
deficiency: possible involvement of PPAR-mediated regulatory effects 
 
We demonstrated that cytosolic lipid accumulation was proportional to the concentration of 
PA and PHY to which cells were exposed. Interestingly, at the concentration at which both 
FA reached toxic levels, cells treated with PA contained more and bigger lipid droplets than 
the ones treated with PHY. PA apparently induced greater steatosis suggesting that this FA 
might be more readily incorporated into TG (triglycerides)-storage droplets and therefore be 
less cytotoxic than PHY. Indeed, promoting lipid storage (and limiting lipolysis) can 
counteract lipotoxicity (224) to a certain extent. An emerging notion regarding lipotoxicity in 
pancreatic islets suggests that, when the availability of FFAs in the serum increases along 
with the concentration of toxic lipid intermediates, the sequestration of cytosolic FFAs into 
TG storage droplets (243) can have a cytoprotective effect. This is because toxic free fatty acyl 
moieties are removed from the cytoplasm and TGs are biologically inert and therefore non- 
toxic (224, 262, 263, 250). 
Since peroxisomes degrade LCFA when mitochondrial -oxidation is blocked or overloaded 
and because they are the only site for PHY degradation they might contribute to the 
protection of -cells against intracellular lipid accumulation and lipotoxicity. In our 
peroxisome-deficient cell culture model we observed a massive increase in the number and 
124  
size of cytoplasmic lipid droplets after the treatment with either PA or PHY. 
The increase in the lipid droplets after the incorporation of PA into our peroxisome-deficient 
model may be explained as a result of incomplete FA oxidation because of saturated 
mitochondrial CPT1-pathway and overload with cytosolic FFA. 
The accumulation of lipid droplets in the Pex13-depleted cells treated with PHY was not as 
prominent as observed for PA and likely due to the fact that this branched-chain FA can 
exclusively be metabolized in intact peroxisomes. 
PPARs are important regulators of lipid metabolism. In liver for example, the gene encoding 
for Acox1, which catalyzes the rate-limiting step in the peroxisomal fatty acid β-oxidation 
pathway, is strongly regulated by the activation of PPARα. Deficiency of PPARα therefore 
leads to the development of hepatic steatosis (191). In pancreas this effect prevents fatty 
acid-induced β-cell dysfunction and apoptosis (264) and improves β-cell function in rodent 
models displaying an insulin resistant phenotype (265). Therefore, PPARs have lately been the 
target for the development of drugs involved in the treatment of T2D. 
It is important to mention at this point that metabolic derivatives of the peroxisomal FFA 
oxidation often serve as a PPAR ligands, which themselves in turn modulate FFA metabolism 
through a so-called peroxisome/PPAR-feedback loop (24). Because of the peroxisomal defect 
non- or wrongly metabolized FFAs accumulate in the cell thereby potentially influencing the 
regulation of PPARs with repercussions on the entire cellular lipid metabolism. 
Our studies showed that PPAR protein abundance was strongly induced by PHY 
independently of the peroxisomal dysfunction. In contrast to this and as described 
elsewhere (250), PA decreased PPAR mRNA expression. Previous in vitro studies reported 
that PHY activates several PPARs subtypes, predominantly PPAR (266, 267). This results in 
enhanced -oxidation, and as we observed, also in the upregulation of the mRNA levels of 
enzymes involved in peroxisomal -oxidation such as Phyh, Acox3 and Scp2. It has been 
recently shown that FALDH-V, an aldehyde dehydrogenase which oxidizes pristanal to 
pristanic acid in the last step of the α-oxidation pathway, is induced by PPARα agonists 
resulting in cell protection against phytanic acid-induced damage (268), probably as a 
peroxisome-PPAR feedback loop. 
Also PPAR was strongly induced by the peroxisomal dysfunction and further upregulated by 
the addition of PHY but not by PA. Apart from polyunsaturated fatty acids, phytanic acid 
is also a natural  PPAR agonist  and  increases glucose  uptake  and  insulin  sensitivity (266). 
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Opposite to the conventional lipogenic role of PPAR as the key transcriptional factor for 
adipogenesis (144) it has been suggested that the activation of PPAR is also beneficial to the 
pancreatic β-cell, preventing lipotoxicity by increasing the capacity of the β-cell lipid- 
buffering and by enhancing the proliferative response of β-cells to insulin resistance (238, 269). 
The role of PPAR in pancreatic -cells, however, remains to be fully clarified primarily due 
to its low expression under physiological conditions (270, 271) and secondly because ablation of 
both PPAR isoforms in -cells did not result in a metabolic phenotype. 
PPAR, the PPAR subtype expressed at the highest level in insulinoma cells and rat 
pancreatic islets, was also activated by PHY and increased lipid oxidation capacity (as shown 
in INS-1E -cells) (272). 
However, a cautious interpretation should be made concerning the effects of PPARs due to 
the species-specific (rodents vs. humans) regulatory effects leading to contradictory results 
(280). Also, it is important to notice that PPARs and PPAR-binding synthetic ligands often 
display overlapping specificity resulting in the activation of the same subsets of genes. 
Indeed, our results show that despite the upregulation of PPARs the treatment of -TC3 
cells with PHY resulted in increased apoptosis. 
Even if the accumulation of lipid droplets may initially be just a cellular defense mechanism 
against FFA, their chronic and massive accumulation, along with a decreased oxidative 
capacity, causes -cell steatosis and cell death (144). Indeed, the apoptotic effect of FFA on - 
cells is related to elevated islet fat content, deposited after a chronic increase of FFA in the 
serum (155). Since the Pex13 knockdown is only active for a short period of time, longer FA 
treatment periods with the purpose of mimicking the effects of chronic steatosis in the 
background of peroxisome deficiency could not be performed at the moment under our 
experimental conditions. However, the use of the CRISPR/Cas9-gRNA complex-technology 
for genome editing could potentially be used in future experiments of our group to 
overcome this obstacle. 
In conclusion, our results suggest that peroxisome deficiency in combination with 
lipotoxicity, alter the lipid storage capability of -cells. Additionally, when -cells face an 
accumulation of FAs like PHY that are exclusively metabolised by peroxisomes, this causes 
an increase of apoptosis as a consequence of highly elevated amount of FFA in the 
cytoplasm that cannot be oxidised. This pinpoints to the importance of intact peroxisomes 
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for the protection of the cell against excess FAs that cannot be metabolised by mitochondria 
in -cells. 
6.6. Alterations in reactive oxygen species (ROS) metabolism induced by peroxisome 
deficiency in -TC3 cells 
The level of oxidative stress exerted on -cells depends on their capacity to scavenge ROS 
generated under conditions of glucolipotoxicity. Disruptions of oxidative stress homeostasis 
either by the exposure to high FA concentrations or by the decrease of the oxidative 
capacity such as when peroxisomes are dysfunctional, has dramatic physiological 
consequences. In this thesis, the levels of two reactive intermediates (H2O2 and superoxide) 
were quantified in the peroxisome-deficient cell culture model. As indicate by the results, 
the Pex13 knockdown and the associated peroxisomal dysfunction, resulted in a strong 
increase of intracellular H2O2 production. In neuronal cultures of PEX13 knockout animals no 
significant differences in H2O2 could be detected in comparison to wildtype animals (186). 
Most likely neuronal tissue has a different susceptibility to the peroxisomal dysfunction or 
possesses other defence mechanisms catalysed by other antioxidative enzymes. 
Since the H2O2 levels increased after the knockdown of Pex13, it was not surprising to find 
that superoxide levels were significantly lower. A plausible explanation could be the up- 
regulation of the SOD2 protein abundance shown in the peroxisome-deficient model. Since 
inside the mitochondrion superoxide is dismutated to H2O2 by SOD2, its upregulation might 
result in an increased inactivation of superoxide radicals, resulting in an increase in H2O2. 
These results also suggest a close interaction between the mitochondrial and the 
peroxisomal oxidative stress metabolism. It has been reported that the absence of 
functional peroxisomes in the Pex5- and Pex13-deficient mice can compromise 
mitochondrial integrity and lead to severe mitochondrial alterations including a marked 
increase of SOD2 suggesting that peroxisomal defects can cause secondary mitochondrial 
pathologies (37, 99, 186). 
Results from other groups concerning the involvement of FFA induced ROS in apoptosis are 
contradictory (139, 252, 255). Previous works have demonstrated that treatments with 
antioxidative enzymes (e.g. SOD and CAT) exert beneficial effects on -cells such as 
significantly inducing cell proliferation through decreased apoptosis and higher levels of 
insulin secretion (256). On the other hand, it is well established that at physiological low 
levels, ROS, particularly H2O2, (274, 275) serve as signalling messengers to mediate various 
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biological responses, including inflammation, immunity, differentiation, cell growth, 
tumorigenesis, and apoptosis (276). Also insulin-related signal transduction pathways are 
regulated by the presence of ROS (277–279). After PA and PHY supplementation we observed 
an increase in -cell death as well as an increase in H2O2 production. The generation of 
superoxide by PHY has been linked to cell cytotoxicity in cardiomyocytes and brain cells (252). 
However, in our experience, the -cell death after PHY supplementation was not 
accompanied by any changes in superoxide levels. There is evidence that in isolated rat 
heart and liver mitochondria, PHY increases ROS generation by partly inhibiting the electron 
transport and, most likely, by changing membrane fluidity (280). Pancreatic β-cells exposed to 
high concentrations of FFAs at non-lethal concentrations showed an elevated generation of 
ROS and NO (281). Similar observations were made in tumor cell lines and in rat pancreatic 
islets as well as in myocytes, where the overexpression of catalase abolished the rise of H2O2 
after PA supplementation (282). Accordingly, our results show that the PA- and PHY- induced 
increase in H2O2 was accompanied by a rise in CAT protein abundance and enzymatic activity 
very likely as a stress response. It has been shown that PPAR is an activator of the catalase 
gene transcription (283), explaining the increased catalase expression after PHY treatment 
observed in this thesis. PA instead activates the transcription of Nrf2 (NF-E2-related factor 
2) target genes (284) that is involved in cellular defenses against oxidative stress and increases 
the expression of catalase (285). NADPH oxidase activation could also be a source of PA 
mediated superoxide radical generation (286) causing lipotoxicity in -cells (287). 
Interestingly, the treatment of Pex13-deficient -cells with PA did not increase cytotoxicity. 
Until now, the source of H2O2 after FFAs supplementation is not clear. It is often assumed 
that mitochondria are the primary source of ROS production in the -cell after FFA exposure 
(252, 288–290). During aging, when the peroxisomal catalase abundance is reduced due to its 
cytosolic mislocalization (204), peroxisomes may become a source of toxic ROS (99), increasing 
the risk of developing age- related diseases including diabetes (209). The considerable clinical 
heterogeneity of T2D, and the large number of pathways that are involved in the 
pathophysiology of this disease, clearly show that the pathogenesis of type 2 diabetes is not 
simple. Our studies suggest that the saturated FFA palmitate and the branched- chain FA 
phytanic acid induce the formation of reactive intermediates (H2O2) in β-TC3 cells that 
independently lead to cell death. Furthermore, our findings suggest that the PEX13 
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knockdown causes secondary mitochondrial oxidative stress, since it massively increased 
SOD2 protein abundance and mRNA levels. However, the elevated cell toxicity observed 
after PHY exposure in our peroxisomal dysfunction model did not correlated with an 
increase in ROS production. 
6.7. Functional significance of peroxisomes in insulin production and secretion in -TC3 
cells exposed to palmitic and phytanic acid 
Insulin secretion can be regulated by several cooperative signalling pathways (291). Glucose 
constitutes the primary extracellular signal triggering insulin secretion. Secondary signals 
augmenting insulin secretion are lipid-derived intracellular signals (e.g. long-chain acyl- 
CoAs) (292, 293). Externally added FFAs can induce enhanced insulin secretion as well (145). 
Our study showed that, when pancreatic -TC3 cells were exposed to toxic concentrations 
of PA under hyperglycaemic condition, the insulin secretion and biosynthesis was 
stimulated. In this thesis, 48 h of toxic concentrations of PA (limited by the necessity to 
sustain the Pex13 silencing) were used. Under these conditions -cells retained their 
functionality. Stronger, irreversible or deleterious alterations in -cell gene expression and 
signalling, which are necessary to provoke -cell failure, might be obtained by longer 
treatment periods. An alternative explanation for the conserved functionality of the -cells 
after the introduction of PA is the upregulation of Pdx1 expression, a transcription factor 
necessary for -cell maturation and for the maintenance of insulin production. Other studies 
showed that a typical symptom for islet lipotoxicity is an initially increased basal insulin 
secretion (220) followed by -cell apoptosis (155). 
Interestingly, opposite to what we observed for PA, elevated concentration of PHY, 
decreased the biosynthesis of insulin, an effect that was stronger in the peroxisome 
deficient -TC3 cells. This effect could be caused by the PHY-mediated activation of PPAR. 
It was indeed demonstrated that PPAR has a direct effect on islet function suppressing 
insulin secretion in insulinoma cells (260). 
6.8. Effect of peroxisomal dysfunction and fatty acid exposure on -cell identity 
6.8.1. Ins gene regulation 
On a purely functional level -cell-identity defines a cell that is capable of synthesizing, 
processing and secreting mature insulin in response to metabolic, hormonal and 
neurological stimuli. On this base, a new concept evolved namely the “loss of -cell 
129  
identity”. This notion proposes that -cells in T2D lose their differentiated specialization 
through the inhibition of key -cell transcription factors such as Pdx1 (pancreatic and 
duodenal homeobox 1) and Pax6 (paired box protein 6) inter alia, thereby silencing -cell- 
specific genes associated with basal and regulated insulin production. Overall, -cell 
differentiation and function result from an interrelated network of transcription factors, 
including apart from those already mentioned, also Pax4 (paired box protein 4) (197, 294–296). 
To our knowledge, the present study is the first one attempting to determine whether 
peroxisomal dysfunction and FFA exposure trigger changes in -cell identity. 
The PAX6 transcription factor is crucial for -cell differentiation and function (297). As 
indicated by our results, the peroxisome deficiency drastically decreased Pax6 expression 
independently of the addition of PA. This phenomenon was associated with a decline in 
Pdx1, Pax4, and ins gene expression. This is in accordance with previous results carried out 
in rat primary -cells and -TC3 cells revealing that silencing of Pax6 controlled the mRNA 
levels of the ins and Pdx1 genes (196). When the peroxisome-deficient model was exposed to 
PA, not only ins, but also Pdx1 and Pax4 were induced, while the mRNA levels of Pax6 were 
not affected. This allows us to hypothesize that other mechanisms play a role in the 
regulation of these genes. However, a cautious interpretation concerning mRNA expression 
should be made, since the protein levels or binding activities of the involved transcription 
factors were not measured in these experiments. 
The results obtained from the experiments carried out with PHY are inconclusive since the 
addition of DMSO alone, which is used to solubilize PHY as is used as a control, affected the 
expression of Pax6, Pdx1, Pax4 and ins. This specific effect of DMSO needs to be elucidated 
in future experiments. 
Emerging evidence from multiple lines of research is suggesting how metabolic stress, in 
particular hyperglycaemia, may lead to compromised -cell identity (298). Despite some 
researchers reported that glucolipotoxicity decreased both insulin mRNA synthesis and 
secretion of insulin (140, 152, 299), we did not observe changes in the ins gene expression after 
PA exposure in the presence of high glucose. Similar results were found in another -cell 
line (INS-1), which displayed no changes in ins expression after 2 days of PA treatment (300). 
While it appears that the PA/glucose exposure time is primarily responsible for this 
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discrepancy, the used cells or organism type and the fatty acid preparation also strongly 
influence the obtained results. 
6.8.2. Insulin secretion 
 
The mechanisms through which fatty acids affect insulin gene expression are distinct from 
those by which they impair insulin secretion. The transcriptional mechanisms by which PA 
inhibits insulin gene expression do not involve changes in insulin mRNA stability but, rather, 
inhibition of glucose- induced insulin promoter activity (226). This is associated with 
decreased binding activity of PDX1, which is affected in its ability to translocate to the 
nucleus (301). Alone, high glucose concentrations (25 mM) chronically decrease the 
expression of Pdx1 and therefore the insulin content in -cells (302). 
As indicated by our results, the changes in Pax6 found after the Pex13 did not correlated 
with any significant changes in insulin content/release at least after 72 h post transfection 
despite its influence on other -cell specific markers. PAX6 regulates insulin biosynthesis (303) 
but is not interfering with the insulin secretory process. 
Our results provide evidence that functional peroxisomes are required for the normal 
expression of -cell-specific genes including ins, Pax6, Pax4 and Pdx1. Thus, Pex13 silencing 
influenced -cell identity by modifying the expression of genes essential for -cell function 
and maturation. 
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7. SUMMARY 
 
Type 2 diabetes is characterized by impaired insulin secretion paralleled by a progressive 
decline in β-cell function and chronic insulin resistance. The failure in β-cell function has 
been attributed to the deleterious effect of chronically elevated levels of glucose and fatty 
acids. These processes, known as glucolipotoxicity, are related to the generation of chronic 
oxidative stress and the alteration of the intracellular energy metabolism in pancreatic - 
cells. 
Peroxisomes are organelles involved in the degradation of a variety of lipid derivatives and 
in the metabolism of reactive oxygen species. To date, scarce information is available 
concerning the function of peroxisomes in pancreatic -cells, however, the abundance of 
this organelle in the pancreatic endocrine region suggests that the metabolic function of 
peroxisomes might be particularly relevant to -cell function. Therefore, we investigated 
whether the dysfunction of peroxisomes is involved in oxidative stress and intracellular lipid 
accumulation which in turn results in -cell dysfunction and death. 
Therefore, the main goal of this thesis was to analyse the role of peroxisomes in maintaining 
normal -cell physiology and protecting -cells against glucolipotoxicity induced by palmitic 
and phytanic acid. 
To this end, a peroxisomal dysfunction was induced in -TC3 cells by siRNA-mediated Pex13 
and Abcd3 knockdown. To obtain an integral overview on the peroxisomal compartment 
and its enzyme composition and to analyse the molecular consequences of peroxisome 
deficiency as well as the induced glucolipotoxicity in the pathology of  cells, total RNA 
isolation, qRT-PCR, Western blot, immunofluorescence analysis, catalase-assay, reactive 
oxygen species indirect measurements, laser capture microdissection and lipid droplet 
accumulation analysis were carried out. Further, we also assessed the capability of the β- 
TC3 cells to store/secrete insulin after the induced peroxisomal defect and lipid overload. 
The results in this thesis stress the importance of functional peroxisomal metabolism for the 
detoxification of excess FA in -cells. Our findings support the notion that peroxisomal 
dysfunction, here achieved by the silencing of Pex13, leads to an increased intracellular H2O2 
production and causes mitochondrial alterations in -TC3 cells. Furthermore, the 
132  
peroxisomal dysfunction (alone or in combination with toxic lipid concentrations) alters the 
lipid storage capability of -cells. 
Novel evidence of the toxicity of PHY for the -cell (which was exacerbated by the Pex13 
knockdown) was presented, which was accompanied by a decrease in insulin biosynthesis. 
We showed a rise in the formation of H2O2 production after PA treatment together with an 
increase in catalase expression and activity suggesting a positive-feedback to re-establish 
the redox homeostasis that was disturbed by the addition of the FA. Moreover, the 
treatment with PA and the Pex13 silencing (but not PHY treatment) resulted in alterations of 
-cell-specific genes involved in -cell function and identity (Pax6, Pax4 and Pdx1). 
Further elucidation of the role of this organelle in -cell function and disease might bring 
new research opportunities to find new targets and strategies in the treatment and 
prevention of diabetes. 
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8. ZUSAMMENFASSUNG 
 
Typ 2 Diabetes ist durch eine beeinträchtigte Insulinsektetion mit einem kombinierten 
Verlust der -Zellen und einer chronischen Insulinresistenz charakterisiert. Dieser Verlust 
der Funktionalität von -Zellen wird einer chronisch erhöhten Konzentration von Glucose 
und Fettsäuren zugeschrieben. Dieser Prozess, bekannt als Glucolipotoxizität, steht im 
Zusammenhang mit oxidativem Stress und verändertem Energie-Metabolismus in 
pankreatischen -Zellen. 
Peroxisomen sind Organellen, die beim Abbau von Fettsäureabkömmlingen und oxidativem 
Stress beteiligt sind. Bis heute stehen nur wenige Informationen über die Funktion der 
Peroxisome in pankreatischen -Zellen zur Verfügung, obwohl die hohe Anzahl dieser 
Organellen im endokrinen Pankreas eine wichtige Rolle in deren Funktionalität nahelegt. 
Daher untersuchten wir, ob eine beeinträchtige Funktion von Peroxisomen zu verändertem 
oxidativem Stress und intrazellulärer Fettakkumulation führt, welche wiederum zu 
Schädigungen der Zellphysiologie bzw. Zelltod führt. 
Daher war das Hauptziel dieser Arbeit die Rolle von Peroxisomen in der Aufrechterhaltung 
eines normalen Stoffwechsels in der -Zelle und dem Schutz vor oxidativem Stress von 
Glucolipotoxizität, induziert durch Phytansäure und Palmitinsäure, zu analysieren. 
Um dies zu untersuchen, haben wir eine peroxisomale Fehlfunktion durch ein siRNA- 
induziertes Knockdown der Gene für Pex13 und Abcd3 herbeigeführt. Um sowohl eine 
Übersicht über die Verteilung und die Enzymfunktion von Peroxisomen, als auch eine 
Analyse über die molekulären Konsequenzen einer Fehlfunktion und der Glucolipotoxizität 
zu erhalten, haben wir zum einen RNA isoliert, Western blots, Immunofluoreszenzen und 
Katalase analysiert, und zum anderen ROS indirekt gemessen, Laser-Mikrodissektionen 
durchgeführt und die Verteilung von Fetttröpfchen in der -Zelle untersucht. Darüber 
hinaus haben wir die Fähigkeit der -Zelle zur Speicherung und Sekretion von Insulin, nach 
vorrausgegangener induzierter Fehlfunktion von Peroxisomen bzw. Fettüberladung, 
untersucht. 
Die Ergebnisse dieser Arbeit unterstreichen die wichtige Rolle der korrekten Funktion des 
peroxisomalen Metabolismus für die Detoxifizierung von überschüssigen Fettsäuren in  - 
Zellen. 
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Unsere Resultate unterstützen weiterhin die Auffassung, dass peroxisomale Fehlfunktion, 
die hier durch das beeinträchtigen des Pex13-Gens herbeigeführt wurde, zu einer erhöhten 
intrazellulären H2O2 Produktion führt und dadurch die Mitochondrien in -TC3 Zellen 
beeinflusst. Außerdem führt die Fehlfunktion von Peroxisomen (alleine oder in Kombination 
mit toxischen Fettsäurekonzentrationen) zu einer veränderten Speicherfähigkeit von Fett in 
-Zellen. 
Neue Evidenz für die Toxizität von PHY für die  -Zelle (welche durch ein Pex13 Knockdown 
verstärkt werden konnte) mit einer einhergehenden Reduktion der Insulinsynthese konnte 
erzeugt werden. Wir zeigten einen Anstieg in der H2O2 Produktion, gefolgt von einer 
erhöhten Katalase Expression und Aktivität nach Behandlung der Zellen mit PA, was auf ein 
positives Feedback hinweist, dass wahrscheinlich die durch Fettsäuren veränderte Redox- 
Homeostase wiederherstellen soll. Abschließend zeigten wir, dass eine Behandlung mit PA 
(aber nicht mit PHY) und ein Knock-Down des Pex13 Gens in einer veränderten Expression in 
 -Zell spezifisches Genen für peroxisomale Funktion bzw. Integrität (Pax6, Pax4 and Pdx1) 
mündet. 
Weitere Untersuchungen über die Rolle dieses Organells in der Funktion von -Zellen, wie 
auch dessen Krankheiten könnten zu neuen Forschungsansätzen, und damit zu neuen 
Strategien in der Bekämpfung bzw. der Prävention von Diabetes, führen. 
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APENDIX 
 
X. Techniques used for catalase over-expression in E.coli and antibody generation 
 
X. 1. Preparation of chemocompetent DH5α bacteria 
DH5α cells were streaked out on a LB plate without antibiotics and incubated overnight at 
37°C. Two clones were selected the next day and grown overnight in  a  5  ml culture in fresh 
LB medium. Subsequently, the culture was diluted 1:20 into 50 ml of LB medium and shaken 
at 300 rpm and 37°C in an incubator shaker until the solution reached an OD600 of 0.45-0.5. 
Thereafter, the culture was incubated on ice for 5 min. All subsequent steps were carried 
out at 4°C and under sterile conditions. The cells were harvested by centrifugation for 15 
min at 3,000 x g in a pre-cooled centrifuge. After removing the supernatant, the cell pellet 
was resuspended in chilled TfbI buffer in 40 % of the culture original volume. Later, the cells 
were incubated on ice for 10 min and centrifuged again at 3,000 x g for 15 min. Following 
the removal of the supernatant, the pellet was resuspended in 4 ml TfbII cold buffer and 
incubated on ice for 15 min more. Finally, 50 µl aliquots of the competent cells were 
immediately frozen using a dry ice chamber and stored at -80°C. 
 
X.2. Transformation of competent DH5α cells for plasmid replication and preparation of 
agarose LB-ampicillin plates 
A 50 l aliquot of frozen competent cells was thawed on ice and then gently mixed with 100 
ng plasmid DNA. After 20 min incubation on ice, the bacteria were heat shocked in a water 
bath for 90 s at 42°C and transferred back on ice for 2 min. Thereafter, 200 l of LB medium 
without antibiotics were added and the cells were allowed to grow in a 37°C incubator for 
30 min. Finally, the transformation was spread onto a 10 cm LB agar plate containing 
ampicillin and incubated overnight at 37°C. 
For the preparation of agarose LB-ampicillin plates, 500 ml Agar-LB solution was 
microwaved at 350 W until dissolved and then allowed to cool to 50°C for 1 h in a water 
bath. The process of preparing the plates was carried out in a fume hood keeping the area 
sterile. Ampicillin (100 µg / ml) was then added to the solution and mixed. Subsequently ~20 
ml of Agar-LB solution was slowly poured into 10 cm polystyrene Petri dishes. After cooling 
the plates for 30-60 min until solidified, they were stored inverted and sealed with parafilm 
at 4°C. 
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X.3. Isolation of plasmid DNA 
X.3.1. Mini preparation for DNA isolation 
After transformation, one single clone was selected from the LB/ampicillin-agar plates to 
inoculate 3 ml of LB medium containing ampicillin (50 g/ml). The bacterial culture was 
incubated at 37°C with constant shaking (300 rpm) overnight. The next day 1 ml of the 
saturated DH5α cells culture was harvested by centrifugation for 30 s at 11,000 x g. The 
supernatant was discarded, and the pellet resuspended in 250 µl Buffer A1 (NucleoSpin 
plasmid QuickPure). After vortexing, 250 µl Buffer A2 was added, gently mixed and 
incubated at RT for 5 min. After the addition of 300 µl Buffer A3 the sample was centrifuged 
again for 5 min at 11,000 x g at RT. Once the supernatant appeared clear, 750 µl were 
transferred onto a NucleoSpin plasmid column and centrifuged for 1 min at 11,000 x g to 
bind the DNA to the matrix. The previous step was repeated with the remaining lysate. 
Thereafter, the silica membrane was washed and centrifuged (1 min at 11,000 x g) first with 
500 µl prewarmed Buffer AW (50°C) and then with 600 µl Buffer A4 at RT. The flow-through 
was discarded and the column was centrifuged for 2 min at 11,000 x g. Finally, the DNA was 
eluted with 50 µl Buffer AE after 1 min incubation at RT followed by 1 min centrifugation at 
11,000 x g. 
X.3.2. Midi preparation for DNA isolation 
After bacterial transformation, a starter culture was prepared inoculating a 3 ml culture of 
LB medium containing ampicillin with a single clone picked from a freshly streaked 
LB/ampicillin-agar plate. The culture was shaken at 37°C and 300 rpm for 8 h. To provide 
enough plasmid DNA for purification, a large culture was set up diluting the pre-culture 
1:1,000 into 200 ml of LB medium containing ampicillin (50 g/ml). The culture was allowed 
to grow overnight at 37°C. The bacteria were then harvested by centrifugation at 6,000 x g 
for 15 min at 4°C. The OD600 allowed the determination of the right culture volume to be 
used for the isolation as follows: Volume (ml) = 800/OD600. After centrifugation, the cell 
pellet was resuspended in 8 ml Resuspension Buffer (RES) containing RNase A (NucleoBond 
Xtra MidiEF). Thereafter, 16 ml of Buffer LYS was added to the suspension and mixed by 
inverting the tube 5 times to lysate the cells. The mixture was incubated at RT for 5 min. 
Subsequently, 16 ml of Buffer NEU was added and the lysate was gently mixed. The 
precipitate formed in the last step was removed by centrifugation at 10,000 x g for 20 min 
at 4°C. The resulting cleared lysate was then loaded onto a pre-equilibrated NucleoBond 
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Xtra Column. For equilibration, 12 ml Buffer EQU were applied onto the rim of the column 
filter and then allowed to empty by gravity flow. The loading of the column was followed by 
two washing steps, the first one with 15 ml Buffer EQU and after the removal of the column 
filter the second one with 25 ml Buffer WASH. Finally, the plasmid DNA was eluted with 15 
ml prewarmed Buffer ELU (50°C), precipitated with 10.5 ml isopropanol at RT, and 
centrifuged at 10,000 x g for 30 min at 4°C. The DNA pellet was washed with 70 % ethanol 
and centrifuged at 10,000 x g for 5 min at RT. The pellet was allowed to air dry for 5 min 
after the complete removal of ethanol and subsequently resuspended in 200 µl TE buffer. 
X.3.3. DNA quantification 
The purity and concentration of the DNA was measured using a NanoDrop 2000 
spectrophotometer (Thermo Scientific). The A260/A280 ratio was ~1.8 and the A260/230 ratio 
was higher than 2.0-2.2. Both ratios are accepted as a measurement for DNA purity. 
X.4. Catalase coding sequence amplification by polymerase chain reaction (PCR) 
The bacterial plasmid cloning vector pCMV-Sport 6 containing the full-length open reading 
frame (ORF) encoding for mouse catalase was used as a template to amplify the coding 
region of catalase via PCR in order to add the restriction sites to both 3´and 5´ends of the 
piece of DNA. The amplification was carried out using self-designed gene-specific cloning 
primers containing the restriction enzymes sites for Sac I / Hind III or Nde I / Nde I. Three 
nucleotides were added upstream of the restriction sites to improve restriction enzymes 
cleaving and cutting efficiency. 
The reaction mix was set using 1-5 ng of template DNA, 1 µl forward primer (equivalent to 
100 pmol), 1 µl reverse primer (100 pmol), 5 µl of 10x PCR reaction buffer, 1 µl of 10 mM 
dNTPs mix (0.2 mM) and 1 U of Taq DNA polymerase. The reaction mix was adjusted with 
dH2O to a final volume of 50 µl. 
Table X.1.: Primers used for the amplification of catalase open reading frame (ORF). 
The restriction sites for Sac I / Hind III and Nde I / Nde I were added (indicated in bold letters) 
Name Sequence (5´→3´) Laboratory storage no. 
MmCAT-Sac I (forward) ATAGAGCTCATGTCGGACAGTCGGGACCCAGC AZ53 
MmCAT-Hind III (reverse) ATAAAGCTTTTACAGGTTAGCTTTTCCCTTC AZ54 
MmCAT-Nde I (forward) ATACATATGTCGGACAGTCGGGACCCAGCCAG BA43 
MmCAT-Nde I (reverse) ATACATATGTTACAGGTTAGCTTTTCCCTTC AZ56 
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The PCR reaction was carried out in a Bio-Rad iCycler C1000 using the following parameters: 
initial denaturation at 95°C for 1 min, followed by 30 cycles of denaturation at 95°C for 30 s, 
annealing at 60°C for 30 s, extension at 72°C for 30 s, and a final extension at 72°C for 7 min. 
X.5. Purification of DNA fragments from agarose gels 
Fragments of DNA that were separated by 1 % agarose gel electrophoresis were excise with 
a clean scalpel and weighed. The PCR products were then purified using a QIAquick Gel 
Extraction kit. Three volumes of Buffer QG were added to 1 volume of gel (300 µl /100 mg) 
and incubated at 50°C for 10 min until the gel slice was completely dissolved. During the 
incubation time the sample was vortexed every 2 min. Subsequently, 100 µl of isopropanol 
were added to the sample, mixed and loaded onto a QIAquick spin column. To bind the DNA 
to the column, the last one was centrifuged twice, each time for 1 min at 9,600 x g 
discarding the flow-through in between. Thereafter, 750 µl Buffer PE were added to wash 
the column and then centrifuged for 1 min at 9,600 x g. After discarding the flow-through, 
the column was allowed to stand 5 min and it was centrifuged again for 1 min at 17,900 x g 
in order to remove residual wash buffer. The DNA was eluted in 30 µl Buffer EB and applied 
directly into the center of the membrane with 2 subsequent centrifugation steps (1 min, 
17,900 x g, RT). 
X.6. Subcloning of the catalase constructs into pGEM-T Easy vector 
To improve the efficiency of ligation of the catalase constructs into the expression plasmids, 
Cat-Sac I / Hind III and Cat-Nde I / Nde I were sub-cloned into the pGEM-T Easy vector 
(Promega). The sub-cloning helped to prevent recircularization of the vector and provided a 
compatible overhang for the catalase-PCR products. 
A molar ratio of 1:5 (vector: insert) was used to set up the reaction on ice as follows: 5 µl of 
2x rapid ligation buffer, 1 µl of pGEM-T Easy vector (equivalent to 50 ng), 5 µl of insert DNA 
(PCR product) and 1 µl of DNA ligase. The reaction was incubated overnight at 16°C. 
X.6.1. Restriction digestion of plasmid DNA 
After selecting the adequate restriction enzymes (Sac I / Hind III or Nde I / Nde I) a double 
digestion of the expression vectors or the Cat-pGEM-T Easy vector construct was carried 
out. The appropriate buffer used in the reaction was determined according to the 
compatibility with both enzymes (or in the case of Pet16b, just for Nde I). The restriction 
digestion reaction was set on ice as follows: 5 µg of DNA, 1 µl of each restriction enzyme 
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(equivalent to 5 U), 3 µl of 10x Buffer and adjusted with dH2O to a final volume of 50 µl. The 
reaction was incubated for 3 h at 37°C. The results were visualized by agarose gel 
electrophoresis and the digested vectors were then extracted and purified. 
X.7. Dephosphorylation of 5´overhangs from Pet16b after Nde I / Nde I digestion 
In the case of Pet16b a single restriction enzyme (Nde I) was used to digest the vector, 
therefore the hydrolysis of 5´-phosphate groups from the DNA was needed to prevent re- 
circularization and re-ligation of the vector during cloning. Calf intestinal alkaline 
phosphatase (CIAP) was used to remove the phosphate groups from both 5´-termini. The 
purified Pet16b DNA was resuspended in 40 µl of Tris-HCl (10 mM, pH 8.0) and incubated at 
37°C for 30 min. The reaction was set up as follows: 40 µl of DNA (equivalent to maximum 
10 pmol of 5´-ends), 5 µl of CIAP 10x reaction buffer and 2.5 µl of diluted CIAP (0.01 U/µl). 
After adding another 2.5 µl of diluted CIAP, the solution was incubated at 37°C for an 
additional 30 min. Finally, 300 µl of CIAP stop buffer were added prior to sample 
purification. 
X.8. DNA ligation 
To clone both catalase inserts into the compatible expression vector backbone (pTrcHis A or 
Pet16b), a ligation reaction was set on ice using a T4 DNA ligase as follows: 20-40 ng of 
vector DNA, 5 µl of insert DNA, 2 µl of 10x ligation buffer, 1 µl of T4 DNA ligase (equivalent 
to 4 U) and adjusted to a final volume of 20 µl using dH2O. The reaction was incubated at 
16°C overnight. 
X.9. Blue-white screening 
 
To identify correctly generated recombinant plasmids, the ligation reaction was transformed 
into competent DH5α cells. One hundred µl of transformants were then spread onto an X-
Gal (5-bromo-4-chloro-indolyl-β-galactopyranoside) plate. Previously, 100 µl LB medium, 40 
µl X-Gal and 20 µl IPTG (isopropyl β-D-1-thiogalactopyranoside) were spread onto an 
LB/ampicillin agar plate and allowed to dry in a laminar flow chamber before use. The cells 
were incubated overnight at 37°C. The next day the recombinant cells in the white colonies 
were selected for PCR and agarose gel electrophoresis screening. 
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X.10. Catalase expression 
 
The plasmid constructs were transformed into BL21(DE3) Rosetta (Novagen) competent 
cells, plated on LB/ampicillin agar plates and incubated overnight at 37°C. The next day a 
single clone was selected and resuspended in 5 ml LB medium supplemented with 100 
µg/ml ampicillin to produce a starter culture. Subsequently, the overnight culture was used 
to inoculate 50 ml of fresh LB medium supplemented with ampicillin at a 1:50 dilution. The 
culture was incubated at 37°C with shaking until OD600 reached 0.45. The catalase 
expression was then induced by the addition of IPTG to a final concentration of 1 mM. After 
induction, the culture was maintained at 20°C with constant shaking (300 rpm) for a period 
of 250 min. Finally, the bacteria were harvested by centrifugation at 20,000 x g for 1 min. 
The bacterial pellet was stored at 20°C until catalase isolation. 
X.11. Catalase affinity purification via His-Tag isolation 
 
The isolation of the recombinant catalase after its expression was carried out using the 
Dynabeads His-Tag isolation & pulldown system (Life Technologies). To prepare a cell lysate, 
the bacterial pellet expressing histidine-tagged catalase was resuspended in Lysate buffer (4 
ml/bacterial pellet from 50 ml culture) containing lysozyme (to increase the lysis efficiency) 
and incubated on ice for 30 min. The lysates were subsequently disrupted and homogenized 
using five 10 s pulses (10 s in between pulses) with a probe sonicator. Samples were kept in 
an ice bath all the time. Cell debris were removed by centrifugation at 5,000 x g for 10 min 
at 4°C. Two mg Dynabeads were added to the lysate supernatant after bead equilibration 
and incubated at 4°C for 1 h on a roller. After magnet attraction, the supernatant was 
discarded and the beads were washed 4 times with 1 ml cold binding/washing buffer 
discarding the supernatant in between. Subsequently the protein was eluted adding 1.5 ml 
elution buffer to the beads and incubating the suspension on a roller for 1 h at 4°C. Finally, 
the beads were resuspended in 1.5 ml binding/washing buffer and were stored at -20°C as 
well as the suspension containing isolated catalase. 
X.12. Chicken antibody (IgY) purification 
X.12.1. Precipitation of IgY 
The egg yolk was diluted 1:5 (v/v) with dH2O and frozen at -20°C overnight. The next day the 
diluted egg yolk was allowed to thaw at RT and then frozen for a second time at -20°C 
overnight. After thawing, the aggregated egg yolk granules were sedimented by 
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centrifugation at 13,500 x g for 5 min at 4°C. The water-soluble fraction was then collected 
to precipitate the IgY and 0.67 volume of saturated ammonium sulfate solution (pH 7.5) was 
slowly added. After centrifugation at 10,000 x g for 5 min at 4°C the supernatant was 
discarded and the pellet dissolved in 1/10 volume dH2O. Thereafter, 0.67 volume of 
saturated ammonium sulfate solution was added and the mixture centrifuged (10,000 x g 
for 5 min). The pellet was dissolved in dH2O and dialyzed in PBS (see below). 
X.12.2. Dialysis of IgY sample 
To remove the ammonium sulfate from the IgY sample after precipitation, a dialysis 
procedure using PBS as a dialysate was performed. A Fisherbrand regenerated cellulose 
tubing was placed for 30 min in dH2O to remove storage solutions and rinsed. The sample 
was carefully loaded into a one-end closed dialysis tube. After removing the air from the 
tube, it was completely closed and placed in a beaker filled with PBS (100 times the sample 
volume). The sample was dialyzed at 4°C for 2 h under constant movement and then the 
dialysate was changed. Subsequently, the sample was allowed to dialyze overnight at 4°C. 
The next day the dialysate was changed again and after 2 more h of dialysis the antibody 
was removed, aliquoted and stored at -20°C. 
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Figure: X.1. Construct maps of catalase containing Sac I/Hind III or Nde I/Nde I restriction enzymes sites sub- 
cloned into the pGEM-T Easy vector 
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